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Chapter 1 
General Introduction 

GENERAL INTRODUCTION 
1.1 The human genome 
1.1.1 Organization 
The haploid human genome comprises approximately 3 billion 
base pairs (bp) of DNA and is estimated to contain 50,000-
100,000 genes. In diploid cells, the nuclear genes are 
distributed over 22 pairs of autosomes in addition to two X-
chromosomes in females and one X and one Y chromosome in 
males. The mitochondrial chromosome has a length of 16,569 bp, 
and is present in thousands of copies (approximately 10 per 
mitochondrion) in a diploid cell. Most genes located on 
nuclear chromosomes are interrupted by introns and are 
separated by long non-coding segments of DNA. Therefore, only 
about 2-5% of the DNA sequence is transcribed into mature 
RNAs. On the basis of reassociation kinetics, it has been 
estimated that approximately 60% of the nuclear genome is 
comprised of repeated sequence DNA. In contrast, the 
mitochondrial chromosome has a very high density of coding 
information; there are no introns, and there is very little 
non-coding DNA between genes (Anderson et al. 1981). 
1.1.2 DNA sequence variation 
While in general, DNA sequences that code for proteins are 
highly invariant, a remarkable degree of polymorphism has been 
found in non-coding single-copy sequences. The first DNA 
polymorphism of this kind was discovered in the 5' flanking 
region of the /3-globin gene by Kan and Dozy (1978) . 
Association of one of the marker alleles with the defect 
underlying sickle cell anaemia permitted, in an indirect way, 
the diagnosis of this disorder without testing for the sickle 
cell mutation itself (Little et al. 1980). In the early 
eighties a large number of anonymous DNA fragments, several of 
which identified RFLPs, were cloned. Such restriction fraepnent 
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length polymorphisms (RFLPs) are numerous, widespread in the 
genome, and segregate in a Mendelian manner. On average, the 
human genome shows sequence variation in every 100 to 1000 bp 
of DNA (Jeffreys 1979; Murray et al. 1984; Hofker et al. 
1986). Jeffreys and coworkers (1985) were the first to 
describe a marker system in which the polymorphism is due to 
variation in the number of tandem repeats of a 10-15 bp DNA 
sequence. Because most individuals will be heterozygous at 
such loci, these markers provide linkage data in almost all 
families. They were named minisatellite or "variable number of 
tandem repeat" (VNTR) markers, and isolated on a large scale 
by Nakamura and coworkers (1987). Recently, a variant on the 
VNTR marker system has been found, which is based on variable 
numbers of simple sequence motifs (VSSMs; Litt and Luty 1989; 
Smeets et al. 1989; Weber and May 1989). In the human genome 
there are 50,000-100,000 interspersed blocks of tandemly 
repeated CA-dimers, which, if uniformly spaced, will provide 
highly polymorphic markers every 30-60 kilobases (kb)(Weber 
and May 1989). 
1.1.3 The X chromosome 
The human X chromosome, as estimated from its DNA content and 
its length in metaphase spreads, comprises 5-6% of the haploid 
genome (Mendelsohn et al. 1973; Southern 1982), which 
corresponds to 160,000-200,000 kb. Studies in lower 
vertebrates, in particular Amphibians and Reptiles, have 
suggested that the X and Y chromosomes have evolved from a 
single pair of chromosomes. Ohno (1967) proposed that the sex 
chromosomes have evolved differently after the occurrence of a 
major inversion inhibiting meiotic crossing over in the 
inverted region and permitting a gradual genetic divergence of 
the two chromosomes. Only the tips of the short arms, the so 
called pseudoautosomal regions, have remained genetically 
identical (Burgoyne 1982). This region is probably needed for 
chromosome pairing and chiasma formation between X and Y, 
which is necessary for the proper distribution of the 
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chromosomes to the daughter cells during meiosls. Other 
regions of homology probably represent more recent events of 
DNA exchange between the X and Y chromosomes (Page et al. 
1984; Geldwerth et al. 1985). 
In the course of evolution, the Y chromosome has become 
largely dysfunctional. No more than 6 functional loci are 
known to be located on the short arm, namely two cell-surface 
markers, MIC2Y and Yg, ZFY, a gene encoding a zinc-finger 
protein involved in spermatogenesis (Page et al. 1987), SRY, a 
candidate gene for the testis determining factor (Sinclair et 
al. 1990), RPS4Y, a gene encoding a ribosomal protein (Fischer 
et al. 1990), and a gene encoding a granulocyte-macrophage 
colony stimulating factor (Gough et al. 1990). In addition, 
other gene(s) involved in spermatogenesis have been assigned 
to the long arm (Tiepolo and Zuffardi 1976). 
Parallel to the loss of Y-chromosomal genes, a dosage 
compensation mechanism evolved on the X chromosome, rendering 
one of the two chromosomes largely inactive in female somatic 
cells. Inactivation of one of the two X chromosomes takes 
place in all embryonic cells in a random fashion during the 
4th day of development, so that both X chromosomes are only 
active during oogenesis and the very early embryonic 
development (Gartler et al. 1975). The process of X chromosome 
inactivation is controlled by a cis-acting locus which maps to 
the Xql3 band (Mattel et al. 1981; Brown et al. 1991b). 
Recently, a candidate gene for X-inactivation control (XIST, X 
inactivation specific transcript) has been identified in the 
same band which is only expressed on the inactive X chromosome 
(Brown et al. 1991a). Initially it had been assumed that only 
genes that map (close) to the pseudoautosomal region escape X-
inactivation, such as the steroid sulphatase gene, MIC2X, and 
Xg. Recently however, several genes from other parts of the X 
chromosome have been found to remain active, too, on 
inactivated X chromosomes (Schneider-GMdicke et al. 1989; 
Brown and Willard 1990; Fischer et al. 1990). It is striking 
that all genes that have been shown to escape from 
inactivation, except for the RPS4X gene (Fischer et al. 1990) , 
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map to the short arm of the human X chromosome. Several of 
these genes may represent evolutionary recent acquisitions of 
the X, as suggested by their autosomal location in various 
marsupials (or 'non-placental' mammals; Sinclair et al. 1988). 
The X chromosome is known to contain a minimum of 160 genes 
and disease loci (McKusick 1990), several of which are 
depicted in Figure 1. Because of their distinctive inheritance 
patterns, X-linked traits have been identified earlier and in 
relatively larger numbers than autosomal traits (McKusick 
1990). The majority of X-linked diseases are only defined as 
clinical entities, while the underlying biochemical defects 
are unknown. Many of these defects have been regionally mapped 
STS 
ZFX 
DMD 
ppo 
ND CSNB1 
RP2 
XIST 
PGK 
TCD 
AS 
XLP 
HPRT 
FRAX 
NDI ALD 
Fig. 1. Map of the X chromosome showing the position of 
various genes and disease loci. STS = steroid sulphatase, ZFX 
= X-borne zinc-finger protein, DMD = Duchenne muscular 
dystrophy, RP2 and RP3 = retinitis pigmentosa type 2 and type 
3, ND = Norrie disease, CSNB1 = congenital stationary night 
blindness type 1, XIST = X inactivation specific transcript, 
PGK = phosphoglycerate kinase, TCD = tapetochoroidal 
dystrophy, AS = Alport syndrome, XLP = X-linked 
lymphoproliferative disease, HPRT = hypoxanthine 
phosphoribosyltransferase, FRAX = fragile (X) syndrome, NDI = 
nephrogenic diabetes insipidus, ALD = adrenoleukodystrophy 
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on the X through linkage studies with DNA markers. This has 
paved the way for the isolation of the relevant genes by 
positional cloning strategies (1.2). 
1.2 Gene mapping and positional cloning 
1.2.1 Genetic and physical mapping 
Conventional biochemical approaches to the cloning of genes 
underlying genetic disorders require that the fundamental 
biochemical defect and the structure of the relevant gene 
product are known. For most of the known Mendelian disorders 
of man, however, this information is not available. This 
explains why, at present, only a minority of the relevant 
genes have been cloned (McKusick 1990). An alternative 
approach, termed "positional cloning" or "reverse genetics 
strategy", aims at the isolation of these genes on the basis 
of their known (sub)chromosomal location. For the chromosomal 
assignment of gene defects, both genetic and physical methods 
have been employed. 
Linkage analysis makes use of large numbers of 
polymorphic DNA markers that have been isolated from the human 
genome. Approximately 150 highly informative markers, evenly 
spaced throughout the genome at a distance of 20 cM, are 
required to establish linkage (Botstein et al. 1980). For the 
X chromosome, approximately 10 evenly spaced informative 
markers suffice, in principle, to detect linkage with any 
given locus. Once linkage is established, additional markers 
can be employed to narrow down the location of the disease 
gene to one or a few centiMorgans (cM) from a polymorphic 
marker. More accurate estimation of genetic distances is 
seldomly possible, given the rarity of most Mendelian 
disorders and the limiting family sizes. 1-5 cM roughly 
correspond to 1,000-5,000 kb. Such a stretch of DNA is too 
large to be bridged by employing conventional lambda or cosmid 
cloning vectors, which can carry 20 and 40 kb of human DNA, 
respectively. 
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Physical mapping methods are based on the analysis of 
chromosomal aberrations, e.g. deletions or translocations, 
that are associated with recognizable genetic disorders. In 
this way, a far more precise localization of disease genes can 
be achieved. On the X-chromosome, numerous gene defects were 
found to be associated with interstitial deletions involving 
bands Xp22.3 (ichthyosis vulgaris, kallmann syndrome, 
chondrodysplasia punctata; Ballabio et al. 1989), Xp21 
(Duchenne muscular dystrophy [DMD], chronic granulomatous 
disease [CGD], McLeod phenotype, and retinitis pigmentosa 
[RP]; Francke et al. 1985), Xpll.3-pll.4 (Norrie disease; Gal 
et al. 1986b), Xq21 (choroideremia, deafness, mental 
retardation; Rosenberg et al. 1986, Hodgson et al. 1987), and 
Xq25 (X-linked lymphoproliferative disease; Wyandt et al. 
1989). A small number of X-linked diseases have been found to 
be associated with balanced x-autosomal translocations in 
females. Here, the clinical symptoms are due to disruption of 
the relevant gene and the fact that in balanced X-autosome 
translocations, the normal X chromosome is preferentially 
inactivated (Mattel et al. 1982). X-autosome translocations 
have facilitated the mapping, and in some cases cloning, of 
disease loci underlying Aicardi syndrome (Ropers et al. 1982) , 
Aarskog syndrome (Bawle et al. 1984), choroideremia (Kaplan et 
al. 1989; Siu et al. 1990; this thesis), DMD (Verrellen-
Dumoulin et al. 1984; Ray et al. 1985), Hunter's disease 
(Mossman et al. 1983), hypohidrotic ectodermal dysplasia 
(Gerald and Brown 1974; Zonana et al. 1988), Hypomelanosis of 
Ito (Hodgson et al. 1985), Lowe oculocerebrorenal syndrome 
(Hodgson et al. 1986), and Menkes syndrome (Kapur et al. 
1987). 
1.2.2 Positional cloning methods 
Several methods are available to bridge the gap between 
genetically or physically linked markers and a disease gene. 
Two of these methods have been employed in this study and will 
be discussed briefly. For chromosome jumping, large DNA 
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molecules (50-500 kb) are circularized and the junction 
fragments containing both ends of the DNA molecule are 
subsequently cloned in a lambda phage or plasmid vector. In 
this way, it is possible to circumvent insert size constraints 
of conventional cloning vectors which limit the distance that 
can be covered by individual chromosome walking steps. When 
the orientation of a given starting clone and the disease 
locus is known, each chromosome "jump" will result in a new 
clone 50-500 kb closer to the disease locus (Collins and 
Weismann 1984; Poustka and Lehrach 1986; Collins et al. 1987; 
Poustka et al. 1987). 
Preparative field inversion gel electrophoresis (FIGE) 
and pulsed field gel electrophoresis (PFGE) aim at the 
enrichment of large DNA fragments carrying the respective 
gene, preferably from a human/rodent cell hybrid containing 
only the human chromosome of interest. By establishing a DNA 
library from an enriched DNA fragment, human clones can be 
identified and isolated by screening with human DNA (Michiels 
et al. 1987; Anand et al. 1988). Following this strategy and 
employing new DNA markers as starting points for extensive 
chromosomal walking, one can ultimately obtain an overlapping 
set of lambda- or cosmid-clones from the critical region. 
The final step involves the identification and isolation 
of genes in the relevant chromosome segment. For this, two 
approaches have been widely employed. The first one is based 
on the expectation that exons are more stringently conserved 
during evolution than non-coding sequences. Therefore, exons 
can be identified by searching for non-repetitive DNA segments 
that detect homologous sequences in DNA from other vertebrate 
species. According to the second strategy, probes from the 
critical chromosome region are hybridized to Northern blots 
containing RNA from tissues in which the disease gene is 
expected to be expressed. Definite proof for the identity of a 
candidate gene must come from studies demonstrating its lack 
or aberrant expression in patients suffering from the disease. 
Chromosomal abnormalities have played a key role in 
positional cloning efforts which resulted in the isolation of 
19 
genes underlying retinoblastoma (Friend et al. 19вб), DMD 
(Monaco et al. 1986), CGD (Royer-Pokora et al. 1986), Wilms 
tumour (Call et al. 1990; Gessler et al. 1990), colon 
carcinoma (DCC, deleted in colon carcinoma; Fearon et al. 
1990), testis-determination (Sinclair et al. 1990), and 
neurofibromatosis type 1 (Cawthon et al. 1990; Viskochil et 
al. 1990; Wallace et al. 1990). In contrast, the regional 
assignment of the cystic fibrosis gene to chromosome 7q31, 
which formed the basis for its subsequent isolation (Kerem et 
al. 1989; Riordan et al. 1989; Rommens et al. 1989), was 
achieved exclusively through large scale RFLP linkage analysis 
(Tsui et al. 1985; Wainwright et al. 1985; White et al. 1985). 
1.3 Chorioretinal disorders 
1.3.1 Genetics of retinal dystrophies 
Retinitis pigmentosa (RP) is the name commonly given to a 
group of hereditary diseases characterized by progressive 
dysfunction of the photoreceptors, which is often followed by 
degeneration of other retinal cell layers. Visual impairment 
usually becomes manifest as night blindness, visual field 
loss, and, in some cases, central visual dysfunction. RP 
encompasses not only a large number of diseases that are 
confined to the eye, including classical RP and choroideremia, 
but also disorders involving other organs or tissues 
(Heckenlively 1988). Classical forms of RP can be inherited in 
an autosomal dominant (AD), autosomal recessive (AR), or X-
1inked (XL) mode. Until very recently, no biochemical defects 
were known for any of the RP-types. Therefore, several 
research groups have set out to localize different forms of RP 
employing both physical and genetic methods aiming at the 
isolation of the respective genes. 
McWilliam et al. (1989), employing a large Irish family, 
were the first to establish linkage between a type I AD-RP 
locus and the chromosome 3q locus D3S47 in the vicinity of the 
rhodopsin gene. With this knowledge at hand. Dryja and co-
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workers (1990) identified a point-mutation in codon 23 of the 
rhodopsin gene, in 17 of 148 unrelated ADRP patients. The 
point-mutation results in the substitution of a proline 
residue which is highly conserved among the opsins and related 
G-protein receptors (Applebury and Hargrave 1986). Dryja's 
finding indicates that the rhodopsin mutation is the cause for 
at least part of the AD forms of RP. The fact that no 
mutations in the rhodopsin gene have been found in the Irish 
ADRP family (Farrar et al. 1990a,b), together with recent 
evidence that there may be a gene locus at another position of 
Зд, indicate that at least one, and possibly several other 
genes, may be involved in AD-RP (A.Gal, personal 
communication) . 
It is likely that autosomal recessive RP is also 
heterogeneous, but linkage analyses have so far failed to 
identify the location of genes that give rise to 'classical' 
AR-RP. In the mouse, two genes underlying recessive retinal 
disorders, i.e. rds (retinal degeneration slow) and rd 
(retinal degeneration) , have been cloned and assigned to 
chromosomes 17 and 5, respectively (Travis et al. 1989; Bowes 
et al. 1990). The rds gene encodes a transmembrane protein 
which is located in the rod outer segment discs (Dr. G.H. 
Travis, personal communication) . The rd gene codes for the β 
subunit of the rod cGMP-phosphodiesterase (Bowes et al. 1990). 
Homologues of these genes could also play a role in the 
etiology of human AR-RP. A gene underlying Usher syndrome type 
II which is characterized by autosomal recessive RP and 
hearing loss, was localized recently to chromosome Iq through 
demonstration of linkage to anonymous DNA markers (Kimberling 
et al. 1990; Lewis et al. 1990) . So far, no candidate genes 
are known so far to lie in the vicinity of these markers. 
Usher syndrome type I families did not show linkage to the Iq 
marker indicating that this syndrome is not allelic to Usher 
type II. 
Linkage between DXS7, a X-chromosomal marker from pll.3, 
and XL-RP was first established by Bhattacharya et al. (1984). 
Subsequent analyses strongly suggested that there are at least 
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two different loci for XL-RP, one gene being just distal to 
OTC (Xp21.1; RP3, Fig. 1), and another gene located between 
DXS14 and DXZ1 (Xpll. 1-pll. 2 ; RP2, Fig. 1). There is evidence 
for even a third XL-RP locus, between DXS28 and DXS164 at Xp21 
(Ott et al. 1990). The location of an XL-RP locus at Xp21 was 
supported by a male patient, "BB", with XL-RP, DMD, CGD, 
McLeod phenotype and a deletion of Xp21 (Francke et al. 1985). 
1.3.2 Choroideremia 
Clinical features 
Choroideremia is a chorioretinal disorder which exhibits an X-
chromosomal pattern of inheritance (Goedbloed 1942; 
Waardenburg 1942; McCulloch and McCulloch 1948). The disease 
was first described by Mauthner (1872) who named the disease 
because of presumed congenital absence of the choroid. Later 
on, several investigators showed that the choroid is present 
in affected young males, and that this disease in fact is 
characterised by progressive degeneration of the retinal 
pigment epithelium (RPE), choroid, and retina. They considered 
the RPE to be the primary site of the defect, and therefore 
renamed this disorder tapeto-choroidal dystrophy (TCD) 
(Waardenburg 1958; Pameijer 1960). According to Heckenlively 
(1988) , TCD is the most frequent of all X-linked types of 
chorioretinal degeneration, with an estimated frequency of 1 
in 70.000 to 1 in 100.000. 
The complete clinical picture can only be seen in 
affected males. Carrier females show striking but much less 
pronounced fundus changes which, with a few exceptions, cause 
no obvious vision impairment. The clinical picture and rate of 
progression can vary between affected individuals from 
different families, but also within the same family. At an 
early stage, affected males show non-specific pigment mottling 
in the midperiphery. Gradually, there is atrophy of the RPE, 
which is accompanied or directly followed by atrophy of the 
capillaries of the choroid. These initial fundus changes cause 
a diffuse dysfunction of the photoreceptors, and as a result, 
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patients experience night blindness. The age of onset of 
symptoms ranges from 3 to 40 years, with a peak between 10 and 
30 (Rubin et al. 1966). Central visual acuity is normal and 
remains unaffected until late in the disease. At a later 
stage, outer retinal layers and large choroidal vessels become 
atrophic, first in the midperiphery, and progressing centrally 
towards the macular region. Consequently, vision deteriorates 
and progresses to so called "tunnel vision". Retinal veins 
appear normal, even in advanced stages, but retinal arteries 
can be somewhat attenuated (Bedell 1937; Cameron et al. 1987). 
Eventually, the entire fundus shows the yellowish-white reflex 
of the sclera, and about 35 years after the onset of symptoms, 
there is complete loss of vision (Rubin et al. 1966) . 
In female carriers, the expression of the disease is very 
variable. In the majority of cases, a characteristic mottling 
in the midperiphery or posterior pole can be observed, which 
closely resembles the fundus anomalies observed in affected 
young males (Pameijer et al. 1960; Krill 1967; McCulloch 
1969). The fundus signs in these carriers are more or less 
stationary, and visual function remains good. The patchy 
changes in the RPE of these females are thought to reflect 
random X-inactivation. In some female carriers, the visual 
field defect resembles that of middle-aged male TCD patients 
(Fraser and Friedman 1968; Harris and Miller 1968). 
Pathogenesis 
Fundus changes characteristic for TCD patients or carrier 
females have been observed in very early childhood (Kurstjens 
1965; McCulloch and McCulloch 1948). These findings suggest, 
but do not prove, that pathological processes have already 
started at, or even before, birth. The site of the primary 
lesion has been a subject of speculation since the disease was 
first described by Mauthner (1872). Pathologic studies have 
been hampered by the low incidence of TCD. The majority of 
donor eyes that have been examined showed an advanced or end-
stage of the disease thus providing no insight into the very 
early changes associated with TCD. Based on ophthalmoscopic 
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investigations in male patients and carrier females, the RPE 
appears to be the tissue that is affected first (Waardenburg 
1942; Pameijer 1960; Mcculloch 1969). The RPE already shows 
pigmentary changes at a stage when the choroid and retina are 
still normal. This finding was corroborated by fluorescence 
angiography studies, which can visualize RPE and 
choriocapillaris loss at a very early stage (Hammerstein et 
al. 1979; Hammerstein and Böhm 1985). 
As the fundus changes in carrier females resemble those 
of affected young males, some investigators believe that these 
changes provide a better clue to the early pathological 
processes. Light- and electron-microscopical studies performed 
on postmortem eyes of a 68 y old female carrier by Ghosh et 
al. (1988), disclosed a patchy loss of the retinal outer cell 
layer. Apart from a generalized thinning, the RPE only showed 
areas of depigmentation. The patches of altered tissue in 
retina and RPE were comparable in size. However, because of 
artificial detachment of the retina from the RPE/choroid, no 
conclusions could be drawn with respect to their spatial 
relation. No atrophy of the capillaries of the choroid could 
be seen, which prompted the authors to suggest that the 
primary defect should be located at the retina-RPE interface. 
A comparable study performed by Flannery and coworkers (1989) 
did not show such a strict correlation between areas of 
depigmented RPE and photoreceptor loss in the retina. In 
contrast, they observed that choroidal capillaries lying 
adjacent to abnormal receptor populations were reduced in 
number or practically absent. Those that were present in these 
patches showed reduced luminal diameter and sparse fenestrae. 
A location of the primary defect in the choroid has also been 
suggested by Cameron et al. (1987), who observed abnormalities 
throughout the entire uveal tract (choroid, iris, ciliary 
body) in a male TCD patient. Hypoproduction of the basement 
membrane of vascular endothelial cells was not only associated 
with loss of the RPE and retina in the posterior uveal tract, 
but also by loss of dilator muscle and flattening of the iris 
pigment epithelium in the anterior uveal tract. No age-matched 
24 
normal eyes were studied in parallel, which possibly could 
rule out uveal changes related to the age (66 y) of this 
individual. The inner retinal layers and RPE are nourished by 
the choroid, and hence, absence of the latter tissue would 
very likely result in the degeneration of the RPE and retina. 
Whether this holds also for the reverse situation in which the 
RPE or parts of the retina degenerate is more difficult to 
assess. 
In conclusion, postmortem eye studies have not provided 
conclusive evidence with respect to the location of the 
initial lesion, nor have they resulted in the identification 
of the biochemical defect underlying TCD. 
Localization of the TCP gene 
Although choroideremia was first described by Mauthner in 
1872, its X-linked mode of transmission was not established 
until 70 years later by Goedbloed (1942) and by Waardenburg 
(1942). Initial studies showed that TCD was not linked to the 
Xg blood group locus (Other et al. 1968; Bell and McCulloch 
1971) , which maps to the distal part of the short arm of the 
X-chromosome. More recent studies using DNA markers have 
localized TCD to Xql3-q22 near DXYSl (Lewis et al. 1985; 
Nussbaum et al. 1985). Subsequent studies showed that the TCD 
locus is closely, but not absolutely, linked to PGK1, DXS72, 
DXS95, DXYSl, DXYS5, and DXYS12 (Jay et al. 1986; Schwartz et 
al. 1986; Lesko et al. 1987; Sankila et al. 1987,1989; Wright 
et al. 1990). The combined lod score between DXYSl and TCD is 
32.3 at a distance of 3 cM (Davies et al. 1987). Due to 
relatively low recombination frequencies in the Xql3-q21 
region (Drayna and White 1985) it was very difficult to 
establish the position of the TCD locus with respect to the 
above mentioned markers. In a family that was informative for 
DXYSl, MacDonald and coworkers (1987) found 2 cross-overs in 9 
phase-known méioses. Both DXYSl and DXS3 showed recombination 
with the disease locus. Given the small genetic distance 
between both markers (0-5 cM, Drayna and White 1985; Lesko et 
al. 1987), this strongly argued against a location of the TCD 
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gene between DXYSl and DXS3. Placing TCD proximal to DXYS1 is, 
however, in apparent conflict with the order proposed by Gal 
et al. (1986a), who positioned the TCD locus distal to DXS3. 
Their gene order was based on haplotype analyses in two small 
families. On the basis of genotype information given for 
individuals of the pedigrees, a location of the TCD locus 
proximal to DXS3 is as likely as a position distal to this 
marker. Although genetic heterogeneity for TCD can not be 
strictly excluded, most data can be reconciled with only one 
TCD gene. 
An alternative approach for fine mapping of the TCD gene 
emerged with the identification of deletions in the Xq21 
region. The first deletion spanning part of Xq21 was described 
in 1983 by Tabor and colleagues in a male (NP) , who suffered 
from cleft lip and palate, agenesis of the corpus callosum, 
and severe mental retardation. After the discovery of linkage 
between DXYSl and the TCD locus (Nussbaum et al. 1985), NP and 
his family were reexamined ophthaImoscopically. His mother and 
sister were diagnosed as being carriers of TCD, while NP 
showed the typical fundus picture of a young male with TCD. 
Moreover, the deletion in his X-chromosome was shown to span 
DXYSl, corroborating the above mentioned linkage studies 
(Rosenberg et al. 1986, 1987; Schwartz et al. 1986). Three 
other microscopically visible deletions were found to be 
associated with TCD, mental retardation (MR), and in two cases 
(DM and XL62) with congenital deafness. Molecular analyses 
revealed that all microscopically visible deletions spanned 
DXYSl and several other markers from Xq21 (Hodgson et al. 
1987; Nussbaum et al. 1987; Schwartz et al 1988; Merry et al. 
1989) . 
By employing the so called 'phenol enhanced reassociation 
technique' (PERT), Nussbaum and coworkers (1987) were able to 
generate a library of cloned DNA enriched for sequences that 
were deleted in a patient with TCD, congenital deafness and MR 
(patient XL45; Ayazi 1981). Two markers were identified that 
were deleted in patient XL45 and in patient XL62 with a 
somewhat larger Xq21 deletion. The deletion in XL45 did not 
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span DXYSl, indicating that the TCD locus is not located in 
the direct vicinity of DXYSl. 
Recently, two balanced translocations have been found in 
females showing mild choroideremia. In both translocations, 
the breakpoint on the X-chromosome were situated in band 
g21.2, while the autosomal breakpoints were at 7pl4 and 13pl2, 
respectively (Kaplan et al. 1989; Siu et al. 1990). Apart from 
TCD, both females showed primary amenorrhea. The X-chromosomal 
breakpoint of the X/13 translocation could be positioned 
distal to the DXS165 locus, and proximal to the DXYSl locus 
(Merry et al. 1990). 
1.4 Outline of this thesis 
The initial aim of this study was the systematic search for 
microdeletions in patients with complex X-linked disorders 
employing more than 200 DNA probes. In the course of these 
investigations it became apparent that cytogenetically 
visible, male viable deletions were clustered in the two 
largest Giemsa-dark staining regions of the X, Xp21 and Xq21 
(chapter 2) . Closer inspection revealed that many of the 
deletions spanning parts of the Xq21 band were associated with 
choroideremia and less frequently with congenital deafness and 
mental retardation (chapter 3) . This finding prompted us to 
concentrate our studies on the molecular characterization of 
the Xq21 region and in particular, on the segment carrying the 
choroideremia gene. Therefore, the major part of this thesis 
deals with the fine mapping of the TCD gene region, and with 
our attempts to isolate this locus by means of positional 
cloning strategies (chapters 4 to 8) . These studies have 
culminated in the isolation and characterization of cDNA 
clones from a gene that overlaps this region and is a likely 
candidate for TCD (chapter 9). 
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Summary 
While performing a systematic search for chromosomal microdeletions in patients with clinically complex 
X-linked syndromes, we have observed that large male-viable deletions and duplications are clustered in 
heterochromatic regions of the X chromosome. Apart from the Xp21 band, where numerous deletions 
have been found that encompass the Duchenne muscular dystrophy gene, an increasing number of dele-
tions and duplications have been observed that span (part of) the Xq21 segment. To refine the molecular 
and genetic map of this region, we have employed 52 cloned single-copy DNA sequences from the Xcen-
q22 segment to characterize two partly overlapping tandem duplications and two interstitial deletions on 
the proximal long arm of the human X chromosome. Together with a panel of somatic cell hybrids that 
had been described earlier, these four rearrangements enabled us to order the 52 probes into nine different 
groups and to narrow the regional assignment of several genes, including those for tapetochoroidal dys-
trophy and anhidrotic ectodermal dysplasia. 
Introduction 
The practical value of X-linked DNA markers for diag-
nosis and molecular elucidation of X-linked gene defects 
is limited by two fundamental problems. First, accurate 
estimation of small genetic distances between a given 
pair of syntenic genes requires that their segregation 
pattern be studied in numerous large families. In the 
absence of recombination, several hundred doubly in-
formative individuals have to be examined to establish 
that the true genetic distance does not exceed 1 cen-
timorgan (cM). Given the rarity of most Mendelian dis-
orders, this implies that reliable estimation of the risk 
of recombination between a disease locus and a closely 
linked diagnostic marker is not possible. Second, there 
is no universally applicable formula to convert genetic 
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distances into physical distances, and, in general, even 
very small genetic distances are still too large to be 
bridged by conventional molecular cloning, bor a vari­
ety of X-linked defects, a solution to these problems 
has come from the analysis of clinically complex, 
X-linked syndromes that could be explained as small 
X-chromosomal deletions encompassing several genes 
and random DNA probes (Francke 1984; Lange et al. 
1985). Minute deletions have been employed very suc­
cessfully to identify useful diagnostic markers in the 
vicinity of the Duchenne muscular dystrophy (DMD) 
gene and elsewhere on the X chromosome, and dele­
tions have played a crucial role for the isolation, by re­
verse genetics strategies, of the genes for DMD (Monaco 
et al. 1985) and chronic granulomatous disease (Royer-
Pokora et al. 1986). 
In the course of family studies, our group encoun­
tered various microdeletions in patients with complex 
X-linked disorders (Gal et al. 1985, 1986; Wieringa 
et al. 1985д, 1985b). These findings encouraged us to 
perform a systematic search for minute deletions in clin­
ically complex X-linked syndromes by employing X 
chromosome-specific DNA sequences as probes. Since 
39 
several of the deletions that had been described were 
detectable by cytogenetic examination (Francke 1984; 
Irancke et al. 1985; Wieringa et al. 1985a, 1985fc), 
we speculated that, on average, deletions spanning sev­
eral genes might encompass at least 1 million bp. As­
suming that the human X chromosome comprises 200 
million bp, we reasoned that 200 random probes should 
suffice to detect more than 60% of all deletions span­
ning several X-chromosomal genes, and this convinced 
us that such a search would be economically and logisti-
cally feasible. Therefore, in collaboration with several 
European and American colleagues, we collected DNA, 
blood, or cell lines from patients with X-lmked syn­
dromes that could be interpreted either as combina­
tions of several X-lmked diseases or as known X-lmked 
disorders with additional clinical features. In parallel, 
numerous X chromosome-specific DNA probes were 
isolated and obtained from various laboratories, charac­
terized, and, if necessary, regionally assigned by em­
ploying a panel of somatic cell hybrids (Wieacker et 
al. 1984). 
While this work was in progress, several other male-
viable deletions were found (Tabor et al. 1983; Old et 
al 1985; Bartley et al. 1986; Hodgson et al. 1987; Nuss­
baum et al. 1987), and it became apparent that large 
deletions are not evenly distributed on the human X. 
Almost invariably, deletions that can be detected by 
cytogenetic analysis map within the two most promi­
nent, dark-staining Giemsa bands of the human X chro­
mosome, Xp21 or Xq21. Because dark Giemsa bands 
are thought to be relatively devoid of functional genes 
(Kurnit and Hoehn 1979), we speculated that in these 
regions male-viable deletions might be larger than av­
erage. It followed that the inverse might be true for the 
remainder of the X, suggesting that detection of dele­
tions outside these regions would require many more 
probes than originally anticipated. To some extent, this 
speculation was corroborated by the limited success of 
our deletion screening, which revealed only a single ad­
ditional deletion (P. Braakhekke, personal communi­
cation). Since significant further enlargement of the 
probe panel did not seem practicable, we felt that in­
stead we should concentrate on specific segments of the 
X and on complex syndromes comprising clinical fea­
tures of regionally assigned gene defects. In addition, 
we decided that, apart from deletion screening, we 
would employ the available probes for the molecular 
analysis of previously described structural rearrange­
ments of the X chromosome. The present paper de­
scribes the molecular analysis of male-viable deletions 
and duplications spanning several gene loa on the prox­
imal long arm of the X chromosome, as well as the 
fine-mapping of 52 cloned DNA sequences in the Xcen-
q22 segment. 
Material and Methods 
Clinical and Cytogenetic Data 
Patient C.N. (Cremers et al. 1987k) suffered from 
muscular hypotony, growth retardation, psychomotor 
retardation, cryptorchidism, and Pelizaeus-Merzbacher 
disease ( PMD) Cytogenetic and molecular analyses re­
vealed a duplication of the Xq21-Xq22 segment, result­
ing from unequal crossing-over between the two mater­
nal X chromosomes. 
Patient K.M. (Veierslev et al. 1985) showed psycho­
motor retardation, cryptorchidism, and various minor 
congenital malformations. Cytogenetic analysis sug­
gested an inherited tandem duplication of the Xql3.1-
q21.2 segment, but an insertion of autosomal matenal 
into the proximal long arm of the X chromosome could 
not be excluded. 
Patient N.P. (Tabor et al. 1983) had cleft lip and pal­
ate (CLP), agenesis of the corpus callosum, and mental 
retardation. At the age of 5, retinal changes indicative 
for choroideremia were observed (Rosenberg et al. 1986; 
Schwanz et al. 1986). Cytogenetic and molecular ex­
amination showed an Xq21.1-q21.33 deletion which 
spanned the DXYS1 locus and was also present in N.P.'s 
mother (Rosenberg et al. 1986). 
Patient R.v.D. is a mentally retarded boy with con­
genital heart defect (VSD), facial and skull deformi­
ties, frontal lobe atrophy, and various minor anoma­
lies. His hearing is severely impaired (up to 75 dB), but 
even at the age of 10 ophthalmologic examination 
yielded no clinical signs of choroideremia. Chromo­
some analysis revealed an interstitial deletion encom­
passing a large portion of the Xq21 band and possibly 
part of band Xq22 (fig. 1). The same deletion was found 
in his mother who, like R.v.D., has a normal ocular 
fundus (J. Beverstock, personal communication). 
Southern Blot Analysis 
Chromosomal DNA from peripheral blood, Epstein-
Barr virus-immortalized В cells, or fibroblast cell lines 
was isolated according to the method of Aldndge et 
al. (1984), with minor modifications. Restriction en-
donuclease-cleaved chromosomal DNA was resolved 
electrophoretically on a 0.7% (w/v) agarose gel. Fol­
lowing depunnation in 0.15 N HCl for 10 mm, DNA 
was denatured in 0.4 N NaOH and blotted onto a ny-
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F i g u r e I Cytogenetic analysis of the X chromosome of anor­
mal male (α) and R.v.D. {b). GTG-banding reveals an interstitial de­
letion within Xq21, possibly extending into Xq22. 
Ion membrane (BioTrace,· Gelman Sciences, Inc.), using 
the same solution. Probe insert DNAs were isolated from 
low-gel-temperature agarose gels and labeled by primed 
synthesis with Klenow DNA polymerase I and a-32P-
dCTP, as described by Feinberg and Vogelstem (1983, 
1984). Prehybndization of the DNA blots was done 
at 65 С for 6-18 h in 6 χ SSC, 0.1% (w/v) BSA, 0.1% 
(w/v) Ficoll, 0.1% (w/v) polyvinylpyrrolidone, 10% 
(w/v) dextran sulfate, 0.2% (w/v) SDS, and 250 μg soni­
cated, single-stranded herring sperm DNA/ml. Hybrid­
ization was performed for 16-20 h at 65 С in the same 
solution at a probe concentration of 1-3 ng/ml (2-5 
χ 108 cpm 32P/Mg). Washing was done at 65 С with 
stringencies increasing stepwise from 2 χ SSC/0.5% 
(w/v) SDS to 0.1 χ SSC/0.5% (w/v) SDS. Filters were 
rinsed in 2 χ SSC and exposed to Kodak X-Omat film 
for 8 h-3 days at - 80 C, using two intensifying screens. 
(so/ation of Single-Copy Sequences from Repetitive Probes 
For some probes containing low or moderately repeti­
tive X-chromosomal inserts, various insert segments 
were tested to obtain unambiguously interpretable hy­
bridization patterns for signal density scanning. To this 
end, 2 μg of plasmid DNA was digested with en-
donuclease SauiA and fragments were separated on a 
1.5% (w/v) low-gel-temperature agarose gel. Distinct 
nonvector fragments were isolated, labeled with a-32P-
dCTP as described above, and hybridized to EcoRl-
digested human control DNA. Unique sequences of 
probes pXG8b (0.6 kb), pXG12 (1.3 kb), p722 (1.2 kb), 
p776 (0.4 kb), and pTAK2 (1.4 kb) subsequently were 
used in the analysis of the rearrangements throughout 
this study. Occasionally, as for probes pX65H7, pX104f, 
pFl, and pF8, which failed to yield single-copy Sau3A 
subfragments, labeled insert DNAs were prehybridized 
to sheared human DNA (Cot = 3,600 mg χ min/ml), 
essentially as described by Litt and White (1985), to 
reduce background hybridization. 
Dosoge Determ/notion 
Signal intensities were quantitated using an LKB 2202 
Ultroscan Laser Densitometer (scan speed 20 mm/mm, 
focus 50 tim). Hybridization signals obtained with 
probe p8 (DXS1), probe p708 (DXS82), or Y-specific 
signals (i.e., the 15-kbp Taql band deteaed with pDP34 
[DXYSl]) were used as internal references, and signal 
ratios were normalized through comparison with ra­
tios of male control DNA. Values ranging from 0.7 to 
1.3 and from 1.7 to 2.3 were considered to represent 
one or two copies, respectively, of the relevant DNA 
sequence. 
Results 
All 52 X-specific probes employed in this study, as 
well as their map positions, are listed in figure 2. For 
several of these, regional assignments have been reported 
elsewhere (Chance et al. 1983; Goodfellow et al. 1985; 
Willard and Riordan 1985; Riddell et al. 1986; Cremers 
et al. 1987fc, 1987c). Others were regionally mapped 
by making use of a cytogenetically reanalyzed subset 
of the hybrid cell lines originally described by Wieacker 
et al. (1984). Recent reexamination of the breakpoint 
in hybrid 749, formerly given as Xql2 (Gerald and 
Brown 1974), has indicated that it may be at the inter­
face of bands ql2 and ql3 or even at ql3.1 (J. Zonana, 
personal communication). Therefore, the positioning 
F i g u r e 2. Signal dosage determination of hybridization intensities for probes located in the proximal Xq region. Horizontal lines 
indicate the cytogenetic assignment of the various breakpoints employed in this study. Lines with arrowheads at the right indicate the break­
points in the hybrid cell lines, whereas lines without arrowheads indicate duplication and deletion breakpoints. The order of probes within 
each segment is arbitrary. The regional assignments of probes given in the third column refer to (a) the present study, (b) Cremers et al. 
(1987fc), (с) Goodfellow et al. (1985), (d; Chance et al. (1983), (e) Willard et al. (1985), (f) Riddell et al. (1986), and (g) Willard and Riordan 
(1985) Probes cpX8, cpX12, cpX58, cpX205, cpX210, and cpX251 were isolated by one of us (M.H.H ); pXG8b was a gift from P. Szabo, 
New York; pFl and pF8 were provided by T. A. Kruse, Aarhus. Quantitation of signal intensities was as described m Material and Methods. 
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of this breakpoint in figure 2 may be somewhat arbitrary, 
and the same applies to the hybrid 676 χ 175K37 
breakpoint, whose exact location within band Xq22 
is not known. 
Molecular analysis of the Xq-proximal rearrange­
ments enabled us to define a total of six new intervals 
spanning this chromosome area. Results from hybrid­
ization with representative probes from within each of 
these intervals are shown in figures 3a and 3b. Figure 
2 summarizes the quantitation data obtained from den-
sitometnc scanning analysis. Out of the 52 sequences 
tested, 19 were duplicated in K.M.'s DNA. Therefore, 
in accordance with the cytogenetic findings of Vejers-
lev et al. (1985), these probes were tentatively assigned 
to the Xql3.1-q21.2 segment. In C.N., 28 probe se­
quences could be assigned to the duplicated Xq21.1-
q22.3 segment. Two of these, pX65H7 (DXS72) and 
pX104f (DXS169), were also duplicated in K.M., which 
indicated that there is a small but detectable overlap 
between these duplications. As is shown in figure 3b, 
an extremely complex array of bands of single and dou­
ble intensities was obtained with probe pHPGK-7e 
(PGK1). Of these, the 1.0- and 5.0-kbp signals, which 
originate from chromosome 19 and chromosome 6, 
respectively (Gartler et al. 1985), were used as refer­
ence signals for quantitation of X-signal dosage. The 
X-specific signal at 7.6 к bp is partly obscured by a sig­
nal of identical size originating from chromosome 6 
(Michelson et al. 1985). I-urthermore, the X-specific 
signals at 0.6, 2.7, and 5.5 kbp represent two loci at 
proximal Xq, namely, the PGK1 gene at ql2-ql3 and 
a PGK pseudogene (РСКШ), tentatively assigned to 
qll-ql2 (Chance et al. 1983; Willard et al. 1985). As 
can be inferred from the au to radiograph, clearly all 
X-specific PGK signals were found to be of double in­
tensity in K.M.'s DNA but not in C.N.'s DNA. We have 
confirmed this result by a similar analysis using restric­
tion enzyme EcoRI to distinguish between the authen­
tic and the pseudo-PGK signals from Xq (not shown). 
In a previous study (Cremers et al. 1987b), we had 
concluded that the two X/Y homologous sequences, 
DXYS1 and DXYS5, one of which had been assigned 
previously to the interface of bands Xql3 and q21 (Page 
et al. 1984), map proximal to the duplicated DNA seg­
ment of patient C.N. Still, neither of the two was found 
to be located on the duplicated segment of patient K.M. 
Critical reexamination of our previous results indicated 
that, contrary to that previous report, all four X-Y ho­
mologous loci tested (i.e., DXYS1, DXYS5, DXYS12, 
and DXYS13) map inside the C.N. duplication and thus 
more distally than had been indicated previously. 
This is corroborated by the failure of all four probes 
to yield X chromosome-specific hybridization signals 
in the DNA of the two deletion patients, N.P. and R.v.D. 
(figs. 2, 3a). In N.P., cytogenetic analysis had revealed 
a large deletion spanning the q21.1-q21.33 segment (Ta­
bor et al. 1983; Rosenberg et al. 1986), and, m R.v.D., 
there was cytogenetic evidence for a deletion encom­
passing part of Xq21 and q22 (see Material and Methods; 
J. Beverstock, personal communication). Our hybrid­
ization experiments suggest that the R.v.D. deletion is 
slightly larger than the N.P. deletion. The former spans 
19 and the latter 15 DNA loci, all of which are located 
on the segment that is duplicated in patient C.N. Both 
deletions overlap the K.M. duplication, as evidenced 
by the fart that they encompass two markers, pX65H7 
(DXS72) and pX104f (DXS169), which are duplicated 
in the DNA of patient K.M. In contrast, none of the 
four markers that are deleted in R.v.D. but not in N.P.— 
i.e., pXG3b (DXS96), p776 (DXS118), pFl, and p F 8 -
are duplicated in this patient. This indicates that all 
of these four markers are situated at the distal end of 
the R.v.D. deletion. As yet we have not identified probes 
that distinguish between the proximal endpoints of the 
two deletions and the C.N. duplication in the vicinity 
of the Xql3.3-q21.1 boundary. 
Previous studies had indicated that, probably as a 
result of unequal crossing-over between the two mater­
nal X chromosomes, C.N. is heterozygous for several 
polymorphic DNA markers from the proximal Xq 
(Cremerset al. 1987fc). In K.M., the search for hetero­
zygosity was unsuccessful with four probes—cpX203 
(DXS106), cpx289 (DXS162), cpX93 (DX135), and 
pHPGK-7e (PGK1)—all located on the duplicated seg­
ment and known to detect two-allelic RFLPs. Given the 
frequencies of the rare alleles —frequencies that are .35, 
.33, .06, and .40, respectively—the probability of two 
different X chromosomes carrying identical alleles at 
all four loci tested is about 14%. Therefore, our findings 
suggest that the K.M. duplication did not arise by une­
qual crossing-over but by a different mechanism. 
Discussion 
Owing to their dual function as genetic and physical 
signposts, DNA markers play an essential role in the 
construction and alignment of genetic and physical 
chromosome maps. While the goal of covering all hu­
man chromosomes with a network of closely linked 
DNA markers has almost been reached (Donis-Keller 
et al. 1987; Nakamura et al. 1987), the accuracy of 
the physical map is still hampered by the limits of 
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Figure 3 Southern blot analysis of genomic DNAs from patients with rearrangements at proximal Xq, using probes from within several 
intervals in the Xpll-Xq24 area, a, For all probes hybridization analysis was on Eco RI-digested (except for pDP34, which was digested 
with Taql) genomic DNA of two controls (male and female) and four patients. Relevant sections from the various autoradiographs are arranged — 
according to the position of the probe—from proximal to distal (compare with fig. 2). fc, Southern analysis using probe pHPGK-7e (PGK1). 
DNAs of patients and controls were digested with restriction enzyme Hmdill. The chromosomal localisation of various X- and autosome-
specific signals is indicated to the right. Size markers are given to the left. 
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cytogenetic resolution. Here we report on our attempt 
to correlate the size of two deletions and two duplica­
tions on the proximal long arm of the X chromosome 
with the presence or absence of specific single-copy 
DNA sequences. This has enabled us to define the end-
points of the duplicated or deleted segments and to refine 
the assignment of numerous DNA probes that had been 
mapped previously by employing a panel of somatic 
cell hybrids (Wieacker et al. 1984). 
Probes in the Xcen-Xq22 region could be ordered 
into nine segments defined by eight discernible chro­
mosome breakpoints (see fig. 2). This is two less than 
expected because the proximal borders of the deletions 
and of one duplication appear to coincide: all three are 
located between the DXS227 and DXS169 loci. Apart 
from coincidence, which seems highly implausible, or 
enhanced proneness of this region to chromosome 
breakage, for which there is no evidence, it is possible 
that DNA sequences from the chromosome segment 
that harbors these breakpoints may be underrepresented 
in our panel of probes. Alternatively, it is conceivable 
that there are functional constraints that prohibit a small 
region near the border of band Xql3 and Xq21 from 
being deleted or duplicated (although, for duplications, 
these constraints cannot be absolute because there is 
a small but detectable overlap between the two dupli­
cations: both encompass DXS72 and DXS169) 
Though there is no evidence for obvious clustering 
or scarcity of probes within the Xcen-q22 segment, this 
possibility cannot be ruled out, because several of the 
breakpoints given may not be precisely defined owing 
to the limited resolution of conventional cytogenetic 
analysis Indeed, the recent observation (J. Zonana, per­
sonal communication) of a more distal localization of 
the breakpoint in hybrid 749 is supported by the fact 
that nine probes that map proximal to this breakpoint 
are still comprised in the duplicated Xql3.1-Xq21.2 seg­
ment of patient K.M. (Vejerslevet al. 1985, see fig. 2). 
Whether these nine probes are derived from nine differ­
ent loci is, however, questionable, as all probes except 
cX37.1 were subcloned from pooled cosmids (Hofker 
et al. 1987). Nonetheless, based on the molecular anal­
ysis, our data suggest a more proximal location of the 
duplicated DNA segment in patient K.M. (Xql2.2-
q21.1; see fig. 2). It is interesting that the 749 break­
point may be located within the locus for AED since 
this hybrid had been originally established from fibro­
blasts of a female with an X-autosome translocation, 
t(X;9) (ql2;p24) and AED (Grzeschik and Siniscalco 
1976; Κ H. Grzeschik, personal communication). This 
would imply that the anhidrotic ectodermal dysplasia 
locus is flanked by the phosphoglycerate kinase (PGKl) 
gene and the PGK pseudogene (PGK1P1), which map 
distal and proximal to this breakpoint, respectively 
(Chance et al. 1983; see fig. 2). 
Recently, Arveiler et al. (1987i>) have presented a 
refined genetic map of the Xqll-q22 region which in­
cludes several of the probes dealt with in the present 
study. Our results are in keeping with their data, ex­
cept for two loci. According to Arveiler et al., the DXS72 
locus maps distal to the sequences within band Xq21 
that show homology to the Y chromosome. In contrast, 
our study assigns this marker proximal to these X-Y 
homologous sequences, and this assignment is corrobo­
rated by linkage studies which point to a location prox­
imal to the DXYS1 marker (B. van Oost, personal 
communication). Second, there is an inconsistency 
pertaining to the regional assignment of the DXS159 
locus (probe cpX73). Using the same somatic cell hy­
brid line (749 or ANLY1), Arveiler et al place this 
marker proximal to the breakpoint while we have 
mapped it to the distal side. This discrepancy can only 
be resolved by assuming that Arveiler et al. have em­
ployed a different probe. In fact, this probe sequence 
detects a Psfl polymorphism (Arveiler et al. 1987a), 
whereas DXS159 is not polymorphic for this enzyme 
(M H.H , unpublished data). 
Because of the strikingly different phenotypes as­
sociated with the two deletions studied, N.P. and R.v.D., 
it is tempting to speculate that they encompass several 
different genes. In part, this is corroborated by the 
cytogenetic finding that the R.v.D. deletion extends into 
the q22 band while the N P. deletion is confined to q21 
(Tabor et al. 1983; Rosenberg et al. 1986). Our hybrid­
ization studies confirm these findings by defining four 
sequences-pXG3b (DXS96), p776 (DXS118), pFl, and 
pF8 — that are only absent in the larger of the two dele­
tions. These findings may account for the presence of 
deafness in patient R.v.D. and its apparent absence in 
patient N.P. Deafness due to stapes fixation is a well-
known X-lmked disorder (McKusick 30440; Cremers 
et al. 1985), and the gene responsible for this disorder 
has recently been assigned to the proximal long arm 
of the X chromosome by demonstration of linkage to 
the DXYS1 marker (H. G. Brunner, personal commu­
nication). Deafness with stapes fixation has also been 
described in another patient with a deletion encom­
passing part of the Xq21 band (Ayazi 1981; Nussbaum 
et al. 1987). 
Presence of CLP, agenesis of the corpus callosum, 
and choroideremia in patient N.P.—and the absence 
of these features in R.v.D., the patient with the larger 
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deletion —points to the possibility that the N.P. dele­
tion may extend farther proximal than the R.v.D. dele­
tion, a possibility for which cytogenetic analysis pro­
vides some support. This would further substantiate 
our speculation that there is a gap in our probe panel 
and may assign the genes responsible for these differ­
ences to the segment between these two breakpoints. 
In particular, this may apply to a gene involved in the 
etiology of CLP, since linkage studies have recently 
mapped a cleft palate gene to the same chromosome 
region (Moore et al. 1987). On the other hand, dele­
tions of the X-lmked CLP gene may not always give 
rise to CLP. Indeed, CLP has not been found in any 
of the other large Xq21 deletions that have been de­
scribed (Hodgson et al. 1987; Nussbaum et al. 1987). 
In contrast, tapetochoroidal dystrophy (TCD) has been 
observed repeatedly and is an almost constant feature 
of these deletions. Comparison of the relevant chro­
mosomal breakpoints has provided clear evidence that 
TCD cannot be located near the interface of Xql3 and 
Xq21 but should map farther distal, probably within 
the Xq21.1-q21.2 segment (F.P.M.C, unpublished data). 
Therefore, it is likely that the TCD gene is deleted in 
R.v.D., too, and that the absence of clinical signs in 
this patient may be a consequence of his young age. 
These examples illustrate the mutual usefulness of 
(1) DNA probes for the genetic and molecular charac­
terization of chromosomal rearrangements and (2) du­
plications and deletions for the fine-mapping of probes. 
The precise regional assignment and ordering of 52 
cloned DNA sequences from the proximal long arm 
of the X chromosome into nine different groups should 
provide the framework for the construction of a con­
tiguous molecular map of this chromosome segment 
by field-inversion gel electrophoresis (FIGE; Carle et 
al. 1986) or related techniques. Moreover, the align­
ment achieved between the physical and the genetic map 
should facilitate the precise regional assignment of other 
genes and gene defects in this region. Known physical 
distances and gene orders will permit a more directed 
search for highly informative diagnostic markers, which 
appear to be less abundant on the X than on other hu­
man chromosomes (Hofkeret al. 1986); and this infor­
mation should be a great asset for the isolation of genes 
by chromosome walking and hopping strategies. For 
TCD, we have already been able to confirm this predic­
tion by defining a DNA sequence in the immediate vi­
cinity of the choroideremia gene, as evidenced by the 
fact that this sequence is deleted in two of eight TCD 
patients tested (Cremers et al. 1987д). Future research 
in our laboratory will concentrate (1) on the physical 
mapping of the TCD gene region by employing FIGE 
and related techniques and, eventually, (2) on the iso­
lation of the TCD gene itself. 
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Characterization of several male-viable deletions 
and duplications with 20 random DNA probes has en­
abled us to subdivide the Xq21 region into seven dis­
cernible intervals. Almost all of the deletions spanning 
part of Xq21 are associated with choroideremia and 
mental retardation, with deafness being another com­
mon feature. The gene locus for choroideremia was 
assigned to Interval 3 spanning the loci DXS95, 
DXS16S, and DXS233. Genes for X-linked deafness 
and mental retardation were tentatively assigned to 
interval 2. Deletions of intervale 4 through 7 were not 
associated with any clinical abnormality. We have 
constructed a preliminary long-range restriction map 
of intervals 2 and 3 using field-inversion gel electro­
phoresis. The DXS232, DXS121, and DXS233 loci are 
located on the same Sfil fragment, whereas the 
DXSiee and DXS9S loci could not be linked to this 
Cluster UBing Sfil and Sail. С lese Academic Pre», Ine 
INTRODUCTION 
Choroideremia is an X-linked retinal dystrophy in 
which affected males suffer from progressive night 
blindness and visual field constriction, leading to 
blindness by the third to fourth decade of life (Goed-
bloed, 1942; Waardenburg, 1942; McCulloch and 
McCulloch, 1948; Sorsby et al., 1952). Female earners, 
although normally asymptomatic, can be detected by 
characteristic patchy changes in the retinal pigmented 
epithelium that reflect random X inactivation. 
The gene locus for choroideremia (tapetochoroidal 
dystrophy: TCD) has been assigned to the proximal 
long arm of the X chromosome through demonstration 
of tight linkage with various restriction fragment length 
polymorphisms (RFLPs) all of which are located in the 
Xql3-q21 region (Nussbaum et ai, 1985; Schwartz et 
^о whom reprint requeete should be addreeaed 
al., 1986; Sankila et aL, 1987; Lesko et al., 1987). More 
accurate mapping of the TCD gene has been hampered 
by relatively low recombination frequencies which are 
characteristic of this part of the X chromosome 
(Drayna and White, 1985; Lesko et aL, 1987; Arveiller 
et ai, 1987). 
Recently, a solution to this problem has come from 
the analysis of a number of male-viable deletions span­
ning part of the proximal Xq region that were found 
to be associated with TCD and other features. Clinical, 
cytogenetic, and molecular characterizations of these 
deletions have allowed the isolation (Nussbaum et ai, 
1987) and physical mapping of markers located in the 
close vicinity of the TCD locus (Schwartz et al, 1986, 
1988; Hodgson et al, 1987; Cremers et ai, 1988). So 
far, however, the number of probes employed in each 
of these studies was too small compared with the size 
of the deletions to permit accurate physical mapping 
of the TCD gene itself. Moreover, none of the previous 
analyses dealt with more than two TCD deletions, 
which ruled out direct comparison and the definition 
of the smallest region of overlap. 
Recently, we have ordered a total of 52 polymorphic 
and nonpolymorphic DNA probes on proximal Xq by 
making use of somatic cell hybrids and large interstitial 
duplications and deletions. These studies enabled us 
to assign the TCD gene, as well as 19 of these probes, 
to the Xq21 band (Cremers et ai, 1987a, 1988). In the 
present study we have employed all available Xq21 
markers to characterize four additional TCD deletions 
that have been described previously (Hodgson et ai, 
1987; Nussbaum et al., 1987; Schwartz et al., 1988). In 
this way, these probes could be assigned to several dif­
ferent intervals of the Xq21 band. Moreover, these 
analyses permitted accurate and unambiguous assign­
ment of the TCD gene. In addition, small chromosomal 
regions that seem to play a role in the etiology of X-
linked deafness and X-linked mental retardation could 
be defined. Finally, the large number of available probes 
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enabled us to construct a preliminary large-scale re-
striction map surrounding the TCD locus using field-
inversion gel electrophoresis (FIGE). 
MATERIALS AND METHODS 
Cytogenetic and Clinical Data 
Table 1 summarizes the cytogenetic findings in the 
patients who were investigated in this study. Patient 
CN suffered from muscular hypotony, growth retar-
dation, psychomotor retardation, cryptorchidism, and 
Pelizaeus-Merzbacher disease (Cremers et aL, 1987a). 
Patient KM showed psychomotor retardation, crypt-
orchidism, and various minor congenital malformations 
(Vejerslev et aL, 1986; Cremerà et aL, 1988). Patient 
RvD is a mentally retarded boy with congenital heart 
defect (VSD), facial and skull deformities, frontal lobe 
atrophy, severe hearing loss (up to 75 dB), and various 
minor anomalies (Cremers et aL, 1988). Patient NP 
showed TCD, cleft lip and palate (CLP), agenesis of 
the corpus callosum, and severe mental retardation 
(Tabor et al., 1983; Rosenberg et aL, 1986; Schwartz et 
aL, 1986,1988). Patient MBU is a mildly retarded boy 
suffering from TCD (Hodgson et aL, 1987). Neither 
patient MBU nor patient NP is deaf. The unrelated 
patients XL62 and XL46 suffer from TCD, mental re-
tardation, and congenital sensorineural deafness (Ay-
azi, 1981). Patient DM was diagnosed as having TCD, 
congenital sensorineural deafness, and mental retar-
dation (Schwartz et aL, 1988). 
DNA Markers 
All probes employed in this study are listed in Fig. 
1. The regional assignments based on structural X-
chromosomal abnormalities (translocations, duplica-
tions, deletions) have been published elsewhere 
(Goodfellowetoi, 1985; Nussbaum etaL, 1987; Cremere 
et al., 1987a, 1988). Probe pXG8b was kindly provided 
TABLE 1 
Summary of Cytogenetic Data 
Patient 
CN 
KM 
MBU 
N P 
RvD 
XL62 
DM 
X U 6 
Rearrangement 
Duplication 
Duplication 
Deletion 
Deletion 
Deletion 
Deletion 
Deletion 
Deletion 
Cytogenetic 
aaeignment 
q21.1-q22.3 
ql2-q21.1 
q21· 
q21.1-q21.33 
q21.1-q22.1 
q21· 
q21.2-q21.31 
q2 l ' 
Reh. 
(8, 10) 
(10, 42) 
(20) 
(10, 32. 39) 
(10) 
(30) 
(37) 
(30) 
' Accurate locations of deletion breakpointa were not establiahed. 
6
 Submicroecopic deletion (30). 
by P. Szabo, New York; pFl and pF8 were gifts from 
T. A. Kruse, Aarhus. 
Southern Blot Analysis 
Chromosomal DNA was isolated according to Ald-
ridge et al. (1984), with minor modifications. DNA (10 
ßg) was digested with the appropriate restriction en-
zyme(s), and fragments were resolved by electropho-
resis and blotted on to Biotrace (Gelman Sciences Inc.) 
or GeneScreen Plus (NEN) membranes as described 
previously (Cremers et al., 1988). Radioactive probes 
were prepared by random oligonucleotide priming 
(Feinberg and Vogelstein, 1983,1984). Insert DNA was 
electrophoretically separated from plasmid vector and 
isolated from low-gelling-temperature agarose. Meth-
ods for (pre)hybridization and washing of filters have 
been published previously (Cremere et al., 1988). 
FIGE Analysis 
Preparation of high-molecular-weight DNA in aga-
rose blocks, restriction enzyme digestion, and FIGE 
gel electrophoresis were performed as described by Van 
Ommen and Verkerk (1986) and Carle et aL (1986). In 
brief, cells of the human cell line LCL127 containing 
four X chromosomes were embedded at a concentration 
of 7.5 X 10e cells/ml in 0.6% low-gelling-temperature 
agarose (0.3 X 10e cells/block). Blocks were incubated 
in 0.5 M EDTA (pH 8.0)/l% (w/v) sodium lauroyl ear-
cosine, 0.5 mg/ml proteinase К at 50°C for 48 h; washed 
several times with distilled water, twice with 10 mM 
Tris-HCl/0.5 mM EDTA (pH 8.0) (TE) plus 0.1 mM 
PMSF for 2 h, twice with ТЕ for 2 h; and stored in 0.5 
M EDTA at 4°C. Digestions were performed with 30-
45 U of enzyme for 5 h in a volume of 100 μΐ. Blocks 
were washed in TE and transferred to preformed slots 
of a 1% (w/v) agarose gel. Gels were run in 0.5X TBE 
buffer (Van Ommen and Verkerk, 1986) for 22 h at 
6°C and 160 V. Switching intervale increased linearly 
from 6 to 60 β for the forward phase and from 2 to 20 
в for the reverse phase. 
After staining with ethidium bromide, gels were 
photographed and prepared for DNA transfer by se­
quential incubation in 0.15 M HCl for 2X 10 min, 0.5 
N NaOH/1.5 M NaCl for 2X 30 min, and 0.5 M Tris-
HC1, pH 7.5/1.5 M NaCl for 2X 30 min. Transfer to 
Hybond-N membranes (Amersham) was performed in 
10X SSC overnight. Binding of DNA and rehybridi-
zation were performed as recommended by the man­
ufacturer. 
RESULTS 
Molecular Analysis of X-Linked Deletions and 
Duplications 
Twenty DNA probes, all of which derived from the 
Xq21 segment, were employed to localize the break-
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FIG. 1, Duplication and deletion map of the Xq21 band. Du­
plicated and deleted segments are indicated hy vertical lines and 
breakpoints by arrowheads. T h e ordering of probes within each in-
terval is arbitrary, except for the probes pJL68, p784, and pJL8, 
which are positioned in accordance with the results of FIGE analysis 
(Fig. 3). 
points and to compare the sizes of two tandem dupli­
cations and six interstitial deletions spanning parts of 
the Xq21 band. In patients CN and KM, the copy 
numbers of the corresponding genomic sequences were 
determined by Southern blot hybridization. Signal 
dosage was quantitated by laser densitometry of the 
autoradiographs, as described previously {Cremers et 
al, 1987a). CN and KM have large, partly overlapping 
duplications which share a small segment of Xq21.1, 
including the DXS72 and DXS169 loci, and extend 
into Xq22.3 and Xql2, respectively (Cremers et al., 
1987a, 1988; see also Fig. 1). The DNA of the six dele­
tion patients was tested for the presence or the absence 
of hybridization signals. In this way, the available 
probes allowed us to subdivide the Xq21 band into 
seven separate intervals, as illustrated in Fig. 1. It is 
noteworthy that several of the breakpoints appear to 
coincide. We cannot distinguish between the proximal 
borders of three deletions (RvD, NP, and XL62) and 
the CN duplication. The same is true for the distal 
demarcation of the KM duplication and the proximal 
border of two other deletions (XL45 and DM) and for 
the distal breakpoints of the RvD and MBU deletions, 
respectively. All probes previously shown to be outside 
the RvD deletion (Cremers et ai, 1988) are also located 
outside the other deletions, as illustrated in Fig. 1 for 
PGK1, DXSI28, DXS227, and DXS17. 
Both X-chromosomal (p47b) and Y-chromosomal 
(p31) sequences of the DXYSS locus have been cloned 
(Goodfellow et ai, 1985). In this study, probe p47b is 
assigned to interval 5, distal to the DM deletion (Fig. 
1). Recently, Schwartz et ai (1988) showed that probe 
p31 overlaps one of the deletion breakpoints in patient 
DM. Our data indicate that DXYSS spans the most 
distal of the two DM breakpoints. Probe 47b does not 
detect this breakpoint in Taçl-digested DNA and 
therefore it must be located distal to the X homolog of 
probe p31. 
As to the location of the genes involved in these 
deletions, comparison with the respective clinical find-
ings yields (nearly) consistent results. With one ex-
ception (RvD, see below), all deletions spanning in-
terval 3 defined by probes pJL8 (DXS233), plbD5 
(DXS16S), and pXG7c (DXS95) are associated with 
choroideremia, which assigns the TCD gene to this re-
gion. Similarly, the absence of a gene or genes in in-
terval 2 seems to evoke deafness, and genes in this 
region appear to play a role in the etiology of mental 
retardation, too. 
Large-Scale Restriction Map of the TCD "Critical" 
Region 
The DNA markers that were shown to be located in 
the smallest syndromic TCD deletion (XL45, see Fig. 
1), probes p784, pJL68, pJL8, plbD5, and pXG7c, were 
hybridized to FIGE blots containing Sfil, Sail, or Sfil/ 
Sail double digests of DNA of cell line LCL127. As 
illustrated in Fig. 2, pJL68, p784, and pJL8 detect 
identical Sfil fragments. Moreover, p784 and pJL8 hy-
bridize to identical Sail and Sfil/Sail fragments, which 
indicates that the maximal physical distance between 
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FIG. 3 . Provieional large-ecale restriction map of part of inter­
vale 2 and 3 which epan the TCD locus. S/il and Safl fragment sizes 
are given in kb. The orientation and positioning of the fragment« 
detected by PlbDS and pXG7c are unknown. 
these two markers should not exceed 220 kb. Probes 
plbDS and pXG7c detect clearly different Sfil and Salí 
fragments. 
Recent studies by Julier and White (1988) have in-
dicated that the mobility of restriction fragments in 
pulsed-field gel electrophoresis (PFGE) is affected by 
the amount of DNA applied to the gel. In our FIGE 
analysis Sfil/Sall fragments have a tendency to run 
more slowly; they comigrated with fragments that were 
on average 30-40 kb larger in size. This effect is not 
seen in Sfil or Satl single digests, probably because of 
a more even distribution of the DNA throughout the 
gel (unpublished results). 
The FIGE data are summarized in Fig. 3. The ori-
entation of the probe cluster pJL68-p784-pJL8 can be 
inferred from the fact that pJL8 is the only probe of 
that cluster mapping inside the MBU deletion (see Fig. 
1; R. L. Nussbaum, unpublished results). In contrast, 
the orientation and positioning of the fragments de-
tected by probes plbDS and pXG7c are not known with 
certainty because we have not yet been able to physi-
cally link these two probes with the nearest proximal 
marker, pJL8. 
DISCUSSION 
On the X chromosome, large male-viable deletions 
are clustered in the two most prominent dark-staining, 
and late-replicating, Giemsa (G) banda, Xp21 (Francke, 
1984; Francke et al., 1986; Old et aL, 1985; Hartley et 
ai, 1986) and Xq21 (Tabor et ai, 1983; Hodgson et aL, 
1987; Nussbaum et aL, 1987; Schwartz et aL, 1988; Cre-
mers et aL, 1988, this study). This is in keeping with 
previous studies which suggested, on the basis of 
karyotype-phenotype correlations, that Giemsa light-
staining bands (reverse or R-bands) are enriched for 
expressed sequences, whereas G bands are genetically 
inert (Comings, 1974; Sanchez and Yunis, 1974; Yunis 
et al., 1977; Korenberg et al., 1978; Kumit and Hoehn, 
1979). A functional link between these observations 
may be provided by the accumulating evidence that 
(the initiation of) replication and transcription are 
partially dependent on the same DNA structures (e.g., 
see review by DePamphilis, 1988). For the Xq21 band, 
this correlation appears to hold, as evidenced by the 
clustering of large, male-viable deletions in this region 
and the conspicuous absence of (grave) clinical symp-
toms in these patients which is confirmed by the pres-
ent study. 
Characterization of several duplications and dele-
tions with 20 probes derived from the Xq21 band has 
enabled us to subdivide this region into seven intervals 
and to determine their (centromere to telomere) ori-
entation. Moreover, at least three disease loci could be 
assigned to two of these intervale through comparison 
with the associated clinical phenotypes. As shown in 
Fig. 1, the deletion in patient XL45, which spans in-
tervals 2 and 3, is associated with TCD, deafness, and 
MR, whereas TCD is the only prominent clinical fea-
ture in patient MBU, whose deletion encompasses in-
tervals 3 through 7. This suggests that the gene un-
derlying TCD maps in interval 3, whereas intervals 4 
through 7 are devoid of functionally important loci. 
TCD is a constant feature of all deletions examined 
that span interval 3, except for one patient, RvD. Here, 
the lack of conspicuous changes in the ocular fundi 
may be related to his youth (11 years). At this age, 
nonmanifestation of TCD in male carriers is not ex-
ceptional (Kärnä, 1986). 
In general, deletions spanning interval 2 are asso-
ciated with deafness. There is one patient (NP), how-
ever, who is not deaf despite a large deletion encom-
passing intervale 1 through 7. Thus it appears that 
deletion of interval 2 predisposes for, but does not nec-
essarily cause, hearing impairment. The genetic clas-
sification of deafness is difficult because of its clinical 
variability. Congenital mixed, that is, conductive and 
sensorineural, deafness with stapes fixation (McKusick 
Catalog No. 30440) is the most frequent X-linked form 
of hearing impairment. Close linkage with the PGK1 
(Brunner et al., 1988) and the DXYS1 markers (P. 
Beighton, personal communication) has recently as-
signed this gene to the proximal Xq, which suggests 
that the same gene may be involved in the hearing 
impairment associated with Xq21 deletions. Indeed, 
stapes fixation has been established in patient XL45, 
but not in patients RvD, XL62, and DM in whom con-
genital sensorineural deafness has been reported. 
Therefore, the possibility that interval 2 carries more 
than one gene that may give rise to deafness cannot 
be excluded. 
About 60% of all cases with X-linked MR are un-
related to the fragile Xq27 syndrome (Mikkelsen, 
1987), and several forms of nonspecific X-linked MR 
have been reported. In addition, MR has been found 
in a large number of other complex X-linked syndromes 
(Tariverdian and Week, 1982). MR is also a common 
feature in complex TCD deletions. A locus (or loci) for 
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MR can be assigned to interval 2 and/or interval 3, 
depending on the clinical findings in patient MBU, 
who is mildly retarded 
Recently, linkage has been demonstrated between a 
gene defect causing X-linked cleft palate and ankylo-
glossia and the DXYSl marker on the proximal long 
arm of the X chromosome (Moore et al, 1987) In view 
of this finding, the observation that one of the deletion 
patients, NP, has (unilateral) cleft lip and palate may 
not be coincidental On the other hand, it is well es­
tablished that X-hnked forms of cleft lip and palate 
are very rare compared to multifactorial ones, and the 
functional role of this gene may be small given the 
absence of cleft lip and palate in all other patients with 
Xq21 deletions 
Previously published cytogenetic data on the syn­
dromic TCD deletions (Table 1) are corroborated by 
our physical mapping studies The MBU and XL62 
deletions were estimated to span half of the Xq21 band 
(Hodgson et al, 1987, Nussbaum et al, 1987) On the 
basis of the relative map positions of the various 
breakpoints, we tentatively assign the MBU deletion 
to Xq21 2-21 33 and the XL62 deletion to Xq21 1-
q2131 
As shown m Fig 1, deletion and duplication break­
points in the Xq21 region appear to be distributed in 
a nonrandon fashion, as judged from the clustering of 
breakpoints which is most notable in the Xq21 1 band 
As shown by FIGE analysis, the DXS121, DXS232, 
and DXS233 loci are located on the same 400-kb Sfil 
fragment, whereas DXS95 and DXS165 are located on 
different Sfil fragments This suggests that probe clus­
tering is at least partly responsible for the observed 
clustering of breakpoints One of the DNA marker se­
quences employed in this study, DXYS5, is directly 
involved in chromosome breakage As shown by 
Schwartz et al (1988), locus DXYS5 demarcates a 
deletion breakpoint in patient DM This finding is 
particularly notable in view of a previous report dealing 
with the participation of the DXYS5 sequence in an­
other chromosome rearrangement (Rouyer et al, 1987). 
This observation may indicate that some sequences 
are characterized by enhanced proneness to chromo­
some breakage 
Physical linkage with TCD is probably closest for 
DXS165, as judged from our recent finding in patients 
with classical TCD of deletions spanning the DXS165 
locus but none of the other markers (Cremers et al, 
1987b). As shown in Fig 1, this implies that all probes 
thought to be located in the vicinity of the TCD locus 
because of close linkage, namely, DXYSl, DXYS12, 
DXS72, and PGK1 (Nussbaum et al, 1985, Schwartz 
et al, 1986, Lesko et al, 1987, Sankila et ai, 1987), 
map outside the region that carries the TCD gene (in­
terval 3) DXS95 (probe pXG7c, Davatehs et al, 1985) 
is the only polymorphic marker in this interval and, 
thus, is probably the most closely linked diagnostic 
marker of TCD available to date 
These data provide a framework for the construction 
of a contiguous molecular map of this chromosome 
segment Future studies will concentrate on the mo­
lecular characterization of deletions in patients with 
classical, ι e , nonsyndromic, TCD using chromosomal 
walking and jumping techniques As judged from the 
clinical phenotype of these individuals, the TCD gene 
may be the only functional gene in these deletions. If 
true, this should considerably facilitate its isolation 
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Summary 
Using various probes from the Xq21 region which is known to carry the 
choroideremia (tapetochoroidal dystrophy, TCD) locus, we have screened 
the DNAs from eight unrelated male choroideremia patients for 
microdeletions. In two of these patients, but not in any of 45 males tested 
as controls, lack of hybridization signals with probe p lbDS suggested a 
deletion encompassing the DXS165 locus and (part of) the TCD gene. 
Absence of additional clinical features in these patients and the fact that 
two closely linked, and probably flanking, TCD markers (DXYS1 and 
DXS72) are not deleted may indicate that the physical distance between 
the DXS165 locus and the TCD gene is small. 
Introduction 
The molecular defect underlying TCD is not known but recent studies have 
indicated close linkage with the polymorphic loci DXYS1, DXYS12, PGK1, 
and DXS72 (Sankila et al. 1987; Lesko et al. 1987) all of which are 
located in the Xq13-q21 region. Moreover, several patients with small 
deletions of band Xq21 have been described where TCD was associated 
with mental retardation (MR)(Hodgson et al. 1987), MR, cleft lip & palate 
and agenesis of the corpus callosum (Rosenberg et al. 1986) or with MR 
and deafness (Lesko et al. 1987). These observations indicate that the 
63 
TCD gene is located in the Xq21.1-q21.33 region. 
As part of an ongoing study aiming at the detection of submicroscopic 
deletions in clinically complex X-linked syndromes we have regionally 
assigned 15 random DNA probes to this chromosome segment (Cremers et 
al. 1987a,b; unpublished results). Because of the conspicuous clustering of 
male-viable deletions in this region we speculated that sizeable deletions 
might also be found in patients where TCD is the only clinical feature. 
Therefore, we have screened DNA from unrelated TCD patients with 
several probes mapping in the relevant region of band Xq21. With one of 
these, deletions were found in two out of eight patients with typical TCD. 
Material and Methods 
In the 8 patients with TCD, blood was collected, DNA prepared and banked 
by the RP Center Munster for Medical Care and Research, a collaborative 
institution of the University of Münster and the German Retinitis 
Pigmentosa Association (Pawlowitzki & Brunsmann 1987). The diagnosis 
had been established by detailed ophthalmological examination. For patients 
3.5 and 7.6, clinical findings have been reported (Hammerstein & Böhm 
1985; Diekstall & Démêler 1986). DNA was isolated according to standard 
protocols and digested with restriction endonucleases EcoRI or Taql. 
Methods for electrophoresis. Southern blotting, probe labeling and 
autoradiography have been described previously (Cremers et al. 1987a). 
The following probes were employed: pDP34 (DXYS1), pX65H7 {DXS72), 
pX20R42 (DXS73), pX104f( p722 (DXS110), p784 (DXS121), pPA20 
(DXS214), pXG7c (DXS95), pXG8b, and plbDS (DXS165). Probes pX104f 
and pXG8b were obtained from Drs. B.N. White and P.Szabo, respectively. 
All other probes have been described elsewhere (Cremers et al. 1987a; 
Goodfellow et al. 1985). 
Results and Discussion 
With 9 out of 10 probes that had been assigned to the relevant segment of 
band Xq21, and with probe pL2.98 (DXS56) which maps outside this 
region (Xq12-q13,· unpublished results), normal hybridization patterns were 
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observed in all individuals tested. In contrast, probe plbDS (DXS165) 
reproducibly failed to detect homologous sequences in the DNA of two out 
of eight TCD patients studied (patients 3.5 and 7.6; see figure 1). To rule 
out the possibility that probe plbDS detects a deletion polymorphism, this 
probe was employed to screen genomic DNA from 45 unrelated male 
controls. Consistently, normal hybridization patterns were observed. This 
renders a deletion polymorphism very unlikely and strongly argues for the 
deletions being the primary cause of TCD in these patients. 
1 2 3 4 5 6 7 8 9 10 11 
kb 
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Fig. 1 p1bD5 (DXS165) hybridization signals in 7 patients with typical TCD 
(individuals 2.1, 3.5, 5.1, 7.6, 9.2, 10.1, 13.2; lanes 3 to 9), 2 patients 
with visible deletions in the Xq21 band (lanes 10 and 11), and female and 
male controls (lanes 1 and 2). pL2.98 (DXS56) signals are shown as 
internal reference. 
p1bD5 
To our knowledge, this is the first time that interstitial deletions have been 
detected in patients where TCD was not associated with additional genetic 
defects. It is noteworthy that both deletions do not include the DXS72 and 
DXYS1 loci which show close linkage with TCD and probably flank the 
TCD locus (Lesko et al. 1987). This finding suggests that the physical 
distance between the DXS165 locus and the TCD locus may be very small. 
If so, this should be a great asset for "reverse genetics" strategies aiming 
at the identification and isolation of the TCD gene. 
For the molecular characterization of the two deletions found in this study, 
field inversion gel electrophoreses (FIGE; Carle et al. 1986) should be 
particularly helpful, and systematic FIGE screening of further TCD patients 
should soon clarify the role of deletions in the etiology of this disorder. 
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ABSTRACT Choroideremia (tapeto-choroidal dystrophy, 
TCD), an X chromosome-linked disorder of retina and choroid, 
causes progressive nightblmdness and central blindness in 
affected males by the third to fourth decade of life. Recently, 
we have been able to map the TCD gene to a small region of 
overlap between five different, male-viable Xq21 deletions that 
were found in patients with TCD and other clinical features. 
Two families were identified in which classical, nonsyndromic 
TCD is associated with small interstitial deletions that are only 
detectable with probe plbDS (DXS165). To characterize these 
and two other deletions that were identified more recently, we 
have used the chromosome walking and jumping techniques to 
generate a set of five chromosomal-jumping clones flanking the 
DXS16S locus at various distances. With these clones, we could 
localize four of the eight deletion endpomts and the breakpoint 
on the X chromosome of a female with a de novo X/13 
translocation and choroideremia. These studies assign the TCD 
gene, or part of it, to a DNA segment of only 15-20 kilobases. 
Hereditary dystrophies of the retina and the choroid constitute 
a clinically heterogeneous group of Mendeltan disorders that 
play an important role in the etiology of blindness in man 
Individual diseases of this group have also been shown to be 
genetically heterogeneous For retinitis pigmentosa (RP), au-
tosomal dominant and recessive forms are known, and at least 
two distinct RP genes have been mapped to different sites on 
the short arm of the X chromosome (1-3) The gene defect 
underlying choroideremia, another member of this group, has 
been assigned to Xql3-q21 because of its tight linkage with 
various polymorphic probes from this region (4-6) Choroid-
eremia is characterized by progressive degeneration of both 
retina and choroid leading to blindness by the third or fourth 
decade of life (7-9) Therefore, tapeto-choroidal dystrophy 
(TCD) is a more appropnate designation for this disorder 
Female earners, although normally asymptomatic, show char-
actenstic patchy changes in the retinal pigmented epithelium 
that reflect random X chromosome mactivation 
To elucidate the molecular and, eventually, the biochem-
ical defect underlying this disorder, we have set out to isolate 
the TCD gene by means of reverse-genetics strategies—ι e , 
by making use of its known chromosomal location In gen­
eral, very precise physical mapping, more accurate than can 
be achieved with linked DNA markers alone, is a prerequisite 
for the successful application of this strategy Physical fine 
The publication costs of this article were defrayed in part by page charge 
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mapping of probes depends on the availability of chromo­
somal aberrations such as translocations, duplications, and 
deletions Indeed, translocations and microdeletions were 
instrumental for the cloning of all four human genes that have 
been isolated in this way (10-13) 
TCD and other clinical features have been desenbed in 
various patients with cytogenetically visible or submicro-
scopic deletions spanning the Xq21 band (14-16) To deter­
mine the location of the TCD locus more precisely, we have 
charactenzed several of these deletions with anonymous 
cloned DNA sequences from proximal Xq (17) This has 
enabled us to divide the Xq21 band into seven different 
intervals and to assign the TCD locus to interval 3 spanning 
the probes pJL8 (DXS233), plbD5, (DXSI65), and pXG7c 
(DXS95) (18) Molecular characterization of patients with 
classical, nonsyndromic TCD revealed several additional 
deletions, part of which was confined to the DXSI65 locus 
(ref 19, and unpublished data) This suggested to us that the 
distance between this locus and the TCD gene might be small 
enough to be bridged by genomic walking and jumping 
expenments 
Chromosome jumping is based on the circulanzation of 
long genomic DNA fragments and subsequent cloning of the 
junction fragments of these circles (20-27) In this way, it is 
possible to circumvent insert-size constraints of conven­
tional cloning vectors, which limit the distance that can be 
covered by individual chromosome walking steps Iterative 
screening of a previously desenbed chromosomal-jumping 
library (21) has enabled us to isolate various new DNA 
sequences in the vicinity of the DXS165 locus and to deter­
mine the size of a DNA segment that is spanned by four 
different deletions detected in TCD patients In addition, we 
used these probes to map the X chromosomal breakpoint of 
a de novo X/13 translocation that has been desenbed in a 
female with typical signs of choroideremia (28). 
MATERIALS AND METHODS 
TCD Patients. For the male patients 3 5, 7 6, 25 6, and 
LGL1134, the diagnosis of classical TCD had been estab­
lished by detailed ophthalmologic examination (see, for in­
stance, refs 29 and 30) A female patient showed mild 
choroideremia and infertility secondary to premature ovarian 
failure (28) By using trypsin-Giemsa staining she was kary­
otyped as 46,X,t(X,13)(q21 2,pl2) Replication studies with 
Abbreviations TCD, choroideremia (tapeto-choroidal dystrophy), 
RP, retimlis pigmentosa 
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BrdUrd showed that the normal X was inactivated Somatic 
cell hybrids formed between skin fibroblasts from this patient 
and mouse Λ9 fibroblasts yielded a mouse-human hybrid 
(CIII-1), which contained the derivative der(13) chromosome 
but not the reciprocal dertX) chromosome 
Southern Blot Analysis. Chromosomal DNA was isolated as 
described elsewhere (31) with minor modifications DNA (10 
μ%) was digested with the appropriate restriction enzyme, 
and fragments were resolved by agarose gel electrophoresis 
and blotted onto GeneScreenP/ui (NEN) membranes as 
described (18) Radioactive probes were prepared by random 
oligonucleotide pnmmg (32, 33) Insert DNAs were eleclro-
phoretically separated from the plasmid vector and isolated 
m low gellmg-temperature agarose Prior to hybridization, 
probes containing weak repetitive sequences (low-copy 
probes, plbDS, plbDS I, pJIS II, and pJ60) were preassoci-
ated with sonicated total human DNA as described (17, 34) 
Details of (pre)hybndization and washing of filters have been 
published (35) 
Libraries. The construction of the 100-kilobase (kb) human 
chromosomal-jumping library has been described elsewhere 
(21) Approximately 2 5 x IO6 chromosomal jumping clones 
("jump clones") of the amplified library (which, before 
amplification, comprised about 1 S x IO* independent clones) 
were plated on the bacterial host MC1061 (supF~) at a density 
of 100,000 plaques per 130-mm plate Plating was performed 
in 0 7% top-agarose/Luna broth supplemented with 30% 
(vol/vol) glycerol for long term storage as described by 
Klinman and Cohen (36) Plaques were lifted on Hybond-N 
membranes (Amersham) and subsequently screened as rec­
ommended by the manufacturer The filters were hybridized 
three times with a combination of four probes Master plates 
were stored at -70°C Phage containing jump inserts were 
recovered from the master plates by drilling with a cut-off 
plastic tip at -20°C (36), and DNAs were purified by standard 
methods (37) 
A phage Λ EMBL 3 genomic library constructed from DNA 
of a human chronic myelogenous leukemia patient was pro­
vided by G Grasveld (Erasmus University, Rotterdam), S x 
105 plaque-forming units were plated on Escherichia coll 
LE392 and screened as described above for the chromosom­
al jumping library A c2RB cosmid library was constructed 
from a cell line containing four X chromosomes (GM1202,49, 
XXXXY) Independent clones (5 χ IO5) were plated and 
screened as described elsewhere (38) 
Subdoning and Mapping of Inserts. Phage DNA was di 
gested with EcoRI, purified by phenol and chloroform ex­
traction, and directly cloned into firoRI-cleaved, phos-
phatase-treated pGEM vectors or ligated into EcoRI-cut, 
dephosphorylated phage AZAPII vector arms (Stratagene) 
The manufacturer's excision protocol was used to convert 
AZAPII constructs into plasmid (Bluescnpt) clones Restric­
tion maps of the inserts were generated by digestion with 
EcoRl,Ava I (which cuts in the middle of the supFgene), and 
EcoRl/Ava I, followed by Southern blotting and hybridiza­
tion with supF and the starting clone 
RESULTS 
Identification of a Third Deletion. In a previous report we 
showed that probe plbDS (DXSI65) detected two deletions 
(patients 3 5 and 7 6) among 8 patients with classical TCD 
(19) Screening of an additional 22 TCD patients resulted in 
the identification of another deletion (patient 25 6) that not 
only spans plbDS (see Fig 3c), but also pXG7c (DXS95), 
pXG8b, p722 (DXSII0), pDP34 (DXYSI), and p47b (DXYSS) 
(data not shown) Therefore, the deletion in patient 25 6 
encompasses part of interval 3, the entire interval 4, and part 
of interval 5 of the Xq21 band (18, 39) 
Chromosomal Walking and Jumping. Employing plbD5 as 
a probe on a human genomic cosmid library, clone c237 was 
isolated, which contained 36 kb of insert DNA (Fig 1) 
Single- or low-copy fragments (plbD5-I to -IV) were sub-
cloned, gel-punfied, labeled, and hybridized to nylon filters 
containing ¿coRl-digested DNA of patients 3 3,7 6, and 25 6 
and a male control In contrast to plbDS, plbDS-IV delects 
homologous sequences in the DNA of patient 7 6 (Fig ib, 
lane 2) Therefore, one end-point of the deletion in patient 7 6 
must be located between plbDS IV and plbDS We have 
used this breakpoint as a specific marker for the presence or 
absence of a deletion in females at nsk for carrying the TCD 
defect (39) For chromosomal jumping from the DXSI65 
locus, we used plbDS and plbDS IV as starting points 
Screening the 100-kb human chromosomal jumping library 
with plbDS-IV resulted in the isolation of one jump clone, 
AJ36 (Fig 2) The insert on this phage (7 S kb £coRI frag-
r л 
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ment; Fig. 2) consists almost entirely of a sequence (7.15-kb 
EcoRl/Ava I fragment) that spans part of plbD5-IV and 
extends to an ÊcoRI site situated outside of c237 (denoted 
plbD5-V, see Fig. 1). The remaining part of this insert, 
designated pJ36 (0.35-kb EcoRÌ/А а I fragment), was used as 
a probe to screen a Southern blot carrying DNA from the 
three deletion patients. As shown in Fig. 3a, pJ36 is located 
outside the 7.6 and 25.6 deletions but still inside the 3.5 
deletion. This indicates that with this jump we have crossed 
an endpoint of deletion 25.6. Since the 25.6 deletion encom­
passes several probes that are located distal to plbD5, this 
breakpoint must be proximal to plbD5. At the same time, this 
proves that the TCD gene must be located telomenc to the 7.6 
deletion breakpoint. 
With probe plbD5, two different jump clones, AJU and 
AJ15, could be isolated (Fig. 2). The end fragments of both 
clones, pJU (1.05-kb EcoR\/Ava I fragment) and pJ15 (2.0-
kb EcoRl/Ava I fragment), are devoid of repetitive se-
pJ15 
A E 
plbD5-IV pJ36 
t k b 
FIG. 2. Restriction maps of the phage 
Λ inserts isolated from the chromosomal-
jumping library. The £1 «RI. //indili, and 
Ava I sites are indicated in all inserts. For 
AJ59, we also indicated the BamHl and 
Bgl 11 sites. The black boxes represent 
single- or low-copy sequences of the 
starting clones [at the left side of the supF 
gene(s)] and the new jump clones (at the 
right side), whereas hatched boxes rep­
resent the supF genes with their internal 
Ava 1 sites. The asterisk indicated in the 
restriction map of AJ59 indicates a 
BamHl site that might be created in the 
cloning procedure. The supF gene was 
originally flanked by BamHl sites, and 
the genomic fragments, by Sou3AI sites 
(21). 
quences and are located within all three deletions (for pJ15, 
see Fig. id). To generate starting probes for further jumps in 
the telomenc direction, both single-copy probes were used to 
isolate corresponding sequences from a A phage human 
genomic library. With probe pJ15, two clones with overlap­
ping inserts were detected (A335-1 and -2), spanning a total of 
23 kb (Fig. 1). The orientation of these clones was deduced 
from the location of two Hindlll sites situated within 500 base 
pairs (bp) of the EcoRl site of pJ15 (Figs. 1 and 2). In the A335 
inserts, two useful sequences were identified, a unique copy 
probe spanning pJ15, pJ15-I (2.5-kb EcoRl fragment), and 
pJ15-II—a low-copy probe (1.3-kb Bgl II/£roRI fragment) 
located just centromeric from an EcoRI site (Fig. 1). 
Screening the chromosomal-jumping library with pJ15-l 
yielded a A phage (AJ59) that contained a fragment of 3.9-kb 
next to the pJ15-I sequences. From this fragment, a single-
copy sequence (pJ59; 0.7-kb BamHl fragment) was derived 
and subsequently used to screen the three deletions. Absence 
25kb 
qler 
pJL8 pJ36 p1bD5-IV p1bD5 pJ15 pJ59 p j l l pJ60 
J Ь ^ \ M I 
pXG7c 
V/-
LGL1134 
V A 
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-//-
FIG 3 Molecular analysis of deletions in patients with classical choroideremia with probes isolated by chromosome walking (plbDS-lV) 
and jumping (pJ36, pJ15. and pJ60) (Upper) (α-e) EcoRl-digested DNA of patients 3.5 (lanes 1), 7.6 (lanes 2), and 25.6 (lanes 3) and a male 
control (lanes 4). The presence of comparable amounts of DNA in each lane was shown by using a probe located outside this region (pL2.98; 
Xql3; ref. 17). (Lower) Deleted regions of patients 3.5,7.6.25.6, and LGL1134 are depicted between arrowheads The position of the centromeric 
deletion endpoint in patient 3.5 and the telomeric deletion endpoints in patients 7.6 and LGL1134 are unknown. The telomenc deletion endpoint 
in patient 25.6 is located in interval 5 of Xq21 (18, 39). The location of the X chromosomal breakpoint of a X/13 translocation in a female with 
choroideremia is shown at the bottom. 
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of hybridization signals revealed that pJ59, like pJU, pJ15, 
and plbDS, maps to the DNA segment that is deleted in ail 
three patients. The sequences in AJ59 that are homologous to 
pJ15-I (0.7-kb EcoRl/Ava I fragment) contained a Bgl II site 
but no //indili sites (Fig. 2), indicatingajump in the telomeric 
direction as depicted in Figs. 1 and 3. 
Screening of the chromosomal-jumping library with pJ15-II 
yielded а Λ phage UJ60; Fig. 2) that contained a low-copy 
sequence, pJ60 (1.7-kb EcoRl/Ava I fragment). This se­
quence is located inside the 7.6 and 25.6 deletions but distal 
to the 3.3 deletion (Fig. 3e). Thus, this jump has provided us 
with the distal demarcation of the segment that all three 
deletions have in common. 
The relative positions of pjll and pJ59 with respect to pJ60 
were deduced from conventional Southern analysis. pJS9 and 
pjll hybridize to the same 16-kb Hmdlll fragment, whereas 
pjll and pJ60 are both located on a BamHl fragment of 
approximately 36 kb (unpublished data). These results sug­
gest the order Xcen-pJ59^pJll-pJ60-pter. Field inversion gel 
electrophoresis analysis indicated that all jump clones, as 
well as DXSI65, are located on a 400-kb Sal I and a 625-kb 
Sfi I fragment (unpublished data). 
With these jump clones as probes, a fourth patient with TCD 
and a microdeletion was found. This deletion (LGL1134) spans 
pJ60, but none of the other jump clones nor the DXS9S 
(pXG7c) locus (for pjll, pJ15, and pJ60, see Fig. 4a). The 
//indili fragment detected by pJll in DNA of patient 
LGL1134 is slightly smaller than that of a male control, which 
indicates that the centromeric deletion endpoint is located 
within this 16-kb Hináill fragment. Preliminary restriction 
mapping data indicate that the deletions in patients 3.5 and 
LGL1134 overlap a DNA segment of approximately 15-20 kb. 
Mapping of the Translocation Breakpoint. DNA of the cell 
hybrid CIII-1 and a male control was analyzed with all jump 
clones from this region, and the anonymous probes plbD5 
(DXSÌ65), pXG7c (DXS9S), and p22.33 (DXSll), which 
maps further telomeric on Xq (40). As shown in Fig. 4fe, 
probes plbD5, pJ15, and pJU fail to hybridize to DNA from 
the CIII-1 hybrid, whereas sequences pJ60, pXG7c (not 
shown), and p22.33 are present on the der(13) chromosome 
of this cell line. Therefore, the X chromosomal breakpoint of 
this translocation can be positioned between pJll and pJ60, 
within or just proximal to the DNA segment that is deleted in 
the four patients described above (Fig. 3). 
DISCUSSION 
So far, there is only a limited number of reports dealing with 
the successful application of chromosome-jumping tech-
niques (21,23-25,27). In this study, we made use of a 100-kb 
human chromosomal-jumping library that had been used 
previously to study the chromosomal region carrying the 
cystic fibrosis locus (21) and the Duchenne gene (24). One of 
the advantages of this library is that any sequence, unless 
located on a EcoRI fragment containing no 5au3AI restric-
tion sites, can be used as a starting clone. Several different 
probes from one locus can be tested, and directional jumping 
can be achieved by using probes that are optimally positioned 
with respect to EcoRl sites (20, 26). Furthermore, the broad 
size range of the jumps (40-120 kb) results in "scanning" of 
neighboring genomic regions. Because of the relatively small 
average insert size (about 5 kb), approximately 2 χ 106 
independent phage must be plated to achieve a 95% coverage 
of the genome. To avoid repeated phage plating and lifting, 
we applied a long-term storage procedure for plated phage 
(38) in combination with plaque-lifting on nylon filters that 
can be rehybridized. Phage plated in this way remained viable 
for at least 1 year. 
We used the DXSI65 locus as a starting point for jumps in 
the centromeric and the telomeric direction. The resulting 
jump clones were positioned with the help of four, partially 
overlapping, deletions present in the genome of classical 
TCD patients. The orientation of the probe cluster depicted 
in Figs. 1 and 3 was established by jump clone pJ36, which 
was located outside the 7.6 and 25.6 deletions, but inside the 
3.5 deletion. As the 25.6 deletion does not only span DXSI65 
(plbD5) but also five loci that map telomeric to this marker, 
the order of loci in interval 3 (18) is firmly established as 
Xcen-DJrS2ii-D^S/65-D^S95-qter. 
In most experiments, the direction of jumping could be 
predetermined by choosing starting clones that were located 
next to EcoRl sites (Fig. 1). The position of the jump clones 
was confirmed by Southern blot analysis of a deletion panel 
(Fig. 3). Jump clone pJ60 is located inside the 7.6 and 25.6 
deletions but outside the 3.5 deletion. This means that we 
have jumped from one proximal deletion endpoint (patient 
7.6) across another one that forms the distal demarcation of 
the deletion in patient 3.5. As one jump (pJU) was almost 
sufficient to bridge this distance, we estimate that the region 
of overlap between these three deletions does not exceed 150 
kb. The broad size range of the jumps performed with this 
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FIG. 4. (a) Southern blot analysis of/findlll-digested DNA of a control male (lanes 1) and patient LGI.U34 (lanes 2). (Left) Southern blot 
hybridized with pjll and pJ15. (Right) The blot was stripped and rehybridized with pJ60, which detects //indili fragments of 2.8 and 3.9 kb (see 
Fig. 1). (/>) Southern blot analysis of £< oRl-digesled DNA of a control male (lanes 3) and cell line CIII-1 (lanes 4). The six lanes were ran in parallel 
and blotted as described. (Center) The lower part was exposed for a longer time to enhance the signal of probe pJU compared to pJ15. (Left) The 
asterisk indicates a second EraRl fragment detected by plbDS, which most likely is due to incomplete digestion of the control DNA. 
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library is illustrated by the fact that two successive jumps, 
pJ15 and pJ59, have resulted in bridging a distance compa­
rable (o that of one jump (pJ l l ) 
Screening of additional TCD patients revealed another 
deletion (LGL1134), which is only detectable with the pJ60 
probe Preliminary data from Southern blot analyses indicate 
that the deletions in patients 3 S and LGL1134 share a DNA 
segment of 15-20 kb that maps between p J l l and pJ60 
Furthermore, we were able to localize a translocation break­
point, which presumably disrupts the TCD gene, between 
these two markers 
The size of the TCD microdeletions can only be estimated 
indirectly The deletion in patient 25 6 contains six anony­
mous DNA loci and is estimated to span >5000 kb The jump 
clones depicted in Figs 1 and 3 are all located on a 625-kb Sfi 
I fragment and a 400-kb Sal I fragment, previously shown to 
contain the DXSI65 locus (18) For patients 3 5, 7 6, and 
LGL1134, deletion sizes cannot be determined with cer­
tainty, as the position of their centromenc (patient 3 5) or 
telomenc endpoints (patients 7 6 and LGL1134) relative to 
Sal I and Sfi I sites cannot be established 
In view of the apparent causal relationship between the 
microdeletions and the TCD phenotype of patients 3 5,7 6, 
25 6, and LGL1134, our studies have provided convincing 
evidence for (part of) the TCD gene to be located on a 15- to 
20-kb segment between p J l l and pJ60 This is corroborated 
by the fact that a translocation breakpoint associated with the 
TCD phenotype in a female is also located within or very 
close to this DNA segment 
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ABSTRACT 
By making use of preparative field inversion gel 
electrophoresis, we have constructed a lambdaZAP 
library that Is highly enriched for sequences from the 
choroideremia locus. In vivo excision of pBluescript 
SK(-) constructs from lambdaZAP obviates the 
subcloning of DNA inserts and allows for rapid 
processing of several hundred recombinants. From a 
625 kb Stn fragment we Isolated 7 clones that were 
physically mapped using microdeletions associated 
with the disease. One of these clones is located within, 
or just telomeric to, the choroideremia gene and 
detects two restriction fragment length polymorphisms 
(RFLPs). Another clone detects a RFLP which maps 
centromeric to the disease locus. Together these 
probes should improve the reliability of linkage analysis 
in choroideremia families and should pave the way for 
the isolation of the choroideremia gene. 
INTRODUCTION 
Choroideremia is ал X-linked chorioretinal dystrophy m which 
affected males suffer from progressive night blindness and visual 
field constriction, leading to blindness by the third to fourth 
decade of life (1 -4) The gene locus for choroideremia 
(tapetochoroidal dystrophy TCD) has been assigned to Xq21 by 
means of genetic linkage and physical mapping studies (5-12) 
Characterization of various deletions associated with clinically 
complex TCD enabled us to refine the assignment of the TCD 
locus to a small segment in Xq21 (13) Deletions encompassing 
only the DXS 165 locus were found in patients with classical TCD 
(14) Chromosomal jumping from the DXSI65 locus allowed 
us to define the minimal region of overlap between four such 
microdeletions, and to map a de novo X,13 translocation 
disrupting the TCD gene in a female TCD patient (15) These 
studies indicated that at least part of the TCD gene is located 
on a 625 kb 5/iI fragment. 
In this paper we describe the use of preparative FIGE to 
establish a library highly enriched for sequences from a 625 kb 
Sfil fragment which contains part of the TCD gene locus 
MATERIALS AND METHODS 
Preparative Field Inversion Gel Electrophoresis 
The somatic cell hybrid 578 contains a Chinese hamster genome 
(parent Wg3-h) and a single human X chromosome Cells were 
grown under HAT selection and embedded at a concentration 
of 7 5X106 cells/ml in 0 6% low-gellmg-temperature (LGT) 
agarose (0 Зх 106 cells/block) as described (16,17) 21 blocks 
were preincubated overnight at 4°C in 5 ml Sfi\ digestion buffer 
as recommended by the manufacturer Digestion was performed 
for 3 h at 50oC in 1 2 ml buffer to which 2 mM spermidine, 
100 /tg/ml BSA, and 200 U Sfil were added Thereafter, 100 
U of enzyme was added, and digestion was allowed to continue 
for another 3 h to assure completeness 
The preparative gel, sized 0 6x 17x21 cm, consisted of 1 % 
(w/v) LGT agarose in 0 5xTBE buffer (16) 20 blocks were 
transferred to a 2 mm-wide and 9 cm-long slot. One block was 
loaded into a separate slot (the 'testlane'), and Saccharomyces 
cerevmae chromosomes were used as size markers Field 
inversion gel electrophoresis (FIGE) was performed for 23 h at 
6°C and 160 V Switching intervals increased linearly from 6 
to 60 s for the forward phase and from 2 to 20 s for the reverse 
phase 
After electrophoresis, the lanes containing size markers and 
the separate test DNA were cut off, stained in 10 mM EDTA 
containing 1 f¿g/ml cthidium bromide for 1 h, destained in 10 
mM EDTA for 1 h and photographed (Fig 2) DNA in the test 
lane was transferred to a Hybond-N membrane (Amersham) as 
desenbed previously (13), rinsed in 2x SSC, allowed to air-dry, 
and exposed to UV-hght (305 nm) for 3 mm Hybridization with 
probe plbDS, and washing of the membrane was performed as 
recommended by the manufacturer The central unstained section 
of the gel was sliced into 2 mm wide strips perpendicular to the 
running direction A small segment of each strip, corresponding 
to one lane of DNA, was used for dotblotting and hybridization 
The remaining strips were stored in 0 5 M EDTA, pH 8 at A°C. 
Dot blotting 
Pieces of the LGT agarose gel corresponding to one lane of DNA 
from cell line 578 (volume 75-100 /il) were melted for 5 mm 
at 95°C, and brought to 0 3 - 0 5 M NaOH After vortexing, 
the samples were incubated at 650C for 10 mm , and spotted 
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onto a Hybond-N membrane by means of a dot blot apparatus 
that had been pre-warmed to 37°C The following samples were 
included as controls ι a I % LOT agarose block m 0 5 TBE 
without DNA (Fig 2c, # 50), и 4 ^g of high molecular weight 
DNA isolated from a male (#47), a female (#48), and a cell 
line containing 4 X chromosomes (LCL127, #49) The 
membrane was neutralized by washing in 0 5 M Tns-HCI pH 
7 5/1 5 M NaCl/1 mM EDTA for 10 mm , air-dried, exposed 
to UV light as described above, and hybridized with probe 
plbD5 
DNA recovery and cloning in lambdaZAP 
LOT agarose strips containing DNA which yielded hybridization 
signals with the plbD5 probe (#31 and #32, Fig 2c), were 
rinsed three times for 2 h in 10 mM Tns-HCI pH 7 5/1 mM 
EDTA/100 mM NaCI, melted at 65°C, and incubated overnight 
with 50 U agarase/ml (Calbiochcm) at 37°C High molecular 
weight DNA was recovered by sequential phenol and chloroform 
extractions (both twice) and by ethanol precipitation in the 
presence of 0 3 M NaAc, pH 6 
From each slice approximately 500 ng of DNA was recovered 
800 ng of pooled DNAs from slices # 31 and # 32 was digested 
with 10 U EcoRI, purified, and concentrated using Geneclean™ 
(BiolOl Ine ) DNA recovery of this step was estimated to be 
40%, yielding approximately 320 ng 150 ng of purified £coRI 
digested DNA was ligated to 2 /ig of EcoRi digested and 
dephosphorylated lambdaZAP arms (Stratagene, La Jolla, CA) 
From 10 μΐ of the ligation mixture, 2 5 /il (0 5 /ig) aliquots were 
packaged using the Promega packaging extracts, resulting in a 
total of I 6ХІ0 5 pfu Screening of randomly picked phage, 
revealed that 75% contained an insert in the size range between 
0 5 and 10 0 kb (not shown) 
Identification of human clones 
Recombinant lambdaZAP phage were allowed to transfert the 
E coli host strain BB4 according to recommendations of the 
manufacturer Approximately ЗхІО 4 insert-containing phage 
were plated on 130 mm plates at a density of 300 phage per plate 
Plaques were lifted onto nitrocellulose niters (Schleicher & 
Schuell, BA85) using routine procedures (18) Two replica filters 
from each master plate were probed with human DNA at a 
concentration of 1 —3 ng/ml Labeling was performed by primed 
synthesis with Klenow DNA polymerase I and a-12P-dCTP as 
described by Femberg and Vogelstein (19,20) Methods for 
(pre)hybridization, washing, and exposure of filters have been 
described elsewhere (21) 
Human plaques were isolated from the plates using sterile 
pasteur pipettes, diluted into SM-buffer (0 1 M NaCl/10 mM 
MgS04 7H2O/I M Tns-HCI pH7 5/0 01% (w/v) gelatin), and 
stored at 4 0C LambdaZAP recombinants were transformed to 
plasmid clones (pBluescnpt) using the Stratagene lambdaZAP 
excision protocol Plasmid containing BB4 cells were plated on 
LB plates containing 50 /ig/ml ampicilline, and grown overnight 
Colonies were individually picked and grown overnight in 
LB/ampicilline (50 /tg/ml) medium at 37 °C Plasmid DNA was 
isolated using the rmmprep boiling-method described by Holmes 
and Quigley (22) Recombinant plasmids were £coRI digested 
and inserts were separated from vector sequences by 
electrophoresis in 1 % agarose-gels Each gel was sequentially 
blotted, for 25 mm and 3 h respectively, to two nitrocellulose 
filters which were then hybridized to labeled human and hamster 
DNA, respectively Recombinants containing inserts that 
appeared to be of human origin were run on a 0 8% LOT agarose 
gel and the inserts were isolated for labeling and hybridization 
Chromosomal localization 
In order to localize the human DNA sequences, we constructed 
three types of blots 
I Filters containing 10 /ig EcoRI digested DNA from two 
patients, NP and RvD, and a control male The deletion in patient 
RvD spans Xq21 1 -q22 1, whereas NP carries a deletion which 
encompasses Xq21 l-q21 33 Clinical features have been 
described in detail elsewhere (11,13) Both patients have complex 
clinical syndromes, NP shows typical signs of TCD, RvD does 
not 
II Filters containing 10 /ig EcoRI digested DNA from 3 patiente 
with classical TCD (3 5 [Fig 3, lane 1], 7 6 [lane 2], 25 6 [lane 
3]), and from a male control (lane 4) Patients 3 5 and 7 6 carry 
submicroscopic deletions that overlap for approximately 120 kb 
in the relevant 625 kb Sfil band, and extend to opposite directions 
as shown by molecular characterization (15) The deletion in 
patient 25 6 overlaps partly with the deletion in patient 3 5, and 
contains the entire segment deleted in patient 7 6 The 25 6 
deletion spans 6 anonymous markers from the Xq2I band 
(Xq2l 2-q21 31), and is estimated to encompass at least 5000 
kb (unpublished data) 
III FIGE blots containing Sfil and Sail digested DNA from 
cell line LCL127 (48, XXXX) Preparation of high-molecular-
weight DNA in agarose blocks, restriction enzyme analysis, FIGE 
electrophoresis, and blotting to Hybond-N membranes have been 
described elsewhere (13) Insert DNAs isolated from LOT 
agarose gels were labeled by pruned synthesis with Klenow DNA 
polymerase I and a-^P-dCTP, as described previously (19,20) 
Labeled inserts were prehybndized to sonicated human DNA 
(Cot = 3,600 mgxmin/ml), essentially as desenbed by Litt and 
White (23), to block highly and moderately repetitive sequences 
present in most of the probes 
Blots described above were stripped following each 
hybridization and re-used several times 
RESULTS 
FIGE analysis using jumpclones 
In a previous study we have reported the isolation of several 
jumpclones from the choroideremia area, employing probes 
plbD5 and plbD5-IV as molecular entry sites (15) These clones 
were hybridized to FIGE blots containing Sfil, Sail, or Sfil/Sall 
digested control DNA (LCL127, 48, XXXX) As shown for the 
most centromeric and telomenc jumpclones (pJ36 and pJ60), all 
clones detect a 625 kb Sfil, a 400 kb Saß (Fig la,b), and a 350 
kb Sfil/Sall fragment (not shown) As the jumpclones flank a 
DNA segment that is deleted in three TCD patients, the 625 kb 
Sfil fragment should contain at least part of the TCD gene 
(Fig 5) 
The proximal deletion breakpoints of patients 7 б and 25 6 map 
within the 625 kb Sfil fragment For patient 3 5, at least the distal 
and possibly the proximal deletion breakpoint map within this 
fragment Of all jumpclones that hybridize to a 625 kb Sfil 
fragment in normal DNA, pJ60 is the only one that yields a 
hybridization signal in DNA of patient 3 5 On FIGE blots of 
this patient, pJ60 detects a 215 kb Sfil fragment (Fig 1c) 
Depending on whether the 3 5 deletion is completely contained 
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Figure I; FIGE analysis with jumpclones, (a,b) LCL 127 DNA was digested 
with the enzymes indicated for each lane, (e). DNA of a control male (lane 1) 
and patient 3.5 (lane 2) was digested with S/ÍI. Blots were hybridized with pJ36 
(a) and pJ60 (b.c). The scale shown on both sides of the panels is based on the 
migration of the Saccharomyces cerevisiae chromosomes which were employed 
as size markers. 
within the 625 kb S/гІ fragment, this might indicate that the size 
of this deletion is 410 kb. 
The combined mapping results of the deletion endpoints divide 
the 625 kb Sfil fragment into 4 segments, denoted A through 
D (Fig. 5). 
Preparative FIGE 
In order to identify the agarose-gel strips that contain the 625 
kb .$/¡1 fragment, plbD5 was hybridized to Sfil digested DNA 
from cell line 578 (Fig. 2a), and to a dotblot containing DNA 
samples from the sliced preparative gel (Fig. 2c). Clearly, slices 
# 31 and # 32 contain sequences that are homologous to probe 
plbD5. DNA recovered from these slices was digested with 
ЕсоШ, and subcloned in lambdaZAP. We plated 3 x IO4 insert-
containing phage from the total library (I.6X 105 pfu) on NZY 
plates, and selected 232 plaques that showed a moderate or strong 
signal when hybridized to human DNA. The lambdaZAP excision 
procedure was performed for each individual recombinant to 
obtain the corresponding pBluescript clone. Small amounts of 
plasmid DNA were isolated, and the origin of the inserts was 
established by hybridization with either 32P-labeled human or 
hamster DNA. Most of the inserts of recombinant clones 
consisted of more than one EcóRl fragment, suggesting either 
concatenization of genomic ЕсоШ inserts during ligation, or 
incomplete ЕсоШ digestion of the original 625 kb Sfil fragment 
prior to cloning. Of 232 clones analysed, 153 were considered 
to be of human origin and selected for further analysis (Table 
1). The remaining clones hybridized strongly to hamster DNA, 
contained no insert, or could not be transformed into Bluescript 
plasmids. No recombinant clones were found that contained both 
human and hamster DNA, which supports our assumption that 
inserts consisting of multiple £coRI fragments are due to 
incomplete £coRI digestion of the 625 kb Sfil fragment, and hence 
are derived from a single site on the X-chromosome. 
M 
4S 10 20 30 40 
t < 4 X 
^XY 
45 
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Figure 2: Isolation of the 625 kb Sfil band, (a) Southern blot analysis of 5/ίΙ digested DNA from cell line 578 which cames a single human X chromosome, (b) 
Dissection of the preparative FIGE gel into 45 fractions and their position relative to yeast chromosome markers (M). The second lane from the left contains ethidium 
bromide-stained, Sfi\ digested DNA from the 578 cell line, (c) Dot blot containing 45 DNA samples from the central preparative part, and high molecular weight 
DNA of control male (#47). female (#48). and a 4 x cell line (LCL127; #49). Blots (a) and (c) were hybridized with probe pIbD5. 
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Localization of human clones 
Hybridization of inserts from the 153 putative human clones to 
EcoRl digested DNA from patients RvD and NP showed that 
9 clones did not yield discrete hybridization signals, 20 were of 
hamster origin, and 124 contained human inserts. From these, 
22 clones were deleted in the DNA of both NP and RvD, and 
3 clones were located only in the RvD deletion, indicating an 
assignment to Xq21.33-q22.1 (Table 2). 
Probes located in the RvD and NP deletions were hybridized 
to Southern blots carrying EcoRl digested DNA from a healthy 
Table I: Cloning DNA from an 623 kb Sfil fragment 
Screening stage No. of clones 
Total recombinants tested 
Human specific upon plaque screening 
Human specific upon miniprep screening 
X-chromosome specific signal 
Localization in Xq21.l-q22.1 
Assigned to 623 kb fragment 
30.000 
232 
153 
124 
25 
7 
Table 2: Fine mapping of probes from the Xq2l.l-q22.l segment by deletion 
analysis 
Clone(s) RvD NP 23.6 3.3 7.6 Assignment 
pZ23 
pZI72 
pZ308 
pZ52l 
pZIl 
pZ169 
pZ23l 
pZ384 
pZ17 
pZ167 
pZ22l 
pZ294 
pZ618 
pZ32l 
pZ537 
pZ138 
pZ381 
-
-
pZ228 
pZ339 
pZ394 
pZ129 
pZI96 
pZ?31 
P7.6I4 
pZ327 
+ 
-
-
-
+ 
+ + 
-
-
+ 
+ 
+ 
+ 
+ 
-
-
+ 
+ 
+ 
Xq21.2 
Xq2l.2 
Xq21.2 
Xq21.24)21.31 
Xq2l.l 
or 
Xq2l.31-421.33 
X(l21.33-q22.1 
male and from 3 patients with typical TCD and small deletions 
encompassing part of the relevant 625 kb S/il fragment. 9 clones 
were found to be located outside all 3 deletions, 13 were assigned 
in at least one of these deletions (Table 2). Five of these probes, 
i.e. pZ25 (Fig. 3a), pZ138, pZ172, pZ381, and pZ508, could 
be assigned to the region deleted in patient 3.5, but were found 
to map outside of the 7.6 and 25.6 deletions. Thus, these probes 
can be positioned in interval A within or centromeric to the 625 
kb Sfil fragment, as depicted in Fig. 5. Clone pZS2l is located 
in all 3 deletions and hence, maps to interval С (see Fig. 3b). 
Clone pZU is located in interval D, which is spanned by the 
deletions 7.6 and 25.6 (Fig. 3c). The remaining 6 clones, i.e. 
pZ169, pZ228, pZ231, pZ359, pZ384, and pZ394 (Fig. 3d), 
are located in deletion 25.6, but not in deletions 3.5 and 7.6. 
There is evidence that these clones are not derived from the 
relevant 625 kb Sfil fragment thought to carry most of the TCD 
gene, but from other Sfil fragments of similar size, as discussed 
below. 
FIGE analysis 
When hybridized to blots carrying Sfil and Sail digested DNA 
from a 48,XXXX cell line, only 2 out of 17 clones previously 
shown to be absent in the DNA of both RvD and NP, failed to 
detect specific Sfil bands. From the remaining 15 clones, 14 
detected Sfil fragments ranging in size from 600 to 650 kb, 
whereas one probe hybridized to a Sfil fragment of 700 kb. 
The five clones that were tentatively assigned to interval A 
detect a 625 kb as well as an 850 kb Sfil fragment (see probe 
pZ25 in Fig. 4a and pZ172 in Fig. 4b). The 850 kb S I^ band 
is also seen with jumpclones that are located on the relevant 625 
kb Sfil fragment, e.g. pJ60 (Fig. 4c). The Saa fragments detected 
by probes from interval A are smaller than 100 kb, or cannot 
be discriminated from the background signal. So far, we did not 
find any clones that map to the 625 kb S/il fragment, but 
centromeric to the 3.5 deletion. The FIGE analysis strongly 
suggests that all five clones from interval A are located on the 
625 kb Sfil fragment. Hence, we cannot exclude that the proximal 
endpoint of deletion 3.5 maps centromeric to the 625 kb Sfil 
fragment. 
1 2 3 4 1 2 3 4 2 3 4 
•••• 
1 2 3 4 
Figure 3: Southern blot analysis of EcoRl digested DNA of classical TCD patients 3.3 (lane 1), 7.6 (lane 2). 25.6 (lane 3), and a control male (lane 4). Blots were 
hybridized with pZ23 (a). pZ32l (b). pZIl (c). and pZ394 (d). 
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Clone pZ521 is located in a DNA segment (interval С) that 
is deleted in 3 patients with classical TCD. Southern analysis 
of all previously isolated genomic sequences from interval С has 
mapped pZ521 within 2 kb of jumpclone pJ15 (15). FIGE 
analysis did not result in discrete hybridization signals, as pZ521 
consists almost entirely of highly repetitive sequences. 
Clone pZl 1 consists of a single copy 1.2 kb £coRI fragment 
(pZl la), and a repetitive 4.2 kb £coRI fragment (pZl lb). pZl la 
and pZl lb are located next to eachother in the X-chromosome 
(unpublished data). pZl la does not only detect the characteristic 
5yil bands of 625 and 850 kb, but also hybridizes to a 400 kb 
San band (Fig. 4d). We have cloned 45 kb of genomic DNA 
spanning the jumpclones pJ59, pJll, and pJ60, as well as the 
distal breakpoint of deletion 3.5. Southern analysis of these 
genomic clones has shown that pZl 1 is not located in this DNA 
segment, and therefore must be situated telomeric to pJ60. 
The six clones found to be deleted in patient 25.6, detect a 
Sfil band of 615 kb, and do not hybridize to the characteristic 
850 kb S/il band (Fig. 4e and 4f). Moreover, they fail to detect 
the typical 400 kb Sail band. Taken together, this indicates that 
these clones are derived from a different S/il fragment in the 
Xq21.2-q21.31 region (Table 2). 
Restriction fragment length polymorphisms 
Southern analysis of DNA from TCD patients and controls 
revealed three new restriction fragment length polymorphisms 
(RFLPs). pZllb detects variable EcoRI bands of 4.2 and 4.5 
kb, and a constant band of 1.4 kb. Both the variable and constant 
bands are located in interval D of the 625 kb Sfil fragment. We 
tested 62 X-chromosomes from unrelated individuals, and 
observed allele frequencies of 66% for the larger (4.5 kb), and 
34% for the smaller (4.2 kb) allele. Also, pZllb detects an 
EcoRV RFLP, with variable bands of 2.0 kb plus 5.3 kb, and 
7.3 kb respectively, and a constant band of 6.7 kb. Estimated 
allele frequencies, were 53% for the 7.3 kb band, and 47% for 
the 2.0/5.3 kb bands. 
pZ172 detects variable £foRl bands of 5.5 and 7.0 kb, and 
a constant band of 3.0 kb. The polymorphic locus recognised 
by pZ172 maps to interval A of the 625 kb S/il fragment; the 
constant band is located outside the Xq21 region. We tested a 
total of 43 X-chromosomes from unrelated individuals and 
observed allele frequencies of 40% for the larger (7.0 kb) and 
60% forthe smaller (5.5 kb) allele. Both for pZl lb and pZ 172, 
no other enzymes were tested for RFLPs. 
DISCUSSION 
The molecular and biochemical defects underlying several genetic 
disorders have been elucidated by means of the so called 'reverse 
genetics' approach (24—27). One of the crucial, and most tedious, 
steps in this approach is the generation of a large number of 
probes from the relevant DNA region, which are then used for 
the isolation of an overlapping set of lambda or cosmid clones 
(27-37). An elegant, but seldomly used, technique makes use 
of preparative FIGE/PFGE (pulsed field gel electrophoresis), to 
enrich for sequences from a well defined, large DNA fragment 
which encompasses the disease gene (38,39). 
In a previous study (15), we described the use of a human 
jumping library that enabled us to isolate several DNA markers 
from the vicinity of the TCD gene in a directional manner. The 
minimal region of overlap between several deletions associated 
with TCD could be positioned on a large S/il fragment of 625 
kb. Thus, two important prerequisites were fulfilled for the 
application of preparative FIGE. First, enrichment of genomic 
sequences from the TCD gene region was facilitated by the fact 
that the fragment of interest is located outside the bulk of the 
Sfil genomic fragments (100-500 kb). Second, the identification 
of relevant probes from this fragment could be rapidly determined 
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Figure 4: FIGE analysis with probes pZ25 (a). pZ172 (b), pJ60 (c). pZll (d), pZ169 (e). and pZ394 (f). LCL127 DNA was digested with Sfil or Sail as indicated 
for each lane The scale on the left is based on the migration of yeast chromosomes as given in Fig. 1. 
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Figure 5: Schematic drawing of the 62S kb Sfil fragment which is flanked by 
open circles Sail restriction sites are indicated by open squares. Through analysis 
of deletions 3 5, 7 6, and 25 6, the 625 kb fragment could be subdivided into 
four regions ι e A . B . C , and О The preparative FIGE clones could be assigned 
to several of these intervals by making use of conventional Southern analysis, 
and analytical FIGE The centromenc deletion endpomt of patient 3 5 has not 
yet been mapped, because so far, no clone has been identified that is located 
centromenc to the 3 5 deletion, and inside the relevant 625 kb S/il fragment. 
Asterisks indicate polymorphic clones. 
by Southern analysis of three small deletions encompassing part 
of the TCD gene. Still, despite the considerable enrichment 
achieved through selection and cloning of this fragment, large 
numbers of human clones had to be analysed to obtain a 
reasonable number of starting points from the fragment of 
interest. This illustrates the crucial importance of the cloning 
system employed. The cloning efficiency should be as high as 
possible because of the limited amount of DNA that can be 
recovered from LGT-agarose slices. In addition, human DNA 
sequences often represent only a minor fraction of the total DNA 
content of hybrid cell lines, necessitating the screening of large 
numbers of recombinant clones. Preferably, the average insert 
length should be large to identify most of the human inserts 
through the presence of human specific interspersed repeats. The 
handling of a few hundred human clones requires rapid and large 
scale DNA isolation and hybridization procedures. 
In our hands, the lambdaZAP cloning system fulfills these 
entena satisfactorily. The in vitro packaging of lambda constructs 
provides for a cloning efficiency which exceeds that of plasmid 
transformation by a factor of 100. Making use of in vivo excision, 
recombinants can be converted directly into plasmid clones, thus 
obviating labour intensive subcloning. Also, there is no bias for 
small inserts as is often observed in plasmid cloning. 
Owing to the limited insert size of the lambdaZAP constructs 
(10 kb; ref. 40), the percentage of clones with human inserts 
that can be detected through hybridization with total human DNA 
is lower compared to vectors that allow for larger inserts (lambda-
replacement or cosmid vectors). Moreover, the relatively small 
average insert size renders isolation of low or single copy 
sequences from human clones difficult. Still, these disadvantages 
are compensated by the speed and convenience of the lambdaZAP 
system. 
We screened 100 phage containing agar plates for the isolation 
of 232 human recombinants, to minimize cross-contamination 
between neighbouring plaques. It is possible to reduce the number 
of plates to be tested by an alternative screening protocol. If 
lambdaZAP recombinants are first amplified, pooled, and 
converted into pBluescript constructs, human plasmid clones can 
be identified by screening of bacterial colonies. These can be 
plated at a higher density (approximately 1500/130 mm plate 
versus 300/130 mm plate for phage plaques), without a higher 
risk of cross-contamination. 
The human X-chromosome comprises approximately 2% of 
the total genome of the S78 cell line, as estimated using dosage 
analysis of several X-probes hybridized to Southern blots 
containing 578 and human male DNA (results not shown). In 
this study we observed that 0.8% (Table 1) of all clones carried 
a human insert. As discussed above, we may have missed a 
considerable percentage of human clones due to the small average 
insert size (6-7 kb). Also, we performed hybridization of human 
DNA sequences to phage DNA under stringent hybridization 
conditions, and thereby might have overlooked some of the 
human inserts. 
5.6% (7/124) of the human clones that showed interpretable 
hybridization signals could be assigned to the 625 kb Sfil 
fragment. Assuming a total length of the X-chromosome of 200 
million bp, this relates to an enrichment of 18-fold, which is 
comparable to the 37-fold found in a study in which an 840 kb 
Sfil fragment was enriched using preparative PFGE (39). 
Three clones isolated from the 625 kb Sfil fragment were 
studied in detail. pZS21 was localised to all three 'classical TCD' 
deletions used in this study, and was shown to map to the 
immediate vicinity of a previously isolated jumpclone pJ 15 (see 
Fig. 1 in ref. 15). pZ172 detects a RFLP centromenc to the TCD 
gene, at an estimated distance of 150—500 kb. pZIl maps 
telomeric to the 3.5 deletion, and shows two RFLPs. These three 
RFLPs should become valuable markers for the diagnosis of the 
disease in families. 
In previous studies, we have characterized a DNA segment 
of approximately 230 kb, which cames part of the TCD gene 
and is completely contained within a SfillSaR fragment of 350 
kb (15). Since pZIl maps to the same 350 kb fragment, its 
distance from pJ60, the most telomenc jumpclone isolated sofar, 
must be less than 120 kb. Recent experiments have indicated that 
pZl 1 detects two additional deletions in patients with TCD. These 
deletions do not overlap deletion 3.5, nor probe pJ60 (manuscript 
in preparation). This indicates, that the TCD gene may well 
extend to, and include the pZIl locus. Therefore the ongoing 
molecular characterization of this region and the search for 
evolutionary conserved and expressed sequences in the vicinity 
of pZl 1 should contribute to the isolation of this gene. 
ACKNOWLEDGMENTS 
The authors are indebted to F.Bmnsmann and Dr.I.H.Pawlowitzki 
for providing blood from patients with TCD. We thank 
F.Oerlemans for technical assistance in cell cultunng. This work 
was supported by Grant 900-504-064 of the Durch 'Stichting voor 
Medisch Onderzoek en Gezondheidszorg' (Medigon NWO). 
REFERENCES 
I. GoedblocdJ. (1942) Ophthalmologica 104. 308-315 
2 Waardenburg,P.J. (1942) Acta Ophthalmol 20, 235-274 
3 McCulloch.C. and McCulloch.R J Ρ (1948) Trans Am Acad Ophthalmol 
Otolaryngol. 52. 160-190. 
4. Sorsby.A , Fnuiceschetti.A , Joseph.R and DaveyJ В (1952) Bnt J 
Ophthalmol 36, 547-581 
5. Nussbaum.R L . Lewis.R A , LeskoJ G and Ferrell.R (1985) Am. J. Hum 
Genet. 37. 473-481 
6 Schwanz,M , Rosenberg.T., Niebuhr.E , Lundsteen.C , Sardemann.H . 
84 
Andersen О . Yang H M and Lamm L l' (ІЧ8Л) Hum Genet 74 
449-4 ,i2 
7 Nussbdum R L Lesko J G . Lewis R A Ltdbellcr.S A and 
LcdbcllcrDH (1987) Ргік Nail Acad Sii USA 84 б ^ І - б Ч Ч 
8 Hodgson S V Robertson. M F Fear С N Goodship.J MaLolm S . 
Jay В Bobrow M and Pembrey.M F (1987) Hum Genel 75.286-290 
9 LeskoJG Lewis RA and Nussbaum R L (1987) Am J Hum Gcmt 
40, 101-111 
10 Sankila E M de la Chapelle.A , Kama 1 Forsius H . Frani!, R and 
Eriksson A (1987) Clin Cenci 31.315-122 
11 Cremers.F Ρ M van de Pol.T J R , Wicrmga.B . Hodter.M H . 
Pearson.Ρ L Pfeifler.R A . Mikkelscn.M . Tabor.A and Ropers H H 
(1988) Am J Hum Genet 43.452-461 
12 Merry.D E Lcsko J G . Scrsnoski.D M . Lewis R A , Lubinski.M . 
Frask В vanden Engh.G . Collins F S and Nussbaum.R L (1989) Am 
J Hum Genel 45 510-540 
13 Cremcrs F Ρ M . van de Pol.TJR. Diergaarde Ρ J . Wiennga.B . 
Nussbaum R L Schwanz,M and Ropers.H -H (1989) Genomics 4.41 -46 
14 Cremers F Ρ M Branbmann.F , van de Pol Τ J R , PawlowiUki.I Η , 
Paulsen Κ Wicrmga.B and Ropers.H -H (1987) Clin Genet 32. 
421-423 
15 Cremer> F Ρ M van de Pol.T J R , Wiennga.B , Collins, F S . Sanklla.E -
M Siu.V M Flintoff.W F , Brunsmann F , Blonden.L A J and 
RopervH H (1989) Proc Natl Acad Sci USA 86. 7510-7314 
16 Van Ommen.G I R and VerkcrkJ M H (1986) In Davies.K E (ed ) Human 
Genetic Diseases, A Practical Approach IRL Press, Oxford, pp 113-133 
17 Carle G F . Frank,M and Olson,M V (1986) Science 232. 65-68 
18 Manutis.T . Fntsch.E F and Sambrook.J (1982) Molecular Cloning A 
Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring 
Harbor. NY 
19 Fcmberg.AP and Vogelstem.B (1983) Anal Biochem 132.6-13 
20 Feinbcrg.A Ρ and Vogelstem.B (1984) Anal Biochem 137, 266-267 
21 Cremeni.F Ρ M . Pfeifler.R A , van de Pol.T J R , Hodter, Μ Η , Kruse, 
Τ A . Wieringa В and Ropers.H -H (1987) Hum Genet 77, 23-27 
22 Holmes,DS and Quigley.M (1981) Anal Biochem 114, 191-197 
21 Litt M andWhite.RL (1985) Proc Natl Acad Sci USA 82 6206-6210 
24 Friend S H , Bcmards.R . Rogelj.S , Weinberg.R A . RapaporU M . 
Albert.D M and Dryja.T Ρ (1986) Nature (London) 323, 643-646 
25 Monaco.A Ρ . Neve.R L , Coletti Feener.C , Benelson.C J . Kumitt.D M 
and Kunkel L M (1986) Nature (London) 323, 646-650 
26 Royer Pokora.B Kunkel.L M . Monaco.A Ρ , GofT.S С . Newburger.P E-. 
Baehner R L . Cole.F S . Curnulte.J Τ and Orkin.S H (1986) Nature 
(London) 322. 32-38 
27 Rommens,J M lanuzzi.M С . Kerem.B S , Dnimm M L . Melmer.G . 
Dean,M , Rozmahel.R . Cole.) L , Kennedy,D , Hidaka.N , Zsiga.M . 
Buchwald.M . Riordan.J R . Tsui.L С and Collins.F S (1989) Science 
245, 1059-1065 
28 Poneous.D J , Morten J Ε N , Cranslon.G , Fletcher,! M , Milchell.A . van 
Heynmgen.V , Fanles.J A , Boyd.P A and Hastie.N D (1986) Mol Cell 
Biol 6, 2223-2232 
29 Ludecke.H J , Senger.G , Claussen.U and Horsthemke.B (1989) Nature 
(London) 338, 348-350 
30 Burke.D Τ , Carle.G F and OIson.M V (1987) Science 236, 806-812 
31 Collins.F S and Weismann.S M (1984) Proc Natl Acad Sci USA 81. 
6812-6816 
32 Poustka.A and Lehrach.H (1986) Trends Genet 2. 174-179 
33 Collins F S . Dminm.M L . Cole J L , Lockwood.W К , VandeWoude.G F 
and lanuzzi.M С (1987) Science 235, 1046-1049 
34 Poustka.A . Pohl,Τ M , Barlow,D Ρ . Frischauf.A M and Lehrach.H 
(1987) Nature (London) 325. 353-355 
35 Smith.C L , Lawrancc.S К . Gillespie.G A , Cantor.C R Weissman.S M 
and Collins.F S (1987) Methods Enzymol 151.461-489 
36 Kenwnck.S I , Smith.T J . England.S , Collins.F S and Davies.K E (1988) 
Nucleic Acids Res 16, 1305-1317 
37 Richards.J E , Gilliam.T С , Cole,! L , Dnimm M L , Wasmulh J J . 
Gusella.J F , and Collins.F S (1988) Proc Natl Acad Sci USA 85. 
6437-6441 
38 Michiels.F , Burmeister.M and Lehrach.H (1987) Science 236, 1305-1308 
39 Anand.R , Honeycnmbe.J , Whittaker.P A , Elder.J К and Southern.Ε M 
(1988) Genomics 3. 177-186 
40 Short J M . Fernandez.J M , SorgcJ A and Huse.W D (1988) Nucleic 
Acids Res 16. 7583-7600 
Θ5 

Chapter 7 
Cloning of the breakpoints of a deletion 
associated with choroideremia 
Reprinted with permission from: 
Hum. Genet. 86:61-64.1990 

Cloning of the breakpoints of a deletion associated with choroiderernia* 
F .P.M.Cremen ' , F.Brunsmann2, W.Berger', E.P.M.vanKerkhoff', T.J.R.vandePol', B.Wieringa', 
I.H.Pawlowitzki2, and H.-H. Ropers' 
' Department of Human Genetics, University Hospital, University of Nijmegen, P.O.Box 9101, NL-6500 HB Nijmegen. The Netherlands 
Mnstitut fur Humangenetik der Università!, W-4400 Münster, Federal Republic of Germany 
Received Apnl 2,1990/ Revised June 1, 1990 
Summary. In order to characterize a previously described 
submicroscopic deletion encompassing (part of) the cho-
roideremia (tapetochoroidal dystrophy: TCD) gene, we 
have cloned a 10.5-kb £coRI fragment from the pa-
tient's DNA; this fragment carries the junction between 
both deletion endpoints ("junction fragment"). The dis-
tal portion of this fragment defines a new marker within, 
or just distal to, the TCD gene. This marker has been 
employed to confirm the diagnosis in several affected 
family members, and to rule out carriership in a female 
at risk with conspicuous clinical signs. 
Introduction 
Tapetochoroidal dystrophy (TCD) is an X-linked disor-
der of the retinal pigment epithelium (RPE), choroid, 
and retina; it causes progressive nightblindness and vis-
ual field constriction in affected males (Goedbloed 1942; 
Waardenburg 1942; McCulloch and McCulloch 1948). 
Female carriers generally show characteristic pigment 
mottling in the midperiphery or posterior pole; this 
closely resembles fundus anomalies observed in affected 
young males (Pameijer et al. 1960; Krill 1967). In most 
cases, the fundus signs in TCD carriers are stationary 
and cause no visual field defects. 
The gene locus for TCD has been assigned to Xq21 
by analysis of deletions in male TCD patients with com-
plex phenotypes (Hodgson et al. 1987; Nussbaum et al. 
1987; Schwanz et al. 1988; Cremers et al. 1988, 1989a). 
Molecular characterization of the Xq21 region in pa-
tients with classical TCD revealed microdeletions that 
spanned the DXS165 locus, but none of the other loci 
tested (Cremers et al. 1987). Cloning of several new 
markers in the vicinity of the DXS165 locus by use of 
chromosomal walking and jumping techniques enabled 
us to define the size of a DNA segment that is spanned 
by four microdeletions, and to characterize the X-chro-
* This work was presented in part at the 5th International Re-
tinitis Pigmentosa Congress, Melbourne 1988 
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mosomal breakpoint of a de novo X;13 translocation 
that was identified in a female with TCD (Cremers et al. 
1989b). 
Here we report on the cloning and characterization 
of a DNA fragment that carries the junction between the 
endpoints of a previously described microdeletion that 
encompasses (part of) the TCD gene (Cremers et al. 
1987, 1989b). The junction fragment was employed to 
perform reliable carrier detection in the patient's family. 
Materials and methods 
TCD patients 
The TCD family shown in Fig. 3 forms part of a five generation 
family previously described in detail by Diekstall and Demeler 
(1988). All members except individuals 7 2 and 7.12 were exam-
ined by funduscopy and functional ophthalmologic methods. TCD 
was diagnosed in three males (7 6,7 7, 7 II). Two obligate earner 
females (7.1,7.4) showed the expected pigmentation alterations in 
the midperiphery of the fundus. In a possible female earner (7 8), 
fundus characteristics were inconclusive (Diekstall and Demeler 
1986, 1988). 
Cloning of the 7.6 deletion-junction fragment 
DNA from patient 7.6 (100μ§) was digested with EcoRI; frag­
ments were ethanol precipitated, and resolved electrophoretically 
on a 0.7% low-gelling-temperature (LGT) agarose gel. Flanking 
lanes containing size markers were subsequently cut off and 
stained with ethidium. The unstained central part of the gel was 
cut into 2 mm-wide strips perpendicular to the running direction. 
A small piece of each strip, corresponding to one lane of DNA, 
was melted for 5 mm at 95°C, and brought to 0.3-0.5 M NaOH. 
The samples were spotted onto a Hybond-N membrane by means 
of a slot-blot apparatus that had been prewarmed to ЗТ'С. DNA 
(4pg) from a male, female, and a cell line containing four X-chro-
mosomes (LCL127) were used as controls. The membrane was 
neutralized by washing in 0.5 M TRIS-HCI pH 7.5, 1.5 M NaCl, 
Im.W EDTA for 10 min, air-dned, and exposed to UV-light 
(305 nm) for 3 mm. 
The membrane was hybridized to probe plbD5-II, a single 
copy sequence located just centramene to plbDS, and washed as 
recommended by the manufacturer. A positive hybridization sig­
nal at 10.5 kb was observed Next, the LGT-agarose stnp contain­
ing DNA from the 10.5 kb EcoRI fragment was nnsed three times 
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in l(lm.WTRIS-HClPH7.5. ІООш.И NaCI. 1 mM EDTA, melted 
at 65*C for Itlmin. and incubated overnight with 50U agarase/ml 
(CalbiiK'hem) at ITC. DNA (2Mg) was recovered by sequential 
phenol and chloroform extraction, and by ethanol precipitation in 
the presence of 0.3.И NaAc. pH 6. A portion (120ng) of the 
10.5 kb £foRI fraction was ligated to 500 ng of £coRI and Sad 
doubly cleaved lambda DASH DNA (Stratagene. La Jolla. Calif). 
The ligation mixture (310 ng) was packaged in vitro using Promega 
packaging extract. After plating on Escherichia coli strain P2392, 
95000 clones were obtained. Identification of plbD5-II positive 
plaques and subcloning of DNA fragments into plasmid vectors 
рСЕМЗ (Promega) or pBluescnpt (Stratagene) were performed 
according to published procedures (Maniatis et al. 1982). The nuc­
leotide sequences of DNA fragments plbD5-I and pJ7.6 were de­
termined in one strand employing the supercoil sequencing meth­
od. essentially as given by Chen and Seeburg (1985). and Hattori 
and Sakaki (1986). 
Southern blot analysis 
Chromosomal DNA was isolated as described by Aldridge et al. 
(1984), with minor modifications DNA (lOpg) was digested with 
the appropriate restriction enzyme, fragments were resolved by 
agarose gel electrophoresis and blotted onto Gene Screen Plus 
(NEN) membranes as described (Cremen et a!. 1989a). All probes 
employed have been described elsewhere (Cremerà et al. 1989a, 
b). Insert DNAs were electrophoretically separated from the plas-
mid vector and isolated in LGT-agarose (Biorad). Radioactive 
probes were prepared by random oligonucleotide priming (Fein-
berg and Vogelstein 1983, 1984). Prior to hybridization, probes 
containing repetitive sequences (plbD5, plbDS-l. plbD5-II. pJ60, 
pJ7.6) were preassociated with sonicated human DNA as described 
by Litt and White (1985). Details of (pre)hybridization and wash-
ing of filters were as published (Church and Gilbert 1984). 
Field inversion gel electrophoresis (FIGE) analysis 
Methods for the preparation of high molecular weight LCL127 
(48.XXXX) DNA in agarose blocks, restriction enzyme digestion. 
FIGE, and blotting, have been described in detail elsewhere (Cre-
mers et al. 1989a). 
Results 
Cloning of the 7.6 deletion junction fragment 
In a previous study, we isolated a cosmid spanning the 
DXS165 locus (c237·. Cremers et al. 1989b). Single- or 
low-copy fragments were subcloned. gel-purified, and 
used as probes. The proximal endpoint of the deletion in 
patient 7.6 was mapped between plbD5 and a more cen-
tromeric subclone of c237, plbD5-IV (Cremers et al. 
1989b). With probe plbD5-I or -II. Southern analysis of 
EcoRI digested DNA from patient 7.6 and a male con-
trol revealed a normal band of 7.8 kb in the control male, 
and an altered (junction) fragment of 10.5 kb in patient 
7.6 (Fig. lb) . Probe plbD5-I detects a 0.9-kb Я/ndIII 
band in DNA of patient 7.6, whereas in healthy controls, 
a 0.5-kb band is seen (results not shown). This indicates 
that the proximal endpoint of this deletion must be lo­
cated within the plbD5-I sequence (Fig. la) . 
The 10.5-kb EcoRI fragment was gel-purified and 
cloned into lambda DASH phage vector DNA. Probes 
plbD5-I and -II detected 4 clones out of 95000 recom­
binants, one of which was analyzed in detail. The restric­
tion pattern of this clone (λ J7.6; Fig. la) agreed with 
that expected for the rearranged chromosome segment. 
The authenticity of the junction clone was determined by 
Southern analysis of genomic DNAs from the deletion 
patients 3.5, 7.6, 25.6, and a control male, and by de­
tailed analysis of λ J7.6 plasmid-borne subclones. The 
6.0-kb Hindlll-EcoRl fragment originating from the 
telomeric part of λ J7.6 (Fig. la) predominantly contains 
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Fig. la-c. Cloning and characterization of the 
deletion junction fragment in TCD patient 7.6. 
a Restriction maps of the DNA segments that 
span the 7.6 deletion endpoints. and of the 
deletion junction clone λ J7.6. Only £coRI (E) 
and Hinálll (Η) sites are indicated. 
b Southern blot analysis of EcoRI-digested 
DNA of TCD patients 3.5 (lanes I). 7.6 (lanes 
2), 25.6 (lanes 3), and a male control (lanes 4), 
employing a probe located just centromeric to 
deletion 7.6 (plbD5-II), and the deletion 
junction clone pJ7.6. The weak hybridization 
signal detected with pJ7.6 in patient 3.5 (lane I), 
is the result of a smaller amount of DNA in this 
lane compared with the others, с FIGE analysis 
with probes pJ60 and pJ7.6. LCL127 DNA was 
digested with Sfil (lanes 1) or Sail (lanes 2). The 
scale shown on the left is based on the migration 
of the Saccharomyces cerevisiae chromosomes 
that were employed as size markers 
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Flg. 2. Deletion map of the TCD locus at Xq21.2. Deleted regions 
are depicted between arrowheads. The centromenc endpoint of 
the deletion in patient 3 S is not accurately mapped as indicated by 
a dashed Ime. Three 5/71 (Si sites are indicated to underscore the 
finding that pJ7 6-B is located on a 230-kb Sfil fragment that does 
not span any of ihe other DNA probes shown here 
moderate or highly repetitive sequences (not shown). 
The actual deletion-breakpoint containing subclone pJ7.6 
(0.9-kb //indili) proved to be a low-copy probe, and 
subsequently was used in Southern analysis. In addi-
tion to the bands detected by plbDS-II, pJ7.6 hybrid-
izes to a 6.8-kb £coRI fragment in patient 3.S and con-
trol male (Fig. lb). This EcoRI band is detected by 
the part of clone pJ7.6 (pJ7.6-B) that is located distal to 
the breakpoint junction, telomeric to the 3.5 deletion, 
and completely contained within the 25.6 deletion (Fig. 2). 
Nucleotide sequencing of clones pJ7.6 and plbD5-I re-
vealed that the junction fragment contains 466 bp of 
the region flanking the centromeric deletion endpoint, 
and approximately 430 bp flanking the telomeric dele-
tion endpoint. 
FIGE analysis 
To determine the physical location of pJ7.6-B, we hyb-
ridized pJ7.6 to a FIGE blot containing Sfil- and Sa/I-di-
gested control DNA. As expected, because approximate-
ly half of the clone (pJ7.6-A) originates from the DXS165 
locus, pJ7.6 detects the Sfil and Sail bands of 625 kb and 
400 kb, reported earlier (Cremers et al. 1989a). In addi-
tion, pJ7.6 detects a 230-kb Sfil band, and two faint Sail 
bands of 230kb and 125 kb (Fig. 1c). From these data, 
combined with the data from deletion analysis, we con-
clude that pJ7.6-B is located at an unknown distance 
telomeric to pJ60, but centromeric to pXG7c (Fig. 2). 
Carrier detection m family 7 
Hybridization of probe plbDS to a blot containing EcoRI-
digested DNA from members of family 7 (see Fig. 3), 
identifies a deletion in the affected males 7.6, 7.7, and 
7.11, as expected. Dosage analysis carried out in order 
to determine TCD carriership in individuals at risk was 
hampered by different factors, such as insufficient av-
ailability of DNAs, blotting conditions, and nonspecific 
degradation of DNA. With the pJ7.6 probe, unambigu-
ous proof could be obtained for the carrier status of 
females 7.1 and 7.4, as they display the junction 10.5-kb 
EcoRI band next to the normal 6.8-kb and 7.8-kb EcoRI 
fragments (Fig.3). Two individuals at risk for carrying 
the TCD deletion, namely female 7.8 and male 7.5, 
showed only the normal 6.8-kb and 7.8-kb EcoRI bands. 
12 11 6 7 1 2 8 5 4 10 
£Tl· Pi* 
kb 
105 *»-ф,<тФ m 
7 8 
8 8 
<*- ν «Ρ «» «KlÉf p J 7 e St 
plbDS 
ïlg. 3. Southern blot analysis of EcoRI-digested DNA of individu-
als from family 7 with probes pJ7.6 and plbD5 
Discussion 
As a prerequisite for cloning of the TCD gene, we iso-
lated several clones from the relevant DNA region by 
chromosomal jumping (Cremers et al. 1989b). In addi-
tion, we have obtained markers from a library highly en-
riched for sequences from the TCD locus by preparative 
FIGE (Pol et al. 1990). As a third approach, described 
here, we have cloned the junction fragment (pJ7.6) of a 
submicroscopic deletion associated with TCD. FIGE 
analysis of control DNA indicated that the junction clone 
detects two different Sfil fragments. Therefore, the cor-
responding deletion is not confined to the 625-kb Sfil 
fragment, which was previously shown to carry part of 
the TCD gene, and we have to conclude that ifeletion 7.6 
extends further distally, encompassing at least one, and 
possibly several, other Sfil fragment(s). 
Cloning of the proximal deletion breakpoint and the 
corresponding junction fragment enabled us to provide a 
reliable diagnostic test for relatives of patient 7.6. The 
presence of a deletion-specific junction fragment con-
firmed the diagnosis of TCD in three affected males and 
the obligate carrier state of two females. The absence of 
the junction fragment in the DNA of a boy (7.5) and a 
girl (7.8), both at risk of inheriting the deletion from 
their carrier mother, ruled out TCD and carriership of 
TCD in these individuals, respectively. It is noteworthy 
that at the age of 8 years, the fundi of individual 7.8 
showed some small midperipheral pigmentations that 
were taken as being indicative of TCD carriership. There-
fore, our finding illustrates that, whenever possible, car-
rier diagnosis in TCD should be corroborated by DNA 
analysis. Recent data from our laboratory indicate that 
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similar deletions encompassing part of the TCD gene 
can be detected in at least 10% of the patients (unpub­
lished results). In most other families, unambiguous 
diagnostic results can be obtained with closely linked 
probes (Pol et al. 1990). 
As depicted in Fig. 2, pJ7.6-B is located between the 
most telomeric jump clone (pJ60) and the anonymous 
probe pXG7c (DXS95), and is therefore useful as a new 
molecular entry site for the chromosomal segment that 
cames the TCD locus. Indeed, employing pJ7.6 as a 
probe, we have recently detected two microdeletions as­
sociated with TCD, one of which had not yet been iden­
tified with any of the anonymous markers and jump clones 
available from the Xq21.2 region (Cremers et al., 1990). 
Characterization of these small deletions will further as­
sist in defining the genomic size of this locus and eventu­
ally help to clone the TCD gene itself. 
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Summary 
Making use of the plbDS probe (DXS165), we have isolated several markers from the choroideremia locus 
by chromosomal jumping, preparative field-inversion gel electrophoresis, and cloning of a deletion junction 
fragment. With these clones we were able to identify and characterize eight deletions in 69 choroideremia 
patients investigated. The deletions are heterogeneous, in both size and location. The smallest deletion (pa-
tient LGL1134) comprises approximately 45 kb of DNA, whereas the largest ones (patients 25.6 and 
LGL2905) span a DNA segment of at least 5 megabases, which is comparable in size to the smallest dele-
tion detected in a TCD patient (patient XL45) showing a complex phenotype. The TCD deletions encom-
pass variable parts of a 150-200-kb DNA segment that is flanked by plbD5 (DXS165) at the centromeric 
side and by pZll at the telomeric side. The deletions in patients 33.1, LGLUOl, and LGL1134 do not span 
a translocation breakpoint which was previously mapped on the X chromosome of a female with TCD. 
The clones isolated from the TCD locus are valuable diagnostic markers for deletion analysis of patients 
or carrier females. In addition, they should be useful for the isolation of expressed sequences that are part 
of the TCD gene. 
Introduction 
Cytogenetically visible deletions in the X chromosome 
of males are almost invariably associated with contigu-
ous gene syndromes and are predominantly located in 
Giemsa dark-staining bands. The absence of large DNA 
segments in Xp22.3 and Xp21 results in complex dis-
orders, of which ichthyosis and Duchenne muscular dys-
trophy, respectively, are the most prominent features 
(Curry et al. 1984; Francke et al. 1985; Wieringa et 
al. 1985; Saito et al. 1986; Pillers et al. 1988). Dele-
tions of various parts of Xq21 are associated with 
choroideremia (tapetochoroidal dystrophy [TCD]), men-
Rcceived February 15, 1990; revision received Apnl 26, 1990. 
Address for correspondence and lepnnts: F. P. M. Cremen, Depart-
ment of Human Genetics, Radboud Hospital, University of Nijme-
gen, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. 
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tal retardation (MR), deafness, or other symptoms, in-
cluding deft lip and palate (CLP) (Rosenberg et al. 1986; 
Schwartz et al. 1986,1988; Hodgson et al. 1987; Nuss-
baum et al. 1987; Cremers et al. 1988,1989л,· Merry 
et al. 1989). Independent evidence for the TCD gene 
being located at Xq21 has been obtained by linkage 
studies (Lewis et al. 1985; Nussbaum et al. 1985; Jay 
et al. 1986; Schwartz et al. 1986; Lesko et al. 1987; 
MacDonald et al. 1987; Sankila et al. 1987, 1989). 
Deletion mapping of five TCD patients showing a 
complex phenotype enabled us to subdivide the Xq21 
band into seven intervals (Cremers et al. 1989л). The 
TCD gene could be positioned in interval 3, which is 
defined by the loci DXS233, DXS165, and DXS95. Fur­
thermore, in two females with TCD, this condition was 
associated with different chromosomal translocations, 
both involving Xq21.2 (Kaplan et al. 1989; Siu et al. 
1990). 
The position of the TCD gene has been determined 
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more precisely by the molecular identification of mi-
crodeletions that span the DXS165 locus (probe plbD5, 
Cremers et al. 1987я) in the DNA of patients with clas­
sical TCD Chromosomal walking and jumping from 
the DXS165 locus enabled us to characterize four of 
these TCD deletions, as well as the Xq21.2 breakpomt 
in the DNA of a TCD female with a de novo X;13 trans­
location (Cremers et al. 19896). The DNA region con­
taining the putative TCD gene was saturated with ad­
ditional clones by the construction of a library enriched 
for sequences from a 625-kb Sfil fragment (van de Pol 
et al. 1990). From this library, several informative clones 
were obtained, one of which was used in the present 
study Also, we have cloned the endpomts of a TCD 
deletion (Cremers et al., in press), which provided us 
with an additional marker for the identification and 
characterization of deletions in patients with TCD. 
Material and Methods 
TCD Paventi 
A total of 69 male paoents showing the classical TCD 
phenotype were ascertained by F.B., B.J., A.J.L.G.R, 
E.-M.S., and M.S. The diagnosis of TCD was inferred 
from the characteristic history and fundus appearance 
(Sorsby et al. 1952; Kurstjens 1965; Kämä 1986), con-
sisting of peripheral pigmentary retinopathy with areas 
of pigmented epithelial and choroidal atrophy. Retinal 
vessels are unremarkable even at advanced stages of the 
disease. The clinical picture of patients 3.5 and 7.6 has 
been described by Hammerstein and Böhm (1985) and 
Diekstall and Demeler (1988), respectively. The TCD 
patients belong to various Caucasian subpopulations, 
including the Finnish (patients LGL1101, LGL1134, and 
LGL2905), the German (patients 3.5, 7.6, 25.6, and 
33.1), and the British (patient C3). 
A female TCD patient who showed mild TCD and 
infertility secondary to premature ovarian failure was 
karyotyped as 46,X,t(X;13) (q21.2;pl2) by using tryp-
sin-Giemsa staining. Somatic cell hybrids formed be-
tween skin fibroblasts from this patient and mouse A9 
fibroblasts yielded a mouse-human hybrid (CIII-1), 
which contained the derivative der(13 ) chromosome but 
not the reciprocal der(X) chromosome (Siu et al. 1990). 
DNA Marken 
The anonymous DNA probes from the Xq21 region 
(fig. 1), have been described elsewhere (Goodfellow et 
al. 1985, Cremers et al. 1987b, 1988; Nussbaum et al. 
1987). Probe pXG8b was provided by P. Szabo; pFl 
and pF8 were gifts from T. A. Kruse ( Aarhus). The jump 
clones pjll, pJ15, pJ36, pJ59, and pJ60 have been de-
senbed elsewhere (Cremers et al 1989ί>). 
pZll was isolated from a library enriched for se­
quences from a 625-kb S/¡] fragment, by using prepara-
uve field-inversion gel electrophoresis (FIGE). pZll con-
tains two £coRI fragments (1.2 and 4.2 kb), which are 
located next to each other in the X chromosome (van 
de Pul et al 1990). The 1.2-kb fragment (pZlla) con-
tains no repenave sequences and is used in the present 
study for mapping purposes The 4.2-kb fragment 
(pZllb) contains highly repetitive sequences (F. P. M. 
Cremers, unpublished results). 
pJ7.6 is a junction clone (0.9-kb HindlH) which con-
tains sequences from the endpomts of deletion 7.6 
(Cremers et al., in press). This clone contains some 
moderately repetitive sequences requiring preassocia-
tion with sonicated human DNA before being used as 
a probe (see below). 
Southern Bfot Analysis 
Chromosomal DNA was isolated according to a 
method described by Aldridge et al. (1984), with mi-
nor modifications. DNA (10 μg) was digested with the 
appropriate restriction enzyme, and fragments were 
resolved by agarose-gel electrophoresis and blotted onto 
GeneScreenPlus (New England Nuclear) membranes 
(Cremers et al. 1989<з). Insen DNAs were electropho-
retically separated from the plasmid veaor and were 
isolated in LGT-agarose (Biolab). Radioactive probes 
were prepared by random oligonucleotide pruning (Fern-
beig and Vogelstem 1983, 1984). Prior to hybridiza­
tion, probes containing repeonve sequences (i.e., probes 
pX65H7, pX104f, pFl, pF8, pJ36, pJ60, and pJ7.6) were 
preassoaated with sonicated human DNA (Litt and 
White 1985). Conditions for (pre)hybndization and 
washing of filters have been published elsewhere 
(Church and Gilbert 1984). 
Pulstd-FMd Cd Ehctnphonsa (PFGE) Analysis 
Methods for the preparation of high-molecular-
weight DNA in agarose blocks and restnction-enzyme 
digestion have been described elsewhere (Cremers et 
al. 1989л). PFGE was earned out using a contour-
damped homogeneous cleane field apparatus accord­
ing to the specifications given by Chu et al. (1986). White 
blood cells from TCD patients LGL526, LGLllOl, 
LGL1134, LGL1307, and LGL2905 and from a control 
female were embedded in LGT agarose (van Ommen 
and Verkerk 1986). Agarose-immobilized DNAs were 
digested with Sfil, as recommended by the manufac-
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F i g u r e I Deletion map of the Xq21 band, with the anonymous DNA probes employed indicated at the left The ordering of probes 
in intervals is based on the molecular analysis of syndromic TCD patients, who ate depicted at the right side for comparison (see Cremers 
e t a l 1989α) 
turer. Blocks were subsequently transferred to slots of 
a 1% (w/v) agarose gel. Electrophoresis was performed 
in 0.25 χ TBE (Mamans et al. 1982) for 72 h at 140C 
and 120 V. The switching interval was kept constant 
at 120 s for the forward phase and 40 s for the reverse 
phase. DNA transfer and hybridization methods were 
the same as previously described for FIGE analysis 
(Cremers et al. 1989д). 
Results 
Using the anonymous probes depicted in figure 1, 
we were able to detect a total of five deletions in 69 
patients with classical TCD. The deletions found in pa­
tients 3.5 and 7.6 are confined to the plbD5 (DXS165) 
marker (Cremers et al. 1987д). The deletion present 
in the DNA of patient 33.1 was not detected with plbDS 
but was deteaed with pXG7c (DXS95), which is also 
located in interval 3, and is situated telomeric to plbD5. 
Patients 25 6 and LGL2905 both carry large intersti­
tial deletions that encompass six anonymous markers. 
The proximal endpoint of deletion LGL2905 is located 
in interval 2 between pJL68 (DXS232) and p784 
(DXS121). Therefore this breakpoint maps to the 400-
kb Sfil fragment which contains both markers (Cremers 
et al. 1989д, Merry et al. 1989). The distal deletion 
endpoint is located in interval 4, thereby allowing as­
signment of pDP34 (DXYS1) distal to pXG8b and p722 
(DXSUO). The proximal deletion endpoint in patient 
25.6 is located just centromenc to plbD5; the telomeric 
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Figure 2 Delenon map of the TCD locus at Xq21 2 Ddeted regions are depiaed between arrawheadi, the location of the X chn>-
mosomal breakpoint of a X,13 translocation in a female with choroideremia is shown at the bottom The cemromenc endpoints of the 
deletions in patients J 5, 33 1, and LGLllOl, as well as the telomenc endpoint of deletion C3, are not accurately mapped, as indicated 
with dashed lines Clones pJ7 6 A and pZll are positioned on the 625 kb SfA fragment which encompasses plbD5 and the jump clones 
indicated pJ7 6 В is located on a 250-kb S/ΐΙ fragment (van de Pol et al 1990, Cremen et al , in press) 
endpoint maps to interval S (Cremers et al. 1989b). 
Deletions 25.6 and LGL2905 overlap to a large extent 
with the complex TCD deletions XL45 and DM (fig 1). 
Physical Fine Mopping of Deletions in Classical 
TCD ftrt/enti 
Employing all DNA markers indicated in figure 2, 
we were able to detect eight deletions in 69 TCD pa­
tients investigated. The jump clones pjll, pJ15, pJ36, 
pJ59, and pJ60 detect six deletions, four of which (3 5, 
7 6,25 6, and LGL1134) have been reported elsewhere 
(Cremerset al. 198 9b). Deletion LGL2905 encompasses 
the entire region depiaed in figure 2 (see above-, fig. 
1). Deletion C3 spans the markers pJ15, pJ59, pjll, and 
pJ60. 
Clones pZll and pJ7.6 have been obtained by em­
ploying alternative cloning strategies (van de Pol et al. 
1990; Cremers et al., in press). pZll is spanned by the 
deletions 7.6,25.6,33.1, LGLUOl, and LGL2905 and 
is located telomenc to the deletions detected m the DNA 
of patients 3 5, LGL1134, and C3. Southern blotting 
results for patients LGLllOl, LGL1134, and LGL2905 
are presented m figure 3. Except for deletion 7.6, pJ7 6-B 
yields the same hybridization results as does pZll (data 
not shown). 
The translocation breakpoint present in the X chro­
mosome of a female showing TCD (46,X,t[X;13] 
[q21.2;pl2]) is located within 2 kb telomenc to pjll 
but just centromenc to deletion LGL1134, as indicated 
in figure 2. For two patients, C3 and LGL1134, PFGE 
analysis can allow for an accurate estimation of dele­
non sizes, since both are completely contained within 
the 625-kb Sfil fragment. Deletion C3 has not been in­
vestigated; the analysis of deletion LGL1134 will be de­
scribed below. 
PFGE Analysis of DeleUons 
High-molecular-weight DNA from several TCD pa­
tients and from a control female was digested with Sfil, 
resolved by PFGE, and hybridized to probe plbDS. 
Compared with controls, plbD5 detects altered DNA 
fragments in patients LGLllOl and LGL1134 (see fig. 
4, lanes 4 and 6). The deletion found in LGL2905 (see 
fig. 4, lane 2) spans all loa depiaed in figure 2. Patient 
LGLllOl shows a band of 575 kb, which does not give 
a clue regarding delenon length, as this deletion ex­
tends beyond the 625-kb Sfl fragment (fig. 2). The 580-
kb Sß band observed m patient LGL1134 direaly re-
lates to a deletion size of 45 kb, as this deletion is 
confined to the 625-kb Sß fragment. 
Discussion 
TCD is an X-lmked chonoretmal dystrophy in which 
affeaed males suffer from progressive night blindness 
and visual field constriction, leading to blindness by 
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Figure 3 Southern blot analysis of Tà^l-digested DNA from 
control female (lanes 1 and 7) and TCD patients LGL1134 (lane 2), 
LGL1101 (lane 3), LGL290J (lane 4), LGLS26 (lane 5), and LGL1307 
(lane 6), with the probes indicated at the right. The upper part of 
the blot was exposed for a longer time to enhance the signals for 
pjll and pJ15 compared with that for pZlla. 
the third to fourth decade of life (Goedbloed 1942; 
Waardenburg 1942; McCulloch and McCulloch 1948; 
Sorsby et al. 1952). Female carriers, although normally 
asymptomatic, can be detected by characteristic patchy 
changes in the retinal pigment epithelium that reflect 
random X inactivation. 
In previous studies, we and others have shown that 
TCD patients showing additional disorders carry dele-
tions that vary considerably in size (Hodgson et al. 1987; 
Nussbaum et al. 1987; Creraers et al. 1988, 1989ІЗ,· 
Schwartz et al. 1988; Merry et al. 1989). The smallest 
deletion associated with a complex phenotype (patient 
XL45) was estimated to span approximately 5,300 kb, 
as determined by flow karyotype analysis (Merry et al. 
1989). This deletion could not be detected with cer­
tainty by high-resolution chromosome analysis but was 
identified with anonymous DNA markers from Xq21 
(Nussbaum et al. 1987). The other four TCD patients 
with complex syndromes showed microscopically visi­
ble deletions in the Xq21 band. On the basis of the 
size estimate for the deletion in the X chromosome of 
patient XL62 (12,000 kb; Merry et al. 1989), we as­
sume that the deletions found in patients NP and MBU 
encompass approximately 15 megabases. 
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Figure 4 PFGE analysis with probe plbD5 oí S/ìl-digested high-
molecular-weight DNA from a control female (lane 1) and TCD pa-
tients LGL2905 (lane 2), LGL526 (lane 3), LGL1101 (lane4), LGL1307 
(lane 5), and LGL1134 (lane 6). The scale shown on the left is based 
on the migration of the Saccharomyces cerevtsiae chromosomes which 
were employed as size markers. 
In an earlier report, we described the identification 
of deletions in TCD patients 3.5 and 7.6. These dele-
tions were presumed to be relatively small, because they 
only spanned the DXS165 locus, and none of the other 
anonymous markers from Xq21 tested. The surprising 
finding in the present study is that patients with classi-
cal TCD show deletions that vary in size from approxi-
mately 45 kb (patient LGL1134) to several megabases 
(patients 25.6 and LGL2905). Taken together, the de-
letions in the latter two patients span part of interval 
2, intervals 3 and 4, and part of interval 5. Apart from 
a small proximal fragment, this DNA segment over-
laps almost entirely the previously analyzed deletions 
of patients DM and XL45 (fig. 1), who show not only 
TCD but also MR and congenital sensorineural deaf-
ness. Therefore, genes involved in MR and deafness may 
be located in the proximal part of interval 2, a DNA 
segment defined by the DXS232 locus. Recently, an-
other probe mapping to interval 2, pHU16 (DXS26), 
was localized centromeric to the LGL2905 deletion 
(Sankila et al. 1990) and should be of use for further 
fine mapping of the loci involved in MR and in congen-
ital sensorineural deafness. Patient NP does not show 
deafness despite the fact that his deletion overlaps the 
entire interval 2, indicating that the absence of this in-
terval predisposes for— but does not necessarily cause— 
hearing impairment. 
To define the subchromosomal region carrying the 
TCD gene, we have isolated DNA clones by making 
101 
use of (1 ) chromosomal walking and jumping from the 
DXS165 locus (Cremers et al. 1989fc), (2) construction, 
by preparative FIGE (van de Pol et al. 1990), of a li­
brary enriched for sequences from a 625-kb Sfil frag­
ment, and (3) forced cloning of a gel-punfied deletion 
junction fragment of the deletion observed in patient 
7.6 (Cremers et al., in press). In a total of 69 TCD pa­
tients investigated with these probes, we were able to 
detect and characterize eight deletions, four of which 
could be identified with probe plbD5 (DXS165). This 
finding is remarkable in view of the results of Merry 
et al. (1990), who did not detect any deletion with probe 
plbDS (DXS165) in 42 unrelated TCD probands. 
The deletions found in patients 33.1 and LGL1101 
do not overlap the deletion in panent 3.5. Cloning of 
the LGL1134 deletion |unction fragment, by making 
use of pjll or pJ59, will enable us to determine the extent 
of nonoverlap of several deletions in this region. The 
location of the X;13 translocation breakpoint just cen-
tromenc to the 45-kb LGL1134 deletion allows for an 
estimate of the minimal size of the TCD gene. On the 
basis of restriction analysis of the pJ59/pJll/pJ60 re­
gion, it must span at least 35 kb of genomic DNA. Em­
ploying the currently available set of DNA sequences 
from the TCD gene region, a search for evolutionanly 
conserved and expressed sequences is in progress, which 
should yield further insight into the molecular organi­
zation of this locus. 
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CHOROIDEREMIA (tapetochoroidal dystrophy, TCD), a com­
mon form of X-linked bUodncss', is characterized by progressive 
dystrophy of the choroid, retinal pigment epithelium and retina". 
•* 
FIG 1 Overlapping cDNA clones, their alignment with respect to genomic 
DNA fragments as well as deletion and translocation breakpoints in the 
Xq21 regran Top, the relative positions of the eight cDNAs shown were 
deduced from restriction enzyme mapping and sequence analysis Genuine 
exon sequences in cDNA inserts are represented by open boxes A-Ε denote 
distinct cDNA segments, each of which may be composed of several exons 
Vertical bars represent exon-exon boundaries as inferred from comparison 
with genomic DNA sequences (clones pJll and 398 for defining 5' and 3' 
borders of segment D. respectively) or from comparisons between different 
cDNAs (Tl. T5. T7. and T8 for both borders of segment С and the 3'-border 
of segmeilt A) The cross-hatched box at the 5' end of TS probably represents 
an intron sequence as a perfect splice acceptor splice site sequence13 was 
identified directly upstream of segment В in this done Four clones (T3, T4, 
T7 and T8) with truncated 3' ends probably originate from oligofdT) primed 
reverse transcription starting at a poly(A) stretch located just 3' of an 
internal Alu repeat, which is indicated by a boxed arrow Clones Tl and T5 
probably result from alternatively or aberrantly spliced precursor RNAs Both 
the segment lacking from T l (segment 0 and the extra stretch Identified 
at the 5' end of T5 (cross-hatched segment) feature genuine splice site 
signals13 at their borders Arrows In clones Tl and T6 indicate sequences 
that are reversed with respect to the sequence determined for the combined 
cONAs These reversed segments contain short Inverted repeats at their 
ends and probably originate from aberrant processing of stem-loop struc­
tures during reverse transcription of the mRNA Bottom, the consensus 
cDNA as deduced from eight cDNA clones is shown in relation to a partial 
genomic map of the corresponding chromosome segments Deletions are 
shown as horizontal bars between triangles The X-chromosomal lxeal<point 
in a female wltn a balanced t(X,13) translocation"5 is indicated The 
positions of the two longest ORFs In the cDNA are given The partial EcoPi 
Previous studies have assigned the TCD geae to a small segmeat 
of the Xq21 band4-'. By making use of reverse genetics strategies 
we have isolated eight overlapping complementary DNA clones 
from the same chromosomal region. The corresponding gene is 
expressed in retina, choroid and retinal pigment epithelium. The 
cDNAs encompass an open reading frame of 948 base pain that 
Is structurally altered in eight TCD patients with deletions, and 
la a female patient with a balanced translocation inralring Xq21. 
These findings provide strong evidence that we have cloned the 
gene underlying cborolderaemia. Elucidation of its function should 
provide new Insights Into the molecular mechanisms responsible 
for this disorder and other hereditary retinopathies. 
In previous studies we and others have shown that the TCD 
gene maps to an interval of the Xq21 band defined by the DNA 
markers DXS95, DXS165 and DXS2337 e. One of these loci, 
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map was constructed by Southern analysis of fcpRI-digested genomic DNA, 
and by restriction analysis of three recombinant phages (A 334, A 353 and 
A 365) The chromosomal origin as well as the telomere-centromere orienta­
tion of the cDNA segments A-Ε is indicated The outermost sections of the 
cDNA are homologous to £coRI fragments that are still unlinked to the 
central region of the genomic map 
METHODS Genomic DNA phage clones with human inserts were Isolated 
employing jump clones pJ60. pJll and pJ59 (see ref 5) using standard 
cloning methodology Phage 353 and 365 originated from a total human 
DNA genomic library In phage EMBL3 (courtesy of G Grosveld, Rotterdam). 
Phage 334 was Isolated from a pool of recombinant A DASH (Stratagene) 
phage containing 14 5 kb fèndili inserts enriched by preparative gel elec-
trophoresis (for methods, see ref 9) Plaque purification, DMA isolation, 
restriction enzyme mapping and subclonlng of phage-insert fragments into 
pGEM 3/4 plasmid vectors (Promega Bratec) was done according to standard 
recombinant DNA procedures23 Single-copy EcoRI inserts identified In Plas-
mids 398 and 413 were subsequently used as probes on zoo blots (see 
Fig 3a) and for screening a AgtlO human retinal cDNA library13. Phage 
recombinants (10°) were screened with a mixture of ^-labelled24 398 and 
413 insert DNAs using standard procedures23 Eight positive cDNA dones, 
T1-T8. were plaque-purified Insert DNA prepared from plate lysates of each 
of the eight recombinant phage was cleaved with fcoRI and subdoned in 
Plasmid pGEM4 Alignment of various cDNAs was based on restriction 
mapping using restriction enzymes Acc\. Bgm, fcoRI, Mndlll, Mool and Pst\ 
and on sequence analysis determination (see Fig. 2). The region between 
nucleotide positions 1 and 1000 shown at the top of the figure and a stretch 
of —250 nucleotides at the 3' ends were sequenced in all cDNA dones. 
Only for done T6 was the insert completely sequenced 
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DXS165, is deleted in several patients with classical TCD4'6. 
As a prerequisite for the molecular characterization of the TCD 
gene region, deletion-breakpoint cloning', preparative field 
inversion gel electrophoresis'0, and walking and jumping tech­
niques5" were used to generate new DNA markers near the 
DXS16S locus. Using these new markers, a genomic segment 
of approximately 45 kilobases (kb) which overlaps most of the 
TCD-associated deletions (Fig. 1) could be cloned. From this 
segment, IS single-copy sequences were isolated and screened 
for evolutionary conservation by hybridization to genomic DNA 
from various vertebrate species. With two of these DNAs, probes 
398and413 (Fig. 1), specific hybridization signals were obtained 
with DNAs from several species including chicken (Fig. 3a). 
On northern blots, probe 398 yielded distinct signals in RNAs 
from retina and retinal cell lines (not shown). Screening of a 
human retinal cDNA library12 resulted in the isolation of eight 
overlapping cDNA clones (T1-T8), which span a total of 4.S kb 
but do not contain the S' and 3' ends of the gene (Fig. 1). Clone 
T8 extends furthest upstream and contains an open reading 
frame (ORF) (Fig. 2a, ORFI) capable of encoding a polypeptide 
of 316 amino acids. Nuclease SI analysis indicated that the 
insert of this clone is fully protected by messenger RNA from 
a retinal cell line up to about SS nucleotides from its S' end 
(Fig. 26). The sequence immediately upstream of position 56 
(Fig. 2a; underlined) has a conspicuous resemblance to the 
consensus sequence for 3' splice sites13, which may indicate that 
these nucleotides originate from an intron extending further 
upstream. At position 61-63, there is a stop codon, and the first 
ATG codon of the ORF at position 127-129 may function as a 
translation start site14. 
None of the cDNA clones contains the poly(A) sequences 
normally indicative of the 3' end of mRNAs. The complete 
sequence deduced from the combined cDNAs (not shown) 
contains a strikingly large 3' untranslated region of 3.4 kb. In 
the middle of this region, starting at position 2,800 and adjacent 
to a sequence that could act as a 3' splice site, we have found 
an ORF spanning 395 base pairs (bp), (Fig. 1; ORFII). The 
functional significance of this sequence remains to be elucidated. 
To ascertain the relationship between the cloned cDNA and 
the TCD gene, genomic DNAs of eight patients with TCD who 
carried submioroscopie deletions of the Xq21 band3'6 were re­
examined with single-copy subclones of cDNA Tl. In all patients 
the deletions had removed at least part of the long ORF that 
spans segments A to E of the consensus cDNA (Figs 1 and 3b). 
In addition, we could locate the position of the X-chromosomal 
breakpoint of a l(X; 13) translocation previously identified in a 
female with typical signs of TCD 5 1 5 , to intron sequences that 
separate segments С and D of the cDNA (Fig. 3c). In combina­
tion, these data provide strong evidence that the cloned cDNA 
is indeed part of the choroideraemia gene. 
RNA analyses have corroborated this conclusion. In 
choroid/retinal pigment epithelium, retina, two retinal cell lines 
(HER XC2 and HER RC2; ref. 16), and HeLa cells, all eight 
cDNA clones hybridize to an mRNA transcript of ~5,400 
residues (Fig. 4a). Surprisingly, this mRNA is also expressed 
in Epstein-Barr virus-immortalized В cells, albeit at a sig­
nificantly lower level. This finding enabled us to study mRNA 
patterns in patients with deletions of various size and should 
pave the way for the detection of point mutations in the TCD 
gene. As shown in Fig. 46, with a probe from the S' end of the 
cDN A (TI EO.S), no hybridization signals were seen on northern 
blots containing RNAs from lymphoblastoid cell lines of TCD 
patients 7.6 and 2S.6. This is not unexpected as both deletions 
span the entire gene. In contrast, patient 3.5, who lacks the 3' 
end of the gene, shows aberrant transcripts of about 4.5 and 
5.5 kb. In this patient, two different novel sites may be used as 
polyadenylation signals. 
Neither the nucleotide nor the predicted amino-acid sequence 
of the putative gene product revealed any significant homology 
to genes or protein sequences in the NBRF (December 1989), 
Swiss-Prot (January 1990) and EMBL (April 1990) databases. 
The protein carries potential phosphorylation sites for protein 
kinase С (residues 76, 122, 175,178, 301) and for casein kinase 
(residues 13, 129, 178, 195, 239, 301), but no other sites associ­
ated with post-translational modification processes. Moreover, 
no topogenic sequences, no domains with known biological 
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FIG. 2 Structure of the candidate TCO cDNA a 
Nucleotide sequence of the region containing the 
largest ORF and the deduced amino-acid sequence 
of the corresponding protein The DNA sequence 
was derived through combination of several с DNAs 
and overlaps the ORF indicated in Fig 1 Upper 
line, nucleotide sequence, lower line, amino-acid 
sequence (single-letter code) beginning at the 
putative methionine initiation codon (see text) A 
putative 3' splice site is underlined- Asterisks 
indicate stop codons b. Nuclease S I protection 
assay using a fragment of clone T8 Lane 1 , marker 
DNA is Plasmid pGEM4 digested with Haelll, 
dephosphatased, and end-labelled with [y-
^ P I A T P Lane 2. hybridization of the 5' end of 
cDNA done T8 to HER Xc2 mRNA, followed by 
nuclease S I digestion, resulted in a protected DNA 
fragment of - 2 7 1 nucleotides 
METHODS a. Inserts of cDNA phage T1-T8 (Fig 
1) were cleaved with restriction enzymes and the 
resulting fragments were recloned on ligation into 
the appropriate sites of the polylinker sequence 
of Plasmid pGEM4 (Promega Brotec) Both strands 
of the relevant plasmid DNAs were sequenced 
with T7 or SP6 sequencing primers (Promega Biotec) following the pro­
cedures of Hattori and Sakaki 2 ' b. A 330-nucleotide EcoRI-ffsal fragment 
from clone T8 was 5' end-labelled with [ y-3 2PlATP using T4 polynucleotide 
lunase, hybridized with 2 5 ^ g total HER XC2 RNA1 6 in 1 0 μΙ PIPES-
f o r m a m i d e 2 " 6 at 4 2 X for 2 0 h before digestion with S I nuclease2 6 
Sl-resistant DNA fragments were resolved m a 6 % (w/v) acrylamide-urea 
gel, autoradiography was for 4 days with one intensifying screen Arrow 
indicates position of a 330-base fragment, corresponding to the size of the 
full-length probe 
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function and no enzymatic active sites could be determined 
using the PCCene PROSITE program. The C-termina! portion 
of the protein between residues 253 and 302 carries a so-called 
PEST region (PEST score of 7.3 according to Rogers er at1 7). 
Proteins containing one or more PEST regions often exhibit 
intracellular half lives of less than 2 h, and several of these, such 
as Fos, Мус and EIA, are important transcriptional regu-
lators17·,8. 
Recently, photoreceptor-specific genes have been implicated 
in autosomal dominant retinitis pigmentosa" and two different 
forms of retinal degeneration of the mouse20·21. It is of note, 
therefore, that the expression of the putative TCD gene is not 
confined to the eye. This finding is not unprecedented, however. 
For example, gyrate atrophy, a choroidal disease with clinical 
similarity to TCD, is caused by a deficiency of an ubiquitously 
expressed protein, the enzyme ornithine aminotransferase22. By 
analogy, this may indicate that TCD also is due to a generalized 
л Х« 
LCL 
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kb 
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FIG. 3 Southern blot analysis of genomic and cDNA clones a, A mixture of 
single-copy probes 413 (0 5 kb fcoRI) and 398 (1.0 kb EcoRI) shows cross-
species homology to DMAs of various mammals, and to chicken, b. Probes 
T1E0.5 (segments A and B: see Fig 1) and T1EN06 (segment D and part 
of segment E, see Fig 11 detect deletions in male patients with TCD Deletions 
in patients 7 6 and 25 6 span all cloned exons from the putative TCD cDNA 
In the DNA of patient 3 5, the fcoRI bands of 26,1.0/1.6. and 7.0 kb are 
deleted The 1 6 kb EcoRI fragment contains only 27 bp of segment D, and 
Is therefore not Identified with probe UENO 6 Deletion LGL1134 spans 
segments В and С deletions LGL1101 and 33.1 merely span segment A. 
с The human-hamster cell hybrid Clll-l contains the der(13) chromosome 
from a female with a balanced t(X; 13) translocation associated with TCD"5. 
This cell line, which contains the Xq21 2-qter part of the human X chromo­
some, carnes all genomic fragments detected by done T1E0.5, and lacks 
the two EcoRI fragments detected by T1EN0.6. The 4.5-kb EcoRI band In 
control male DNA (control) Is represented by a polymorphic variant of 4.2 kb 
In cell line Clll-l, which (»migrates with a hamster band (triangle; F.P.M.C., 
unpublished results) The extra fragments detected by T1E0 5 In Clll-l DNA 
are hamster-specific (see asterisks). 
METHODS Genomic DMAs (10 μg of each) were digested with EcoRI The 
fragments were subjected to electrophoresis and blotted to GeneScreenPlus 
(NEN) as described7 Isolation and radiolabelling of plasmld inserts was done 
as described24 The blot in a was hybridized In 0 5M NaH2P04 pH6 8, 7% (w/v) SOS, 1 mM EDTA. 50 μg m l - 1 sonicated, denatured herring sperm DNA, 
at 50 °C, tor 18 h. Washing was in 40 mM NaH2P04,196 (w/v) SOS at 60 °C 
for 1 h. The hybridization and washing procedures for b and с have been 
published elsewhere7 
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FIG. 4 Northern blot analysis of RNA from several human cell lines and 
tissues using cDNA done T l . a. Blot containing RNA from HeLa, two retinal 
cell lines (HER RC2 and HER XC2; ref 16). an EBV-lmmortalized lymphoblas-
toid cell line (LCL1154), as well as human choroid/retmal pigment epithelium 
and retina, b. Blot containing RNA from lymphoblastoid cell lines from patients 
with different microdeletions encompassing the TCD locus (Fig. 1, and ref s 
5 and 6), and from two male controls (LCU.148 and LCL1154) с d. Hybridiz­
ation of a hamster actln cDNA done (pAct-l, ref 27) to the same blots as 
In a and b, respectively. The positions of the 18S and 28S ribosomal RNA 
bands are indicated. 
METHODS Total cellular RNA was isolated from cells and tissues using the 
modified UCI-urea extraction procedure2829 Approximately 10 μg of RNA 
was dissolved In 30 μΙ of 50% (v/v) formamide, 2 2 M formaldehyde, 20 mM 
MOPS, pH 7.0 buffer (4-morpholine-propanesulphonic acid. 5 mM Na-acetate, 
1 mM EDTA), loaded onto a 1 % agarose gel containing 2 2 M formaldehyde 
In 20 mM MOPS buffer, and resolved by electrophoresis at 1V c m " 1 for 
16 h. The gel was rinsed extensively with sterile water for 15 min and RNA 
blotted to a GeneScreenPlus membrane (NEN) in 10 xSSC. After baking for 
2 h at 80 °C, blots were hybridized with random-primed probes Prehybridiz-
ation and hybridization was done m SxSSFE, 10% (w/v) dextransulphate. 
1 % (w/v) SOS, and 100 tig m l " 1 sonicated, denatured herring sperm DNA 
at 60 °C for 4 and 16 h respectively Washing was done at the same 
temperature in 2 xSSC, 1 % (w/v) SOS for 40 mm. 
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metabolic defect As this is the first candidate gene for any of 
the X-hnked forms of chorioretinal degeneration, elucidation 
of its structure and function may provide deeper insight into 
the molecular mechanisms underlying degenerative process« 
of the retina, retinal pigment epithelium and choroid. G 
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Chapter 10 
General discussion and outlook 

GENERAL DISCUSSION AND OUTLOOK 
10.1 Χα21 deletion syndromes: correlation of molecular and 
clinical features reveals inconsistencies 
Characterization of several male-viable duplications and 
deletions with 52 random DNA probes has enabled us to refine 
the molecular map of the Xcen-q22 region. Almost all of the 
deletions spanning part of Xg21 are associated with 
choroideremia and mental retardation, with deafness being 
another common feature. Through correlation of clinical and 
molecular findings, the gene loci for these diseases could be 
assigned to specific chromosomal intervals, but these studies 
did not resolve a number of inconsistencies between the 
genotype and the phenotype of these patients. 
Molecular characterization of patients with complex and 
classical TCD by using anonymous DNA probes (chapter 3) 
assigned the TCD gene to interval 3 of Xq21 (chapter 3: fig. 
1). On the basis of this assignment a likely candidate gene for 
TCD could be isolated that is expressed in choroid and retina 
(chapter 9). It is surprising therefore, that clinical symptoms 
of TCD are lacking in the patient with the largest deletion of 
all which spans almost the whole Xg21 band (patient RvD; 
chapter 3). We assume that the absence of ocular signs in this 
patient is due to his young age of only 10 years at the time of 
the most recent examination. In TCD, the first characteristic 
symptom i.e. night blindness, may become apparent between 3 to 
40 years of age (Rubin et al. 1966). Though fundus changes may 
precede clinical symptoms by a number of years, normal fundi 
have been reported for several young male carriers of the TCD 
gene (Kärnä 1986). 
Deletions spanning interval 2 are associated with different 
types of deafness. There is one patient (NP) however, who is 
not deaf in spite of his large deletion encompassing intervals 
1 through 6. Thus, it appears that deletion of interval 2 
predisposes for, but does not necessarily cause, hearing 
impairment. Patient XL45 shows congenital mixed, i.e., 
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conductive and sensorineural, deafness with stapes fixation, 
whereas the deafness in patients RvD, XL62 and DM is of the 
sensorineural type. Whether this clinical variability is due to 
the presence of more than one gene in interval 2 must await the 
identification of the underlying gene defect(s). Additional 
proof for the presence of a deafness gene in this chromosomal 
region has come from linkage studies performed by Brunner and 
coworkers (1988) and Wallis and coworkers (1988) employing PGK1 
and DXYS1, respectively, as genetic markers. Close linkage was 
established between both markers and a gene underlying a mixed 
type of deafness with stapes fixation. 
Sex-linked mental retardation (MR) has been found in 
approximately 1 out of 1000 males (Opitz 1986). Fra(X) accounts 
for about 40% of XL-MR; 60% of cases can be attributed to non-
fra (X) or non-specific MR (Mikkelsen 1987). MR is also a common 
feature in a large number of clinically complex X-linked 
syndromes, including those that are associated with TCD and 
microscopically visible deletions at Xg21. A locus for MR can 
be assigned to interval 2 and/or interval 3 of the Xg21 band, 
depending on the interpretation of the clinical findings of 
patient MBU (Hodgson et al. 1987; chapter 3). Additional 
information has come from a patient with classical TCD, who 
showed normal intelligence, in spite of the presence of a 
deletion extending from interval 2 to interval 5 (chapter 8; 
patient IiGL2905). This finding excludes a locus for MR from 
interval 3, and narrows its location to the proximal part of 
interval 2. Linkage analyses, performed by others in large 
families with MR have provided additional evidence for the 
presence of a gene for MR in the Xgl3-q21 region, but these 
studies have failed to define the location of the gene(s) more 
precisely (Sutherland et al. 1987; Chudley et al. 1988; 
Schwartz et al. 1990; H. Brunner, personal communication). 
Alternatively, the variable manifestation of MR and 
deafness in patients with Xg21 deletions could be due to 
position effects (Henikoff 1990, and references therein) if 
both relevant genes are not located within but close to the 
Xq21 deletions. Their expression might be influenced by changes 
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in the higher order chromatin structure secondary to the 
repositioning of inactive chromatin blocks. Also, the 
expression of genes located near the deletions could be 
disrupted through the influence of silencers that have been 
positioned nearby, or by the loss of enhancer elements (Orkin 
1990). 
10.2 Implications and prospects for diagnosis of TCP 
Detection of deletions and point mutations 
Employing the candidate TCD cDNA as a probe, we have identified 
deletions in 10 out of 80 TCD patients (chapter 8 and 
unpublished results). For several of these deletions, one of 
the breakpoints has been identified by conventional gel 
electrophoresis and Southern analysis, and in other deletions 
the breakpoints could be identified using PFG electrophoresis. 
In families where these molecular data are available, 
absolutely reliable carrier detection is possible. In the 
remaining 7 0 patients no structural abnormalities could be 
detected using conventional Southern analysis. Here, diagnostic 
identification of the underlying mutation will require 
screening of the entire protein coding region, as well as the 
transcriptional control regions and the intron-exon boundaries 
of the TCD gene. Northern blotting experiments have indicated 
that the expression of the putative TCD gene is not confined to 
the retina and choroid, but includes, HeLa cells and 
lymphoblastoid cell lines, albeit at a lower level. This 
finding will enable us to study some of the specific regulatory 
features associated with the expression of the gene. 
Preliminary results employing RNA blotting of lymphoblastoid 
cell lines from patients with TCD that show no gross structural 
abnormalities at the DNA level, have indicated that in several 
patients, there is little or no transcription of the candidate 
TCD gene. Whether these findings result from promoter mutations 
influencing the expression of the gene, splice mutations 
preventing correct transport into the cytoplasm, or mutations 
altering the stability of the transcript, remains to be 
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elucidated. In order to identify and characterize small 
structural mutations, two approaches will be used, depending on 
the transcriptional pattern. Firstly, for those patients that 
show transcripts of normal size and abundance in EBV 
immortalized B-cells, the protein-coding region can be studied 
after first strand cDNA synthesis and subsequent PCR 
amplification. These cDNA products can be subjected to the 
chemical mismatch cleavage procedure (Grompe et al. 1989; 
Cotton et al. 1989), followed by sequence analysis of the 
region of interest. Alternatively, the ORF is subcloned into a 
Plasmid vector following amplification and subjected to 
sequence analysis. Secondly, patients that show no, or 
aberrant, transcripts in EBV-lines can be investigated for 
mutations in their genomic DNA by amplification of exons of the 
gene. For this, all exon-intron boundaries must be subcloned 
and the sequences flanking the exons must be determined. 
Following amplification, the PCR products will be rapidly 
screened employing a recently developed technique based on 
single-strand conformation polymorphism (SSCP; Orita et al. 
1989a,b). Aberrant PCR products will be subcloned into a 
Plasmid vector and studied at the nucleotide level, or 
sequenced directly. 
By employing both approaches simultaneously, it should be 
possible to identify nearly all mutations underlying the 
disease. As many patients belong to large families, 
particularly from Finland and Canada, identification of the 
underlying mutations should have a considerable impact on 
diagnosis. 
Linkage analysis 
Until direct mutation detection is feasible, presymptomatic 
diagnosis and carrier detection will have to rely on family 
studies and the use of closely linked markers. Our studies have 
resulted in the identification of RFLPs which are positioned 
in, or very close to the candidate TCD gene. pZ172 shows an 
EcoRI polymorphism at a maximal distance of 250 kb centromeric 
to the gene; pZll shows RFLPs for EcoRI. EcoRV. and Mspl 
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(chapter 6 and unpublished results). One of the MSPI alleles is 
also identified by the 5' part of the candidate TCD cDNA. 
Moreover, preliminary data obtained by analysing a recently 
identified deletion indicates that pZll is located inside the 
candidate TCD gene. In addition, rare PstI restriction patterns 
have been detected with pJ15 and pJ60 in three English TCD 
families, but not in approximately 40 normal individuals. pJ15 
maps very closely but centromeric to the TCD gene; pJ60 is 
located in the middle of the gene (F.P.M.C., unpublished data). 
Deletion analysis has enabled us to order all closely linked 
polymorpic probes from the Xq21 band that flank the TCD gene: 
Xcen-pX65H7-pCHl-pZ172-(TCD,pZll)-pXG7c-pDP34-qter. 
pZll has been employed in linkage studies in Finnish TCD 
families; so far no recombination between this marker and the 
disease gene has been observed (z^ = 15.6; E.-M. Sankila, 
personal communication). 
10.3 Outlook: study of structure-function relationships for 
the candidate TCD gene 
As discussed in chapter 9, searches in nucleotide and amino 
acid data banks have not yet revealed homologies with 
previously cloned genes, and no conspicuous features like zinc 
fingers, leucine zippers, or transmembrane segments could be 
detected so far. However, the polypeptide contains a so-called 
PEST sequence which is characterized by a high concentration of 
the amino acids proline, glutamic acid, serine, and threonine, 
and has been associated with rapid protein turn-over (Rogers et 
al. 1986). This may indicate that the putative TCD gene product 
plays a role in the regulation of gene expression. 
Future efforts to elucidate the function of the candidate 
TCD gene, and to obtain formal proof for its identity, will 
concentrate on the in vitro synthesis of its gene product, and 
on the generation of specific antibodies (Marston et al. 1986, 
and references therein). These will enable us to study the 
tissue-specific expression of this gene, as well as the 
subcellular distribution of its gene product. 
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Secondly, we will try to develop a mouse model for TCD by 
making use of recently developed embryonic stem cell and gene 
targeting technologies (Smithies et al. 1985; Thomas and 
Capecchi 1987). Embryological and histochemical studies of 
chimaeric, heterozygous and hemizygous mutant mice may enable 
us to gain new insights into the pathogenesis of TCD and 
related disorders. As a prerequisite for these studies, we have 
recently cloned part of the murine TCD gene (T.J.R van de Pol 
et al., unpublished results), the molecular characterization of 
which is in progress. 
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SUMMARY 
The initial aim of this study was the identification and 
characterization of deletions associated with X-linked 
contiguous gene syndromes. Employing approximately 200 random 
DNA probes from the X-chromosome, several male patients with 
complex syndromes were investigated, the majority of which 
showed structural abnormalities in the proximal long arm of the 
X-chromosome. Both duplications and deletions were 
characterized by 52 DNA probes, which enabled us to construct a 
detailed physical map of the Xcen-q22 region (chapter 2). With 
one exception, the deletions spanning part of Xq21 are 
associated with TCD and MR, with deafness being another common 
feature. The gene locus for TCD was assigned to the interval 
spanning the loci DXS95, DXS165, and DXS233. Genes for X-linked 
deafness and MR were tentatively assigned to the interval 
defined by the loci DXS121 and DXS232 (chapter 3). By employing 
probes from the TCD interval, two submicroscopic deletions were 
identified in patients with non-syndromic TCD which spanned the 
DXS165 (plbD5) locus, but none of the other markers from Xq21 
(chapter 4). 
The chromosomal region near DXS165 was saturated with new 
markers employing several cloning strategies simultaneously. 
Successive chromosomal walking and jumping resulted in the 
isolation of 5 new markers in the vicinity of DXS165, and the 
identification of two additional deletions in patients with 
classical TCD. With these clones we could localize four of the 
eight deletion endpoints and the breakpoint on the X-chromosome 
of a female with a de novo X/13 translocation and TCD (chapter 
5). In addition, we constructed a lambdaZAP library highly 
enriched for sequences from the TCD locus by making use of 
preparative FIGE. From a 625 kb Sf il fragment known to carry 
(part of) the TCD gene, 7 clones were isolated. One of these 
clones, pZll, apart from being located inside the gene, proved 
to be polymorphic for three enzymes (chapter 6 and unpublished 
results). Finally, a deletion junction clone was isolated which 
yielded a new marker that is most likely located telomeric to 
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the TCD gene (chapter 7). 
Employing all new probes from the TCD locus we could 
identify 8 deletions in 69 patients with TCD, and narrow down 
the position of part of the TCD gene to a DNA segment of 15-20 
kbp (chapter 8). A total of 45 kb of genomic DNA spanning this 
region was cloned into lambda phage vectors. From this segment, 
15 single or low copy sequences were isolated and screened for 
evolutionary conservation. With two of these DNAs, specific 
hybridisation signals were obtained with DNAs from several 
vertebrate species, including chicken. Screening of a human 
retinal cDNA library resulted in the isolation of eight 
overlapping cDNA clones, that span 4.5 kb, but do not contain 
the 5' and 3' ends of the cDNA. The corresponding gene is not 
only expressed in retina, choroid and RPE, and two retinal cell 
lines, but also in HeLa cells and EBV immortalised В cells. The 
cDNAs encompass an open reading frame of 948 bp which is 
structurally altered in 8 TCD patients with deletions and in a 
female with a balanced translocation involving Xq21. These 
findings provide strong evidence that we have cloned the gene 
underlying choroideremia. Neither the nucleotide sequence nor 
the predicted amino acid sequence of the putative gene product 
revealed any significant homology to genes or protein sequences 
in NBRF (december 1989), Swiss-Prot (January 1990) and EMBL 
(april 1990) databases. No topogenic sequences, no domains with 
known biological function and no enzymatic active sites could 
be determined using the PCGene PROSITE program (chapter 9). 
Elucidation of the function of the putative TCD protein should 
provide new insights into the molecular mechanisms underlying 
this disorder and other hereditary retinopathies. Strategies 
for these types of studies are proposed (chapter 10). 
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SAMENVATTING 
Het primaire doel van deze studie was de identificatie en 
moleculaire karakterisatie van deleties die geassocieerd zijn 
met complexe X-gebonden syndromen. Gebruik makend van ongeveer 
200 DNA sequenties die willekeurig over het X-chromosoom 
verspreid liggen, werden diverse mannelijke patiënten met 
complexe syndromen bestudeerd. De meeste hiervan vertoonden 
structurele afwijkingen in het proximale gedeelte van de lange 
arm van het X-chromosoom. Interstitiële duplicaties en deleties 
werden gekarakteriseerd m.b.v. 52 DNA sequenties, waardoor wij 
in staat waren een nauwkeurige fysische kaart van het Xcen-q22 
gebied te construeren (hoofdstuk 2). Het fenotype geassocieerd 
met Xq21 deleties bestaat (met één uitzondering) uit TCD en MR, 
en dikwijls ook uit doofheid. Het gen locus voor TCD werd 
toegewezen aan interval 3, hetgeen de loei DXS95, DXS165, en 
DXS233 omvat. Genen voor X-gebonden doofheid en MR werden 
voorlopig toegewezen aan interval 2, gedefinieerd door de loei 
DXS121 en DXS232 (hoofdstuk 3). Gebruik makend van DNA 
sequenties van interval 3 konden twee submicroscopische 
deleties gevonden worden in patiënten met niet-syndromische 
TCD. Deze deleties omvatten het DXS165 (plbD5) locus, maar geen 
van de andere markers van Xq21 omvatten (hoofdstuk 4). 
Het chromosomale gebied rondom plbD5 werd verzadigd met 
nieuwe DNA markers door gebruik te maken van diverse 
kloneringstechnieken. Chromosoom walking en jumping resulteerde 
in de isolatie van 5 nieuwe markers nabij plbDS, en de 
identificatie van twee additionele deleties in patiënten met 
klassieke TCD. Met deze DNA sequenties konden wij 4 van de 8 
deletie-breekpunten en een breekpunt op het X-chromosoom van 
een vrouw met een de novo X/13 translokatie en TCD lokaliseren 
(hoofdstuk 5). Verder hebben wij een lambdaZAF DNA bibliotheek 
geconstrueerd die sterk verrijkt was voor sequenties van het 
TCD locus door gebruik te maken van préparâtieve FIGE. Van een 
625 kb Sfil fragment, waarvan bekend was dat een deel van het 
TCD gen zich er op moest bevinden, werden 7 DNA sequenties 
geïsoleerd. Een van deze sequenties, pZll, bleek niet alleen 
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gelokaliseerd te zijn in het TCD gen, maar vertoonde ook RFLPs 
m.b.v. drie enzymen (hoofdstuk б en niet gepubliceerde 
resultaten). Tenslotte werd er een DNA fragment geïsoleerd die 
sequenties bevat welke flankeren aan een microdeletie, hetgeen 
een nieuwe DNA marker aan de telomere zijde van het gen 
opleverde. Door vervolgens gebruik te maken van alle nieuwe DNA 
sequenties van het TCD locus hebben wij 8 deleties gevonden in 
69 patiënten met TCD, en kon de positie van een deel van het 
gen gelokaliseerd worden binnen een DNA segment van 15-20 kb 
(hoofdstuk 8). 
Een gebied van 45 kb genomisch DNA die dit segment bevat 
werd gekloneerd in faag lambda vectoren. Van dit segment werden 
in totaal 15 unieke of laag-repetitieve sequenties geïsoleerd 
en getest op evolutionaire conservering. Met twee van deze 
sequenties werden specifieke hybridisatie signalen verkregen 
met DNAs van diverse vertebraten, waaronder de kip. Screening 
van een humane cDNA bibliotheek resulteerde in de isolatie van 
8 overlappende cDNAs die samen een consensus vormen van 4.5 kb. 
Dit stuk bevat echter niet de uiterste 5' en 3' delen van het 
cDNA. Het corresponderende gen komt niet alleen tot expressie 
in retina, choroid en RPE, en twee retinale cellijnen, maar ook 
in HeLa cellen en EBV geimmortaliseerde В cellen. In de cDNAs 
zit een open leesraam van 948 baseparen dat structureel 
veranderd is in 8 TCD patiënten met deleties en in een vrouw 
met een gebalanceerde translokatie met een breekpunt in Xq21. 
Deze bevindingen maken het zeer aannemelijk dat we het gen 
betrokken bij TCD gekloneerd hebben. Zowel de nucleotiden als 
de daarmee corresponderende aminozuur volgorde vertoonden geen 
significante homologie met genen of eiwitten die verzameld zijn 
in de NBRF (december 1989), Swiss-Prot (januari 1990) en EMBL 
(april 1990) databanken. M.b.v. het PCGene PROSITE programma 
konden geen topogene domeinen, geen domeinen met bekende 
biologische funkties en geen enzym-actieve posities in het 
eiwit gevonden worden (hoofdstuk 9). Opheldering van de funktie 
van het TCD eiwit kan nieuwe inzichten verschaffen in de 
moleculaire mechanismen die aan chorioderemie en andere 
erfelijke retinopathieën ten grondslag liggen. 
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EENVOUDIGER GEZEGD 
In het menselijke oog worden een drietal lagen onderscheiden 
die betrokken zijn bij het zien. In één van deze lagen, het 
netvlies, wordt het licht opgevangen, omgezet in een electrisch 
stroompje, en doorgegeven naar de hersenen. De andere twee 
lagen zorgen voor het goed functioneren van het netvlies door 
o.a. "afvalstoffen" te verwerken en "brandstof" aan te leveren. 
De drie hierboven genoemde lagen zijn opgebouwd uit hele kleine 
eenheden, de cellen. Een cel kan men zich voorstellen als een 
zak met vloeistof waarin zich allerlei eiwitten bevinden. De 
aard van deze eiwitten, hun plaats en funktie, wordt bepaald 
door een soort regelcentrum dat zich middenin de cel bevindt. 
In dit regelcentrum, ook wel de kern genoemd, ligt alle 
erfelijke informatie opgeslagen in de vorm van DNA, verdeeld 
over 46 chromosomen. In dit DNA bevinden zich ongeveer 100.000 
pakketjes informatie, de zogenaamde genen. Elk pakketje 
informatie of gen bevat de "blauwdruk" voor een van de eiwitten 
die zich in de cel bevinden. Indien er met een van de genen 
iets mis is, kan er sprake zijn van een erfelijke ziekte, want 
het "defecte" gen kan dan worden doorgegeven aan nakomelingen. 
In dit proefschrift staat een erfelijke oogziekte, genaamd 
choroideremie, centraal. Deze ziekte geeft bij mannen eerst 
aanleiding tot slecht zien gedurende de nacht, en verergert 
zich langzaam tot totale blindheid. Toen wij met onze studie 
begonnen was niet bekend welk gen verantwoordelijk was voor 
deze ziekte. Voor de meeste erfelijke ziektes is het heel 
moeilijk te achterhalen, welke van de 100.000 genen defect is. 
Wij wisten wel dat het gen zich op het X-chromosoom, een van de 
geslachts-chromosomen, moest bevinden. Ook werd onze speurtocht 
vergemakkelijkt door de bevinding dat bij een deel van de 
choroideremie patiënten het betrokken gen geheel of 
gedeeltelijk afwezig was. Door uit normale individuen de 
ontbrekende stukken gen te identificeren, kon uiteindelijk het 
"normale" gen relatief snel gevonden en nauwkeurig bestudeerd 
worden. 
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Wat is nu het nut van dergelijk onderzoek? De hierboven 
genoemde oogziekte komt relatief zelden voor, maar maakt deel 
uit van een grotere groep erfelijke oogziektes waarvan de 
oorzaken nagenoeg onbekend zijn. De opheldering van de 
oogziekte choroideremie kan ons dus mogelijk meer inzicht 
verschaffen in het onstaan van vergelijkbare ziektes. Of dit in 
de toekomst kan leiden tot een bepaalde vorm van behandeling, 
is moeilijk te voorspellen. Hiervoor zal nog veel onderzoek met 
betrekking tot de funktie van het betreffende eiwit nodig zijn. 
In ieder geval kan er in families waarin deze ziekte voorkomt 
nu bekeken worden welke personen "drager" zijn van de ziekte, 
en welke niet. Dit zal de erfelijkheidsadvisering een stuk 
betrouwbaarder maken. Mijn onderzoek kan tevens een wezenlijke 
bijdrage leveren aan de fundamentele kennis omtrent tot dusver 
nog totaal onbegrepen processen die betrokken zijn bij de 
werking van het netvlies en vaatvlies van het oog. 
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Stellingen 
I 
Choroideremie komt als gevolg van Xq21 deleties niet alleen 
voor als onderdeel van een complex syndroom in combinatie met 
doofheid en mentale retardatie, maar ook als een geïsoleerde 
aandoening. Dit doet vermoeden dat ook X-gebonden doofheid en 
mentale retardatie afzonderlijk veroorzaakt kunnen worden door 
microdeleties in Xq21. 
Dit proefschrift. 
Il 
Gezien het ogenschijnlijk gering aantal genen in Xq21 lijkt 
een complete opheldering van de nucleotidenvolgorde van dit 
chromosomale segment in het kader van het Humane Genoom analy-
se project weinig zinvol. 
III 
De identificatie van mutaties in het staafjespigment rhodopsi-
ne in patiënten met een autosomale vorm van retinitis pigmen-
tosa maakt het aannemelijk dat mutaties in kegeltjespigmenten 
eveneens verantwoordelijk kunnen zijn voor retinale dystro-
fiëen. 
IV 
In tegenstelling tot de meeste auto-immuunziektes vinden 
spondyloarthopathiëen hun belangrijkste oorzaak in de expres-
sie van een specifiek HLA-antigen. 
Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD (1990) 
Cell 63, 1099-1112. 
V 
De conclusies aangaande de identificatie van glyceringsplaat-
sen in α-, ß-, en 7-crystallines van lenzen afkomstig van 
diabete ratten lijken ongefundeerd aangezien de getoonde 
aminozuur samenstellingen van de peptides identiek blijken te 
zijn met runder-, i.p.v. met ratte o-, ß-, en γ-crystallines. 
Abraham EC, Perry RE, Abraham A, Swamy MS (1991) Exp. Eye Res. 
52, 107-112. 
VI 
Door hun snelle opeenvolging en door ondeskundig gebruik 
schieten nieuwe, "verbeterde", versies van tekstverwerkings­
programma 's hun doel vaak voorbij. 
VII 
Om te voorkomen dat belangrijke berichten verloren gaan tussen 
de talrijke faxen kan men ze beter per post versturen. 
VIII 
Een algemeen verbod op het gebruik van de auto voor woon-verk 
verkeer binnen een afstand van 10 km zou zowel de gezondheid 
van de mens als het milieu dienen. 
IX 
De materialen- en middelenbudgetten ten behoeve van moleculair 
genetisch onderzoek ontwikkelen zich omgekeerd evenredig aan 
de gestegen kosten. 
Nijmegen, 18 april 1991 
Frans cremers 


